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GLUT4 mobilisation involves endocytic and exocytic processes that are 
profoundly enhanced by insulin. Insulin indirectly mediates GLUT4 sorting into 
storage or recycling pools via endosomal trafficking proteins and 
phosphoinositides. The Endosomal Sorting Complex Required for Transport 
(ESCRT) machinery is involved in the endosomal sorting of ubiquitinated and 
phosphoinositide regulated cargo into subcellular pools. The findings in this thesis 
implicate the involvement of the ESCRT machinery in sorting ubiquitinated 
GLUT4 to direct it to its specialised storage compartment. Overexpression of 
ESCRT-III dominant negative constructs (CHMP3 1-179 and Vps4 E235Q) in rat 
adipocytes led to accumulation of GLUT4 in enlarged compartments. 
Consequently, GLUT4 seems to be trapped in the enlarged compartment and 
prevented from sorting to storage and recycling pools. The enlarged GLUT4 
containing compartment was positive for early endosomal and TGN-associated 
markers, suggesting that it is a hybrid compartment formed during ESCRT-III- 
dependent sorting of GLUT4 into other subcellular pools. 
 
Once sorted into its specialised storage compartment, GLUT4 movement to the 
plasma membrane requires exocytic proteins involved in vesicle translocation, 
tethering, docking and fusion. The study described in this thesis aimed to 
characterise the involvement of Rab3B as a potential regulator of GLUT4 
exocytosis. Rab3B was identified as an insulin-responsive Rab that regulated 
GLUT4 trafficking. Overexpression of the constitutively active Rab3B construct 
led to an increase in cell surface GLUT4 in basal rat adipocytes compared to the 
wild type or dominant negative Rab3B constructs. Noc2 was explored as a 
potential Rab3B effector due to its known involvement in Rab3-mediated 
trafficking in other vesicular trafficking processes. Noc2 showed reduced 
interaction with Rab3B in insulin-treated adipocytes and the overexpression of 
wild type Noc2 in adipocytes led to a reduction in cell surface GLUT4 upon insulin 
stimulation. It was concluded that Noc2 has an inhibitory effect on Rab3B action 
in GLUT4 exocytosis.  
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The findings in this thesis uncover novel signalling and trafficking pathways that 
are important in regulating cell surface levels of GLUT4 in response to insulin. 
The proteins described in this thesis were shown to influence GLUT4 mobilisation 
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AAA ATPases associated with diverse cellular activities 
AIP1 Actin interacting protein 1 
AMSH Associated molecule with the SH3 domain of STAM 
AP Adaptor protein 
APS Ammonium persulfate 
APS Adaptor protein with pleckstrin homology and Src 
homology 2 domains 
 
AS160  Akt substrate of 160 kDa  
ATP Adenosine 5’-triphosphate 
BCA Bicinchoninic acid 
Bro1 domain Baculovirus repeated open reading frames 
BSA Bovine serum albumin 
C-terminus Carboxy-terminal region 
cDNA Complementary DNA 
CDR Complementarity determining region 
CHMP Charged multivesicular body protein 
COPI/II Coat protein I/II 
Ct Threshold cycle 
Daxx Death domain-associated protein 
ddH2O Double-distilled water 






Dulbeco’s modified Eagle’s medium 
Doa4 Degradation of alpha 4 
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Doc2b Double C2-like domain-containing protein beta 
DTT Dithiothreitol 
DUB Deubiquitinase 
EAP20 ELL-associated protein of 20 kDa 
ECL Enhanced chemiluminescence 
E.coli Escherichia coli 
EDL Extensor digitorum longus 
EDTA Diaminoethanetetraacetic acid disodium salt 
EEA1 Early endosome antigen 1 
EGFP Enhanced green fluorescent protein 
EM Electron microscopy 
ERK Extracellular-signal-regulated kinase 
ESCRT Endosomal Sorting Complex Required for Transport 
FDB Flexor digitorum brevis 
FDG Fluorescein di-β-D-galactopyranoside 
FYVE Fab1p, YOTB, Vac1p and EEA1 
GAP GTPase activating protein 
GDI GDP dissociation inhibitor 
GDF GDI-displacement factor 
GDP Guanosine diphosphate  
GEF GDP/GTP exchange factor 
GGA Golgi-localized, gamma adaptin ear-containing, Arf-
binding 
 
GGT Geranylgeranyl transferase 
GLUE domain GRAM-like ubiquitin-binding in EAP45 
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GLUT Glucose transporter 
GLUT4 Glucose transporter 4 
GRP Glucose-regulated protein 
GSV GLUT4 storage vesicle 
GST Glutatione S-transferase 
GTP Guanosine triphosphate 
GTPγS Guanosine [gamma thio] triphosphate 
h Hours 
HA Haemagglutinin 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HES HEPES/EDTA/sucrose 
HG HA-GLUT4 translocation assay 
HRP Horseradish peroxidise 
HRS Hepatocyte growth factor-regulated tyrosine kinase 
substrate 
 
Hsp (Hsc) Heat shock protein or heat shock cognate 
IF Immunofluorescence 
IR Insulin receptor 
IRAP Insulin-responsive aminopeptidase  
IRS Insulin receptor substrate  
IPTG Isopropyl β-D-1-thiogalactopyranoside 
KD Knock down 
kDa Kilo Daltons 
KIF Kinesin superfamily proteins 
KRH Krebs-Ringer-HEPES 
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LB Lysogeny broth 
LIP5 Lysosomal trafficking regulator-interacting protein 5 
LRP1 Lipoprotein receptor-related protein 1 
M Molar 
M6PR Mannose-6-phosphate receptor 
MADD MAP-kinase activating death domain 
MAPK Mitogen-activated protein kinase 
MBP Maltose-binding protein 
MIM domain Missing in metastases 
Min Minutes 
MIT domain Microtubule interacting and trafficking 
mRNA Messenger ribonucleic acid 
mTOR Mammalian target of rapamycin 
Munc18 Mammalian uncoordinated-18 
N-terminus Amino-terminal region 
Noc2 No C2 domain protein 
NSF N-ethylmaleimide sensitive factor 
OCRL-1 Oculocerebrorenal syndrome of Lowe (inositol 
polyphosphate 5-phosphatase) 
O-GlcNAc O-linked N-acetylglucosamine 
PBS Phosphate-buffered saline 
PCR Polymerase chain reaction 
PDK1 3’-Phosphoinositide-dependent kinase-1 
PI 3K Phosphatidylinositol 3-kinase 
PH domain Pleckstrin-homology domain 
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PKB/Akt Protein kinase B 
PKC Protein kinase C 
PM Plasma membrane 
PtdIns Phosphatidylinositol 
PTP1B Protein tyrosine phosphatase 1 B 
PX domain Phox homology domain 
qPCR Quantitative PCR or real-time PCR (RT-PCR) 
REP Rab escort protein 
RICTOR Rapamycin-insensitive companion of mTOR 
RIM Rab3-interacting molecule 
s Seconds 
SDS Sodium dodecyl sulphate 
SDS-PAGE Sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis 
 
SH2 Src homology 2 
SHIP Syntaxin 6-interacting protein 
siRNA Small interfering RNA 
SKD1 Suppressor of K+ transport growth defect 1 
Slp4a Synaptotagmin-like protein 4-a or granuphilin 
SNAP Soluble NSF attachment protein 
SNARE SNAP receptor 
SM proteins Sec/mammalian uncoordinated proteins (Munc) 
SOCS Suppressor of cytokine signalling 
STAM Signal-transducing adaptor molecule 
SUMO Small ubiquitin-like modifier 
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TA Tibialis anterior 
TBS Tris-buffered saline 
TBS-T Tris-buffered saline containing Tween-20 
TEMED N,N,N,N’-tetramethylethylenediamine 
TFB Transformation buffer 
TfR Transferrin receptor 
TGN Trans-Golgi network 
TIRF Total internal reflection fluorescence microscopy 
Tm Primer melting temperature 
Tris Tris(hydroxymethyl)methylamine 
Tsg-101 Tumour susceptibility gene 101  
TUG Tether containing an UBX domain, for GLUT4 
Tween-20 Polyoxyethylene sorbitan monolaureate 
U Unit 
Ub Ubiquitin 
UBAP1 Ubiquitin-associated protein 1 
Ubc9 Ubiquitin-conjugating enzyme 9 
UBPY Ubiquitin-specific protease Y 
UEV Ubiquitin E2 variant 
UIM Ubiquitin-interacting motif 
VAMP Vesicle-associated membrane protein 
VHS domain Vps-27, Hrs and STAM 
Vps Vacuolar protein sorting 
WB Western blotting 
WT Wild type 
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Glucose uptake in insulin target tissues involves coordination between insulin 
signalling and the vesicular movement of the glucose transporter GLUT4. This 
thesis aims to investigate key proteins that are involved in GLUT4 movement ‘to’ 
and ‘from’ the plasma membrane (PM). A complete investigation of these key 
proteins will aid in understanding which proteins are crucial for GLUT4 
mobilisation. These findings will also help us understand if some proteins can be 
pharmacologically manipulated at the subcellular level to increase the efficiency 
of glucose transport in disorders such as type 2 diabetes. 
 
 
1.1 Glucose homeostasis 
 
Whole body homeostasis or equilibrium is maintained by a number of 
physiological and biochemical processes. One of the important regulators of 
physiological homeostasis is control of blood glucose. A postprandial rise in 
blood glucose is countered by pancreatic insulin secretion. Insulin causes 
glucose to be assimilated by insulin-responsive tissues. In hypoglycaemic 
conditions, the pancreas secretes glucagon that causes cells to release glucose 
into the bloodstream. Both insulin and glucagon participate in normalising blood 
glucose to a baseline level of ~5.4 mM. In cells, glucose is necessary for the 
glycolytic pathway and the citric acid cycle, to generate the energy-yielding 
molecule ATP. Excess glucose may be stored as glycogen in skeletal muscles 
and hepatocytes or as triglycerides in cells such as adipocytes. Impairment in 
maintaining blood glucose to baseline levels is a hallmark of diabetes. A 
complete review of glucose homeostasis is beyond the scope of this thesis but 
the reader is referred to (Gibbs et al., 1995; Herman and Kahn, 2006; Liu et al., 
1993; Wallberg-Henriksson and Zierath, 2001) for consideration of the 





1.2 Impairment of glucose uptake in type 2 diabetes 
 
As impaired glucose transport is associated with insulin resistance, it is pertinent 
here to consider the relationship of insulin-regulated glucose transport to type 2 
diabetes. With an ever increasing incidence of obesity and an unbalanced diet 
or hereditary risks, the odds of developing type 2 diabetes are proportionally 
increased (Mokdad et al., 2001; Mokdad et al., 2003; Scott et al., 2007; 
Tuomilehto et al., 2001). The pathophysiology of type 2 diabetes includes 
reduced pancreatic insulin secretion or insulin resistance as primary causes of 
this disorder (Buchanan et al., 2002; Reaven, 1988). Some of the changes at 
the molecular level of insulin-responsive tissues that contribute to type 2 
diabetes include desensitisation at the insulin target receptor (abbreviated as IR) 
(Draznin, 2006; Longo et al., 2002), reduced glucose transporter 4 (GLUT4) 
expression (Gaster et al., 2001) or genetic mutations in GLUT4 associating 
proteins (Yoshimura et al., 1997). These abnormalities can result in reduced 
glucose uptake. Combatting this disease-associated impairment will require a 
better understanding of the GLUT4 transporter and factors that regulate its 
expression at the cell surface. This thesis adds information on novel 
intermediates that can in the future be investigated as disease related factors. 
These factors could in the future be investigated in patients. 
 
 
1.3 The GLUT family 
 
The GLUT family is a group of 14 known facilitative glucose transporters. The 
GLUT transporter comprises 12 trans-membrane spanning α-helices with 
intracellular N and C termini (depicted in Fig. 1.1). A number of exofacial 
residues on the GLUT transporter recognise the glucose molecule while helices 
5, 7, 10 and 11 of the GLUT transporter are thought to help in glucose 
permeation (Hruz and Mueckler, 2001). A recent study proposed the 
involvement of an ICH (intracellular helical bundle) domain in GLUT1 that helps 
in facilitated glucose transport. This ICH domain allows GLUT1 to maintain an 
‘outward open’ conformation facilitating glucose binding; upon ligand binding the 
interactions within the ICH domain weaken leading to an ‘inward open’ 
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conformation thereby allowing glucose release into the intracellular space (Deng 
et al., 2014). GLUTs 1-4 are the most studied isoforms of this GLUT transporter 
family and are classified as class I GLUTs. In the class I family, GLUT1 was the 
first GLUT to be identified and has been well characterised due to its expression 
in a number of tissues. The brain accounts for most of the body glucose uptake 
and GLUT1 accounts for most of this glucose supply across the blood brain 
barrier (where it is extensively expressed) (Redzic, 2011). GLUT2 is localised to 
the PM of pancreatic β-cells, intestines, kidney and liver cells. GLUT2 is involved 
in the bidirectional transport of a number of different sugars (Leturque et al., 
2005). GLUT3 is restricted to neurons and is involved in cerebral glucose uptake 
(Vannucci et al., 1997). GLUT4 is the main insulin-responsive glucose 
transporter in adipose tissue and skeletal muscle. GLUT4 trafficking has been 
studied in detail in recent years due to its association with insulin resistance and 
type 2 diabetes (Gaster et al., 2001). Class II- (GLUTs 5, 7, 9, 11) and class III- 
(GLUTs 6, 8, 10, 12 and HMIT) transporters show structural differences to the 
class I GLUTs. Little is known about class II and class III GLUTs, though some 
of them have shown specificity to bind and transport glucose, fructose and 
inositol (Uldry et al., 2001; Zhao and Keating, 2007). Table 1.1 lists the known 
GLUT transporters, their tissue expression and function. 
 
Figure 1.1:  Diagram depicting the class I GLUTs. The GLUT transporter consists of 12 
predicted transmembrane alpha helices. A glycosylation site is present at the N-terminal 
exofacial loop. Substrate binding likely occurs via a QLS motif in helix 7 (in GLUTs 1, 3 and 
4), an STSIF motif in loop 7 and amino acids (Trp 388 and Gln 161) in helix 5. The cytoplasmic 
F5QQI and LL 490 motifs are recognition sites for proteins that facilitate subcellular GLUT4 
mobilisation. Figure adapted from Augustin, 2010, Joost and Thorens, 2001. 
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Table 1.1:  Table with a list of GLUT transporters, location and function. Data adapted 
from Epstein et al., 1999; Joost and Thorens, 2001. 
 
 
1.3.1 GLUT4: The insulin-responsive glucose transporter 











barrier, adipocytes, muscle 
  
Glucose, galactose and 
ascorbic acid transport; 
basal glucose uptake 
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Renal, hepatic and 








Brain and neurons. Low 
expression in hepatocytes, 
myocardium, testes and 
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High expression in testes 
and brain; some expression 
detected in liver, heart and 
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Glucose and fructose 
transport; insulin- 
stimulated glucose 
transport in blastocyst 
 
GLU10 
High expression in liver and 
pancreas; heart, lung, brain, 
skeletal muscle, kidney 
 




Highly expressed in heart; 













Preliminary studies on cellular glucose transport used an inhibitor of hexose 
transporters called cytochalasin b to help characterise hexose trafficking 
mechanisms (Jung and Rampal, 1977). Cytochalasin b studies led to an 
understanding of subcellular distribution of glucose transporters and their 
transport to the PM (Cushman and Wardzala, 1980; Delicado et al., 1988). 
However, use of cytochalasin b was unable to distinguish between different 
hexose transporters and so it was unable to identify which glucose transporter 
responded to insulin (Holman et al., 1990; Joost et al., 1988; Shisheva et al., 
1999). The GLUT4 transporter was cloned in 1988 and identified as an insulin 
regulatable transporter that translocates to the PM in response to insulin in 
adipocytes (James et al., 1988; James et al., 1989). These findings were 
corroborated by studies on skeletal muscles supporting the translocation 
mechanism of GLUT4 (Friedman et al., 1991; Fushiki et al., 1989; Marette et al., 
1992). A bis-mannose photolabelling technique in combination with 
GLUT4/GLUT1 immuno-specific antibodies was used in studies to characterise 
the insulin-responsive GLUT transporter. This technique helped quantify the 
amount of GLUT4 or GLUT1 at the PM of rat adipocytes treated with insulin 
(Holman et al., 1990). The photolabelling-immunoprecipitation technique 
showed a 15-20 fold increase in GLUT4 at the PM upon insulin stimulation and 
only a 5 fold increase in GLUT1 at the PM, confirming GLUT4 is the 
predominantly insulin-responsive glucose transporter (Holman et al., 1990).   
 
GLUT4-mediated glucose uptake by insulin-responsive tissues contributes to 
maintenance of whole body glucose homeostasis (Kotani et al., 2004; Liu et al., 
1993; Shepherd et al., 1993; Ziel et al., 1988). GLUT4 heterozygous knockout 
mice (GLUT4+/-) become insulin resistant and are susceptible to diabetes 
(Stenbit et al., 1997), while mice overexpressing the GLUT4 transporter show 
improved basal and insulin glucose uptake (Brozinick et al., 2001). 
Understanding the mechanisms of GLUT4 trafficking is crucial to deciphering the 
current (incompletely understood) insulin signalling pathway.  
 
 
1.4 The insulin signalling pathway
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Insulin stimulation of cells initiates a number of downstream cellular signals. One 
of the crucial downstream signals is GLUT4 trafficking and glucose uptake. The 
first point of contact for insulin is the IR (insulin receptor). The IR is a 
heterotetrameric protein consisting of two extracellular α subunits linked via 
disulphide bonds to two transmembrane β subunits (Jacobs et al., 1980), the 
latter of which possesses catalytic potential (Baltensperger et al., 1992). Insulin 
binding to the IR causes a conformational change in the α subunits leading to 
autophosphorylation at intracellular IR residues (Lee et al., 1997). This 
autophosphorylation event activates IR tyrosine kinases that catalytically 
phosphorylate the insulin receptor substrate (IRS), adapter proteins with 
pleckstrin homology and Src homology 2 domains (APS), signal regulatory 
proteins (SIRPs), Cbl and Gab-1 on specific tyrosine residues (Saltiel and Kahn, 
2001). Autophosphorylation of the IR can be negatively regulated by protein 
tyrosine phosphatase 1 B (PTP1B) that deactivates the IR by dephosphorylation 
(Goldstein et al., 2000). Other negative regulators include suppressors of 
cytokine signalling (SOCS1, SOCS3) (Ueki et al., 2004), plasma cell 
glycoprotein (PC1) (Maddux and Goldfine, 2000) and growth factor receptor-
bound protein 10 (Grb10) (Wick et al., 2003) that sterically interfere with the 
interaction between the IR and IRS. Tyrosine phosphorylated IRS1 and IRS2 
provide docking sites to the Src homology 2 (SH2) domain molecules (Lee et al., 
1993; White, 1998). Two important SH2 proteins include the Grb2 and class IA 
phosphatidylinositol-3-kinase (PI 3K). Grb2 is involved in the Ras mitogen-
activated protein kinase/extracellular-signal-regulated kinase (MAPK/ERK) 
pathway regulating nuclear transcription (Myers et al., 1994). PI 3K will be 
discussed in more detail due to its relevance in the GLUT4 trafficking pathway. 
 
PI 3K is recruited to the IRS at the PM upon insulin stimulation and converts the 
phosphoinositide PtdIns(4,5)P2 to PtdIns(3,4,5)P3 (Whitman et al., 1988). PI 3K 
is a heterodimer consisting of a regulatory (p85) subunit and a catalytic (p110) 
subunit (Carpenter et al., 1990). The p85 subunit contains an SH2 domain that 
is capable of binding the tyrosine phosphorylated IRS. Inactivation of PI 3K by 
using its inhibitor wortmannin (Clarke et al., 1994) or by overexpression of a 
dominant negative PI 3K construct leads to an inhibition of many aspects of 
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cellular insulin signalling and suppressed glucose uptake (Cheatham et al., 
1994). However, overexpression of the p85 regulatory subunit in mice has been 
linked to insulin resistance (Barbour et al., 2004), while mice lacking p85 show 
increased insulin sensitivity (Terauchi et al., 1999). To understand these effects 
of p85, we must keep in mind that p85 is generally present as a monomer in 
excess to the p85-p110 heterodimer (Mauvais-Jarvis et al., 2002; Ueki et al., 
2000). The p85 monomer competes for IRS with the p85-p110 heterodimer 
(Ueki et al., 2000). This competition serves to negatively regulate the IRS signal 
(Luo et al., 2005). In the insulin-stimulated state, it is likely that phosphorylation 
of the IRS may far outweigh any cellular monomeric p85, thereby facilitating 
p85-p110 (PI 3K) binding and PtdIns(3,4,5)P3 synthesis (Mauvais-Jarvis et al., 
2002). 
 
The PI 3K synthesised lipid secondary messenger PtdIns(3,4,5)P3 interacts with 
pleckstrin homology (PH) domain proteins such as 3-phosphoinositide protein 
kinase 1 (PDK1) and protein kinase C (PKC) isozymes ς and λ, thereby 
activating them. Though PKC activation is reduced in type 2 diabetic individuals 
(Koya and King, 1998) and disrupting it can lead to defective GLUT4 transport 
(Bandyopadhyay et al., 1999), its precise role in regulating GLUT4 traffic still 
needs more investigation. The other PI 3K activated kinase, PDK1, 
phosphorylates Thr308 of an important signalling intermediate, protein kinase B 
(PKB/Akt) (Alessi et al., 1997). Akt is one of the most well studied signalling 
intermediates in the insulin signalling pathway. There are 3 isoforms of Akt: 
Akt1, Akt2 and Akt3. Akt2 is the functionally important isoform in insulin-
responsive tissues and will be explored in this literature review. Akt2, is also 
phosphorylated on Ser473 (in addition to Thr308) by another protein complex, 
mammalian target of rapamycin (mTOR) that associates with the regulatory 
protein (RICTOR) (Vander Haar et al., 2007). A crucial event that follows Akt 
activation is the phosphorylation and subsequent inactivation of the 160 kDa 
Rab GTPase activating protein (GAP) AS160/TBC1D4 (Kane et al., 2002). It is 
believed that insulin-mediated inactivation of AS160 removes a restriction in 
GLUT4 traffic leading to recruitment of Rab GTPases to facilitate GLUT4 





1.5 GLUT4 trafficking 
 
 
Figure 1.2:  Insulin signalling cascade in adipocytes. Insulin binding to its receptor leads 
to autophosphorylation by the receptor tyrosine kinase in the beta subunit of the insulin 
receptor (IR). The IR in turn phosphorylates the insulin receptor substrate (IRS1), which 
binds to the regulatory (p85) subunit of phosphatidylinositol 3-kinase (PI 3K) and 
phosphorylates p85. PI 3K synthesises PtdIns(3,4,5)P3 from PtdIns(3,4)P2. An elevation in 
PtdIns(3,4,5)P3 levels leads to recruitment of a phosphoinositide dependent kinase 1 
(PDK1), protein kinase B (Akt/PKB) and protein kinase C (PKC) to the plasma membrane 
(PM). Akt is phosphorylated by PDK1 and mammalian target of rapamycin complex 2 
(mTORC2) while PKC is phosphorylated by PDK1. Akt and PKC both regulate downstream 
effects of insulin signalling. Phosphorylation of Akt is a key event in the insulin signalling 
cascade as it activates pathways for glucose metabolism, lipid/protein synthesis, cell growth, 
gene expression and GLUT4 translocation. For activation of GLUT4 translocation, Akt 
phosphorylates a Rab GAP called AS160 (TBC1D4), which results in AS160 inactivation. 
Inactivation of AS160 leads to Rabs being GTP bound and this causes Rabs to be activated. 
Activated Rabs facilitate GLUT4 translocation and glucose uptake. The insulin signalling 
cascade also involves activation of a PI 3K independent pathway that assists in GLUT4 
exocytosis. Tyrosine phosphorylation of the IR activates two adaptor proteins APS and CAP 
and protooncogene (cCBL). Tyrosine phosphorylation of cCBL leads to recruitment of the 
CRK adaptor protein and a guanine nucleotide exchange factor C3G. C3G exchanges the 
TC10 bound GDP for GTP leading to activation of TC10. TC10 is responsible for facilitating 
the activation of a number of proteins associated with an exocyst complex that helps in 
GLUT4 vesicle docking to the PM. 
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Considerations of the GLUT4 trafficking mechanism are assembled from a 
number of studies that have aimed to characterise either cellular localisation of 
GLUT4 or signalling intermediates that may directly or indirectly influence 
GLUT4 movement.  
 
 
1.5.1 From biogenesis to the plasma membrane 
 
GLUT4 is mainly localised to intracellular stores in the basal state and 
translocates to the PM rapidly upon insulin activation. Using techniques such as 
electron microscopy (EM) to scan rat adipocyte cryosections, it was shown that 
GLUT4 primarily associated with intracellular tubulo-vesicular structures in the 
basal state (Malide et al., 2000). This EM study demonstrated that about 60% of 
GLUT4 was sequestered in vesicular structures in the basal state, 35% was not 
associated with membranous structures and only ~5% was present at the PM. 
Insulin-stimulated adipocytes however, showed a ~38% increase in GLUT4 at 
the PM (Malide et al., 2000). This corroborates the 15-20 fold increase in 
surface GLUT4 upon insulin stimulation that was reported using the bis-
mannose photolabelling technique (Holman et al., 1990).  
 
Some translated proteins are transported from the rough endoplasmic reticulum 
to the Golgi, which serves as a hub for protein sorting. Around 20% of 
intracellular GLUT4 was shown to be sequestered in the trans-Golgi network 
(TGN) (Slot et al., 1991). GLUT4 also colocalised with a number of Golgi 
markers such as TGN38 (Ralston and Ploug, 1996), golgin-130 (Blot and 
McGraw, 2006; Williams et al., 2006), syntaxin-6 and syntaxin-16 (Shewan et 
al., 2003). GLUT4 sorting from the TGN to insulin-responsive compartments was 
shown to require Golgi-localized, γ-ear-containing, Arf-binding (GGA) proteins 
(Li and Kandror, 2005). Dominant negative GGA constructs inhibited biogenesis 
of insulin-responsive GLUT4 compartments and led to impaired glucose uptake 
(Li and Kandror, 2005). The insulin-responsive compartments that originated 
from the TGN have been characterised as GLUT4 storage vesicles (GSVs) to 
distinguish them from any GLUT4 ‘containing’ vesicles that do not respond to 
insulin (Rea and James, 1997). It is worth noting that another marker called 
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insulin-responsive aminopeptidase (IRAP) is also localised to GLUT4 vesicles 
and may aid in GSV formation (Yeh et al., 2007). Besides IRAP, vesicle sorting 
proteins such as sortilin (Shi and Kandror, 2005) and LRP1 (Jedrychowski et al., 
2010) also aid in GSV biogenesis. IRAP, LRP1 and sortilin may be considered 




1.5.2 Tethering, docking and fusion 
 
GLUT4 vesicles translocate from a storage pool towards the PM (Martin et al., 
2000). A coiled-coil domain on the Exo70 protein was shown to assist GLUT4 
vesicle tethering to the PM (Inoue et al., 2003). Exo70 complexes with a 
multimeric exocyst to assist in tethering GLUT4 to the PM (Inoue et al., 2003). 
The exocyst interacts with Rho and Ral small GTPases that are regulated in an 
insulin-dependent manner and recruited to the PM (Chen et al., 2007). It is a 
combination of the exocyst, GLUT4 vesicle proteins and small GTPases that 
tether a vesicle to the PM (Novick and Guo, 2002). Docking and fusion to the PM 
is dependent on soluble N-ethylmaleimide sensitive factor (NSF) acceptor protein 
receptor (SNARE), which forms a multi-subunit complex with the GLUT4 vesicle 
(Cheatham et al., 1996). A technique called total internal reflection fluorescence 
microscopy (TIRFM) was used to monitor GSVs at the periphery of the PM. 
Studies using TIRFM showed that upon insulin stimulation, a number of GLUT4-
containing vesicles accumulated ~200 nm below the PM leading to vesicle 
tethering and ultimately PM fusion (Lizunov et al., 2005). TIRFM studies by 
another group revealed that insulin decreased the time needed for GLUT4 
vesicles to dock to the PM and increased the number of fusion events (Huang et 
al., 2007). Shuttling of GLUT4 vesicles to the PM and their subsequent tethering, 
docking and fusion events are thought to occur with the help of Rabs and the cell 
cytoskeleton. En-route to the PM, microtubule elements called kinesins have also 
been reported to associate with the GSVs (Emoto et al., 2001). Two specific 
kinesins, KIF5B (Semiz et al., 2003) and KIF3A (Guo et al., 2012) escort GLUT4 
vesicles along the microtubule towards the PM. Actin binding myosin motors 
Myosin-2A (Chung et al., 2010), Myosin-5A (Chen et al., 2012) and Myosin-1C 
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(Bose et al., 2004) further advance GLUT4 vesicle motility along actin filaments. 
GLUT4 vesicle tethering to the PM occurs prior to the association of the vesicle 
with the SNARE machinery. Myosin-1C was shown to participate in actin 
remodelling thereby facilitating GLUT4 vesicle tethering process to the PM 
(Boguslavsky et al., 2012). Myosin-5A together with Myosin-2A are involved in 
docking the GSV to the PM (Chen et al., 2012; Chung et al., 2010).  
 
Insulin stimulation rapidly increases the flux of GSV exocytosis and subsequent 
vesicle docking/fusion with the PM. TIRFM studies show the involvement of a 
vesicle associated membrane protein 2 (VAMP2) in GLUT4 vesicle fusion (Xu et 
al., 2011). A distinguishing feature of GSVs is that they do contain VAMP2 
(Martin et al., 1998), which makes them competent for PM fusion. VAMP2 
however, does not act alone and interacts with syntaxin-4 (Olson et al., 1997) 
and synaptosomal-associated membrane protein of 23 kDa (SNAP-23) 
(Kawanishi et al., 2000) to form a ternary fusion ‘ready’ SNARE complex. This 
multi-subunit ternary complex allows the GLUT4 vesicle to fuse with the PM, 
which is facilitated by two additional proteins, Munc18c (Thurmond et al., 2000) 
and Doc2b (Fukuda et al., 2008).  
 
The IR tyrosine kinase phosphorylates Munc18c (on Tyr521) and activates it 
(Schmelzle et al., 2006). Activated Munc18c competes with VAMP2 for syntaxin-
4 binding (Thurmond et al., 1998). Activation of Munc18c (Bakke et al., 2013) 
leads to its dissociation from syntaxin-4 thereby allowing syntaxin-4 to interact 
with the SNARE complex during insulin stimulation and facilitate vesicle fusion 
(Aran et al., 2011; Jewell et al., 2011). Doc2b is another syntaxin-4 interacting 
protein (Fukuda et al., 2008) that likely associates with syntaxin-4 following 
Munc18c dissociation. Doc2b promotes SNARE dependent fusion of GLUT4 
vesicles in a calcium dependent manner (Fukuda et al., 2008; Yu et al., 2013). 
Munc18c has hence been postulated to be a negative regulator of GLUT4 
exocytosis whereby it possibly sequesters syntaxin-4, preventing vesicle fusion. 
A study using Munc18c-/- mice showed enhanced insulin-stimulated GLUT4 
externalisation in adipocytes (Kanda et al., 2005). However, further 
characterisation studies on insulin signalling have shown that Munc18c 
phosphorylation by the IR was necessary for SNARE dependent vesicle fusion 
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(Jewell et al., 2011). The phosphorylation of Munc18-c by the IR implies that 
insulin stimulation not only activates GLUT4 translocation via the PI 3K 
signalling cascade but also readies the SNARE complex for GLUT4 vesicle 
fusion to the PM. Thus, the role of IR phosphorylated Munc18c is to regulate 
SNARE-mediated fusion of docked vesicles mainly by releasing syntaxin-4. 
However, it is still unclear how exactly Munc18c facilitates vesicle fusion (Jewell 
et al., 2011). Two possible hypotheses are that the IR may only phosphorylate a 
Munc18c-syntaxin-4 complex or that phosphorylated Munc18c is required for 
Doc2b binding and a Doc2b-Munc18c complex positively regulates GLUT4 
exocytosis (Jewell et al., 2008; Jewell et al., 2011). 
 
 
Figure 1.3: Exocytosis of GLUT4 to the plasma membrane. Insulin stimulation enriches 
GLUT4 storage vesicles (GSVs) with a number of molecules that assist in its delivery to the 
plasma membrane (PM). Some of the key molecules on GSVs include AS160, activated 
Rabs (namely Rab8A and Rab10), the SNARE component VAMP2 and the insulin 
regulatable aminopeptidase (IRAP). GSV movement along microtubules is brought about by 
kinesins (KIF3 and KIF5B). Myosins motors (Myosin-5A and Myosin-1C) drive GSVs along 
the actin cytoskeleton towards the PM. Tethering of GSVs to the PM is facilitated by AS160 
and actin. Rab effectors possess lipid interacting motifs that may play a role in the tethering 
process. Tethering and docking of the GSV is stabilised by a multi-subunit exocyst. The 
exocyst interacts with actin, Rabs and other small molecule GTPases such as Rho, Ral and 
TC10 to stabilise the GSV at the PM. Following docking of the GSV at the PM, SNARE 
fusion machinery (syntaxin-4 and SNAP23) are recruited to the GSV. The SNARE 
machinery interacts with VAMP2 and mediates GLUT4 vesicle fusion with the PM. Doc2b 
and Munc18c also regulate the fusion process. Figure adapted from Stöckli et al., 2012. 
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1.5.3 Endocytosis and recycling 
 
GLUT4 is rapidly internalised together with IRAP from the PM. Two possible 
mechanisms for retrograde traffic from the PM have been reported for GLUT4 in 
adipocytes. In the basal state, majority of GLUT4 is endocytosed by cholesterol-
mediated endocytosis (CME) requiring lipid rafts and caveolin (Ros-Baro et al., 
2001). In the insulin-stimulated state however, most GLUT4 is endocytosed via 
the clathrin adapter AP-2 pathway and formation of clathrin coated pits (Blot and 
McGraw, 2006; Huang et al., 2007). The N-terminal F5QQI motif of GLUT4 is 
crucial for this interaction with AP-2 (Blot and McGraw, 2006). Knockdown of 
AP2 inhibits internalisation of GLUT4 under insulin conditions while cholesterol 
inhibition using a nystatin inhibitor reduces basal GLUT4 CME internalisation 
(Blot and McGraw, 2006).  
 
Rab5 guides endocytic GLUT4 vesicles along microtubules in retrograde 
transport (Huang et al., 2001). Dynein, a minus end microtubule motor is 
anchored by Rab5 onto the GLUT4 vesicle (Huang et al., 2001). Early 
endosomal markers such as EEA1 (Ramm et al., 2000) and TfR (Zeigerer et al., 
2002) have also been detected on recently endocytosed GLUT4 vesicles. The 
fate of endocytic GLUT4 vesicles depends on which signalling molecules are 
involved. Rab4 and its interacting protein Rabip4 cause GLUT4 to recycle back 
to the PM from insulin-responsive sequestered vesicle pools (Mari et al., 2006). 
GLUT4 may also be sorted away from the recycling route and directed towards 
the TGN via another clathrin adapter AP-1 (Blot and McGraw, 2008; Martin et 
al., 2000). AP-1 interacts with the LL490 motif on GLUT4. Knockdown of the AP-1 
complex or mutating the LL490 motif increases the basal GLUT4 retention time 
by 2-fold after withdrawal of insulin (Blot and McGraw, 2008).  
 
One of the hallmarks of endocytosed cargo is ubiquitination. Ubiquitin generally 
‘labels’ cargo for endocytosis and degradation. Removal of ubiquitin 
(deubiquitination) controls cargo degradation, recycling to a storage pool or 
trafficking towards the plasma membrane. Studies in yeast have indicated that 
GLUT4 ubiquitination is necessary for trafficking in the endocytic pathway 
(Shewan et al., 2013). Another set of proteins called the GGA proteins were 
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described in section 1.5.1 as being responsible for sorting GLUT4 into GSVs. 
Studies have shown that for GGA-mediated TGN sorting of GLUT4 into GSVs, 
ubiquitination was necessary (Lamb et al., 2010). These interactions have been 
investigated in this thesis. 
 
 
1.5.4 GLUT4: Intracellular sequestration and trafficking routes 
 
In the absence of insulin, intracellular movement of GLUT4 is proposed to occur 
in two possible ways. GLUT4 may either be present in GSVs in a non-cycling 
‘static’ pool or a continuously cycling ‘dynamic’ pool. The static pool GSVs do not 
associate with the GLUT4 in a dynamic pool. Static retention of GLUT4 might 
occur with the help of proteins such as TUG (tether containing a UBX domain) 
(Bogan et al., 2003) or p115 (belonging to the PI 3K subunit) (Hosaka et al., 
2005) in the basal state (Larance et al., 2007). Dynamic GLUT4 cycles from the 
cytoplasm to the PM and may undergo endosomal recycling via the TGN (Martin 
et al., 2006). Insulin stimulation increases the rate of GLUT4 cycling and likely 
causes the release of GLUT4 from the static pool into a rapidly recycling pool. 
This phenomenon is best be described by a model proposed by Coster et al., 
(2004) which suggests that exchange of GLUT4 between endosomes and the 
static GSV pool occurs in a transient manner in the basal state. However, only in 
the presence of insulin is there a transient but ‘quantal release’ of GLUT4 from 
the static pool into the continuously cycling pool (Coster et al., 2004). This quantal 
release increases the size of the cycling pool but the release of GSVs by this 
quantal mechanism is mainly dependent on the rate of GLUT4 endocytosis 
(Muretta and Mastick, 2009). 
 
Cycling of GLUT4 through pools is regulated by a number of proteins. Figure 1.4 
demonstrates the currently known routes of GLUT4 trafficking upon insulin 
stimulation and likely storage/recycling pools. Fast recycling may occur if GLUT4 
enters an endosomal-recycling compartment (ERC). Slow recycling is likely to 
occur if endocytosed GLUT4 is shunted to the TGN. The TGN acts as a hub 
where GLUT4 may recycle to the PM in a retrograde fashion or new GLUT4 




Figure 1.4: GLUT4 trafficking routes during insulin stimulation. Ubiquitinated 
GLUT4 undergoes endocytosis together with the transferrin receptor (TfR) via clathrin-
coated pits. Newly endocytosed GLUT4 is sorted into early endosomes that contain the 
early endosomal antigen 1 (EEA1) and Rab5. (1) From early endosomes, TfR and 
GLUT4 may independently recycle back to the plasma membrane (PM) via the 
endosomal-recycling compartment (ERC) (fast recycling). GLUT4 may also traffic into 
sorting compartments and/or mature into late endosomes leading to formation of a 
multi-vesicular body (MVB). (2) GLUT4 from the sorting compartment may recycle to 
the ERC, undergo retrograde trafficking via the trans-Golgi network (TGN) or mature 
into late endosomes followed by formation of a MVB. (3) A small amount of GLUT4 that 
enters into a MVB is destined for lysosomal degradation. Recent studies suggest that 
GLUT4 may be rescued from the MVB into sorting/recycling endosomes or to the TGN. 
(4) The endosomal recycling compartment (ERC) is insulin-regulated and rapidly 
traffics GLUT4 to the PM. Insulin also regulates the steps downstream of the ERC that 
include tethering, docking and fusion of GLUT4 vesicles. Recently, Rab14 positive 
GLUT4 vesicles were shown to traffic from the ERC to the PM. Alternatively, the ERC 
may also sort GLUT4 into ‘slow cycling’ GSV pools or to the TGN. (5) GLUT4 enters 
the TGN from compartments associated with retrograde GLUT4 trafficking. TGN-
regulated biogenesis involves packaging of GLUT4 into vesicles and delivery to the 
ERC or GSVs. (6) GLUT4 storage vesicles (GSVs) are insulin-regulated and exocytose 
GLUT4 to the PM after recruitment of the necessary trafficking machinery (that include 
VAMP2, Rab10 and IRAP). Figure adapted from Foley et al., 2011; Muretta and 
Mastick, 2009. For more detailed information on GLUT4 trafficking models, please refer 
to a review by Muretta and Mastick (2009). 
 
 
1.5.5 AS160 as a regulator of GLUT4 traffic  
 
During the insulin signalling cascade, one of the downstream substrates of Akt is 
AS160. Activation of Akt leads to Ser/Thr phosphorylation of AS160 (see Figure 
1.2). Phosphorylation of AS160 renders it inactive and unable to bind Rab 
GTPases (Bruss et al., 2005; Karlsson et al., 2005). AS160 is a Rab GAP 
(Mîinea et al., 2005) and GAPs are known to hydrolyse the guanine within a Rab 
from GTP to GDP. This GTP hydrolysis renders a Rab being GDP-bound, 
inactive and unable to perform its function. Hence the phosphorylation and 
inactivation of AS160 by Akt results in active (GTP-bound) Rabs. Active Rabs 
can hence facilitate GLUT4 vesicle exocytosis. 
 
Studies in humans with type 2 diabetes showed that Akt dependent AS160 
phosphorylation was reduced in skeletal muscle in comparison to individuals 
without type 2 diabetes (Karlsson et al., 2005). Phosphorylation at Thr308 on 
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AS160 was reduced by 51% in the skeletal muscle of type 2 diabetic individuals 
(Karlsson et al., 2005). Another study found that in individuals with a rare 
inherited heterozygous truncation mutant of AS160, there was postprandial 
hyperinsulinemia that contributed to the development of insulin resistance. 
Expression of the AS160 truncated mutant in 3T3L1 adipocytes showed a 
significant reduction in GLUT4 translocation to the PM in insulin-stimulated 
adipocytes (Dash et al., 2009; Koumanov et al., 2011). The truncated AS160 
mutant increased basal GLUT4 translocation but reduced insulin-stimulated 
GLUT4 translocation in 3T3L1 adipocytes (Dash et al., 2009). These results 
possibly implicate AS160 and/or Rab GTPases as signalling intermediates that, 
when functionally impaired, can lead to insulin resistance.  
 
Human AS160 has six potential consensus Akt phosphorylation sites (Ser318, 
Ser570, Ser588, Ser711, Thr642, Thr751). Mutating four of these 
phosphorylation sites to alanine generates an AS160-4P mutant. AS160-4P is a 
phosphorylation deficient mutant that inhibits GLUT4 translocation and causes 
impaired glucose uptake (Kramer et al., 2006; Sano, 2003). Adipocytes with 
siRNA knockdown (KD) of AS160 show increased basal GLUT4 translocation 
and increased basal glucose uptake implying that AS160 is a negative regulator 
of basal GLUT4 exocytosis (Eguez et al., 2005). However, overexpression of 
wild type AS160 does not inhibit insulin-regulated glucose uptake in the 3T3-L1 
cell system (Kramer et al., 2006). Overexpressing a dominant negative AS160 
R973K GAP mutant also removes the inhibitory potential of the AS160-4P mutant 
(Eguez et al., 2005). The studies hence suggest that AS160 helps maintain 
GLUT4 to intracellular stores (in the absence of insulin) and for this it requires a 
functional GAP domain (Eguez et al., 2005, Larance et al., 2005). However, the 
key steps in AS160 modulation of GLUT4 exocytosis need more investigation. 
AS160 has been clearly detected on GLUT4 vesicles and does not dissociate 
from them following insulin stimulation of adipocytes (Koumanov et al., 2011), 
though some studies claim that AS160 dissociates from trafficking GLUT4 




AS160’s presence on GLUT4 vesicles likely regulates the activation states of 
one or more key Rabs upon insulin signalling. The study undertaken in this 
thesis aims to identify Rabs downstream of Akt/AS160 phosphorylation that may 
be involved in GLUT4 exocytosis. A number of exocytic Rabs have been 
identified in vesicle exocytosis in other cell types. A preliminary study in the 
Holman lab identified Rabs that associated with total membrane preparations in 
adipocytes upon insulin stimulation of these cells. Among these identified Rabs, 
the exocytic Rabs will be explored in this thesis to study their role (if any) in 
GLUT4 translocation. The findings will hopefully bring us closer to identifying 
Rabs that may be involved in the final stages of GLUT4 translocation to the 
plasma membrane i.e. vesicle docking and fusion. 
 
 
1.5.6 Rabs in GLUT4 traffic 
 
The discovery that a GAP played such a crucial role in GLUT4 translocation 
automatically led to a number of studies to identify Rabs that may be targets 
downstream of AS160. One of the first studies to identify potential Rabs that 
could be substrates of AS160 led to the identification of Rab2, Rab8, Rab10 
and Rab14 as targets for AS160 GAP activity; these Rabs were also present on 
GLUT4 vesicles (Mîinea et al., 2005; Sano et al., 2008). Other studies identified 
Rab4 (Cormont et al., 1996), Rab5 (Huang et al., 2001), Rab11 (Zeigerer et al., 
2002), Rab13 (Sun et al., 2010), Rab31 (Lodhi et al., 2007) and Rab35 (Davey 
et al., 2012) as associating with different compartments (or pools) of GLUT4 
vesicles (see Table 1.1 for functions of these Rabs). Out of these Rabs, Rab10 
is particularly well characterised as being responsible for delivering GSVs to the 
plasma membrane. Knockdown of Rab10 inhibited insulin-stimulated GLUT4 
translocation in adipocytes making it an important regulator of GLUT4 traffic 
(Sano et al., 2008). The microtubule motor Myosin-5A was identified as a 
Rab10 effector, linking Rab10 to the cytoskeletal movement of the GSV to the 
PM (Chen et al., 2012). At the PM periphery, Rab10 and AS160’s involvement 
was demonstrated at the vesicle-docking step, but it is unclear whether these 
two proteins regulate vesicle fusion (Chen and Lippincott-Schwartz, 2013; Chen 




Table 1.2: Rab GTPases in GLUT4 traffic. A list of the Rabs identified as playing a part in 
GLUT4 trafficking together with their proposed function. 
 
 
The Rabs identified in insulin signalling have been implicated in either endocytic 
or exocytic stages of GLUT4 trafficking. However, none of these recently 
identified Rabs have been directly implicated with GLUT4 vesicle fusion to the 
plasma membrane. In order to implicate Rabs in the PM docking/fusion stages, 
an association with the SNARE machinery and/or microfilaments would be 
needed. This opens the possibilities to exocytic Rabs that may be involved in 
GLUT4 vesicle docking/fusion to the PM that have not yet been characterised in 
adipocytes. Preliminary studies in the Holman lab used a photolabelling 
technique to identify Rabs that may be activated upon insulin stimulation in rat 
adipocytes. Rab3B was identified by this photolabelling technique as being an 
insulin activated Rab on total membranes. Members of the Rab3 family have 
Rab4 Sorting of GLUT4 from endosomes (Cormont et al., 1996) and 
possible role in GSV formation (Chen and Lippincott-Schwartz, 
2013; Leto and Saltiel, 2012). 
Rab5 GLUT4 internalisation from the plasma membrane via the 
dynein microtubule motor (Huang et al., 2001). 
Rab8A AS160 dependent Rab involved in GLUT4 translocation to the 
plasma membrane mainly in muscle cells (Ishikura and Klip, 
2008; Randhawa et al., 2008; Sun et al., 2010; Sun et al., 
2014). 
Rab10 AS160-regulated Rab that associates with GSVs and facilitates 
their translocation and docking to the PM (Chen et al., 2012; 
Sadacca et al., 2013; Sano et al., 2007; Sano et al., 2008). 
Rab11 Endosomal recycling of the GLUT4 transporter and GLUT4 
translocation to the plasma membrane (Kessler et al., 2000; 
Uhlig et al., 2005; Zeigerer et al., 2002). 
Rab13 Another possibly AS160-regulated Rab involved in GLUT4 
translocation in muscle (Sun et al., 2010). 
Rab14 Endosomal GLUT4 trafficking (Chen et al., 2012; Reed et al., 
2013). 
Rab31 A possible negative regulator of GLUT4 exocytosis. Rab31 is 
localised to the TGN-endosomal interface (Lodhi et al., 2007). 
Rab35 Regulation of GLUT4 translocation (Davey et al., 2012). 
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been implicated together with Rab effectors in vesicle docking/fusion in synaptic 
and endocrine cells (Martelli et al., 2000; van Weering et al., 2007; Wang et al., 
1997). The studies described in this thesis investigate the involvement of 
Rab3B as a regulator of GLUT4 exocytosis and aims to identify its binding 
partners that may assist in GLUT4 vesicle docking/fusion. 
 
 
1.5.7 Role of phosphoinositides in GLUT4 traffic 
 
Cargo recognition proteins are fundamental for correctly trafficking vesicles and 
recruiting necessary machinery to assist vesicle movement. Rabs constitute one 
such set of proteins, as they are involved in recruiting machinery and facilitating 
vesicle movement. Phosphoinositides are another class of cellular signalling 
molecules. Phosphoinositides serve as lipid secondary messengers that 
orchestrate vesicle identity leading to regulation of vesicle traffic at different 
stages of a signalling pathway (Behnia and Munro, 2005; Fili et al., 2006). 
Phosphoinositides are the phosphorylated form of a phosphatidylinositol and 
contain a glycerol backbone, two non-polar fatty acid tails and a polar inositol 
head conjugated to one or more phosphate groups. The position and number of 
the phosphate groups on the inositol head are responsible for the diversity of 
cargo recognition. Recognition between phosphate groups and cytosolic or 
membrane cargo proteins occurs via electrostatic interactions between the 
inositol phosphate head and basic amino acids in the cargo protein. The binding 
between a phosphoinositide and cargo protein is further strengthened by the 
interaction between the phosphoinositide and membrane lipids (Lemmon, 2003). 
It is hence not surprising that a number of phosphoinositides are involved in the 
different stages of vesicle trafficking. Maintenance of phosphoinositide levels is 
key for successful GLUT4 trafficking (Shisheva, 2008).  
 
Phosphoinositides were briefly described earlier in section 1.4 in relation to the 
insulin signalling pathway and with regard to the conversion of PtdIns(4,5)P2 to 
PtdIns(3,4,5)P3 by the insulin activated class IA PI 3K. The class IA PI 3K 
regulatory subunit (p110) is a Rab5 effector (Christoforidis et al., 1999). Rab5 is 
also involved in the generation of PtdIns(3)P on early endosomes by recruiting 
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the phosphoinositide kinases Vps34 and PI 3Kβ and phosphatases PI 4-
phosphatase and PI 5-phosphatase (Shin et al., 2005). PtdIns(3)P though 
comprising a small percentage of the total phosphoinositides in a cell, is 
postulated to increase at the PM in the insulin activated state (Maffucci et al., 
2003). Increase in PtdIns(3)P levels may be attributed to activation of the class 
III PI 3K (known as Vps34 in yeast) or the class II PI 3K-C2α. In insulin-
stimulated cells, the class II PI 3K-C2α is shown to increase PtdIns(3)P levels 
(Falasca et al., 2007). Inhibition of PtdIns(3)P levels in L6 muscle cells by 
knocking down its kinase (PI 3K-C2α) has been linked to impaired glucose 
uptake and reduced GLUT4 translocation (Falasca et al., 2007). Studies on 
Munc18c-/- mice (that exhibited impaired GLUT4 trafficking) showed that 
exogenous delivery of PtdIns(3)P to adipocytes induced GLUT4 externalisation 
to the PM in the absence of insulin stimulation (Kanda et al., 2005). PtdIns(3)P 
may help in GLUT4 vesicle trafficking by associating with early endosomes via 
endosomal proteins containing the Fab1p, YOTB, Vac1p and EEA1 (FYVE) or 
phox homology domain (PX) domain (Cozier et al., 2002; Falasca et al., 2007; 
Stenmark et al., 1996). PtdIns(3)P may hence function in the insulin-signalling 
pathway by facilitating early endosomal and plasma membrane recycling.  
 
PtdIns(3,5)P2 is another predominantly intracellular phosphoinositide that may be 
synthesised on early endosomes (Cooke, 2002). Disruption of PtdIns(3,5)P2 can 
cause mis-sorting of cargo in the endocytic pathway leading to enlarged/swollen 
endosomes (Dong et al., 2010). PtdIns(3,5)P2 levels on intracellular membranes 
increases in response to insulin (Ikonomov et al., 2007). This increase in 
PtdIns(3,5)P2 can be attributed to its kinase PIKfyve, which is present on 
endosomal membranes and phosphorylates PtdIns(3)P to yield PtdIns(3,5)P2 
(Shisheva et al., 1999; Zolov et al., 2012). The essential requirement for PIKfyve 
was demonstrated by siRNA knockdown of PIKfyve and/or its regulator 
ArPIKfyve. This knockdown led to a reduction in GLUT4 on the cell surface and 
which in turn led to impaired glucose uptake in insulin-stimulated 3T3L1 
adipocytes (Ikonomov et al., 2007). The impaired glucose uptake has been 
attributed to a reduction in levels of PtdIns(3,5)P2 (Shisheva, 2008). Additional 
studies that disrupted levels of PtdIns(3,5)P2 by using a PIKfyve inhibitor called 
 39 
YM201636 also showed reduced glucose uptake and inhibition of insulin-induced 
GLUT4 translocation (Ikonomov et al., 2009; Jefferies et al., 2008). With the 
understanding that PtdIns(3)P, PtdIns(3,5)P2 and the PtdIns(3,5)P2 synthesising 
kinase PIKfyve are indispensable in glucose uptake, it is worth studying their 
interacting partners in relation to GLUT4 trafficking.  
 
One group of PtdIns(3)P and PtdIns(3,5)P2 interacting proteins are those 
belonging to the Endosomal Sorting Complex Required for Transport (ESCRT) 
family. ESCRTs are a group of proteins that interact directly with PtdIns(3)P and 
PtdIns(3,5)P2 and have hence been a focus of the studies described in this 
thesis. ESCRTs recognise both PtdIns(3)P and PtdIns(3,5)P2 on endocytosed 
vesicles (Stahelin et al., 2002; Whitley et al., 2003). ESCRT proteins contain 
FYVE or GLUE domains (within which is embedded a positive zinc finger motif) 
that interacts with PtdIns(3)P (Kutateladze and Overduin, 2001). The FYVE 
domain contains histidine residues in a conserved RR/KHHCR motif that links 
the zinc clusters in the zinc finger motif. It is these histidine residues which when 
protonated coordinate PtdIns(3)P and ESCRT protein binding (Kutateladze, 
2010; Lee et al., 2005). PtdIns(3,5)P2 is also involved with ESCRT mediated 
endosomal trafficking and interacts with an ESCRT protein further downstream 
of PtdIns(3)P interacting proteins. This ESCRT protein is CHMP3 (Muzioł et al., 
2006; Whitley et al., 2003). CHMP3 is crucial for mediating ESCRT disassembly. 
Overexpression of a truncation mutant of CHMP3 leads to vacuolation and a 
disruption in ESCRT-mediated endosomal trafficking (Teis et al., 2008; Whitley 
et al., 2003). Phosphoinositides and phosphoinositide interacting ESCRT 
components are hence crucial for ESCRT-dependent endosomal trafficking. 
 
 
1.6 Aims and motivation for the work described in this thesis 
 
Studies using insulin-responsive tissues have given us considerable knowledge 
on glucose flux in maintaining body homeostasis and in understanding GLUT4 
trafficking. The overall aims of the study described in this thesis is to identify 
novel regulators of GLUT4 trafficking at the subcellular level by using primary 
adipocytes as the test system.  
 40 
 
The endocytic route for GLUT4 is incompletely understood. PtdIns(3)P and 
PtdIns(3,5)P2 are well characterised as key lipid signalling molecules in 
endosomal GLUT4 vesicle traffic. PtdIns(3,5)P2 is synthesised in response to 
insulin signalling and is required for GLUT4 translocation. PtdIns(3,5)P2 also 
forms a part of the endosomal ESCRT signalling pathway where it interacts with 
the ESCRT component, CHMP3. Is the functional ESCRT machinery required 
for insulin-stimulated GLUT4 translocation? 
 
The recent evidence showing that postprandial hyperinsulinemia and insulin 
resistance are caused due to a truncation mutant of a Rab GAP called AS160 
opens the possibility to involvement of Rab GTPases as regulators of GLUT4 
translocation and glucose uptake in insulin responsive tissues. Akt (which is a 
key insulin activated kinase) directly regulates AS160 in the insulin signalling 
cascade, implicating that Rabs may well be insulin-regulated via AS160 or 
another insulin signalling protein. Preliminary studies in the Holman lab identified 
the exocytic Rab3B as being insulin responsive whereby it gets GTP-loaded in 
response to an insulin stimulus. Though a number of Rabs have been identified 
in GLUT4 trafficking, the Rabs involved in the final stages of GLUT4 vesicle 
docking and fusion have not been clearly documented. Until recently, only 
Rab10 was shown to be involved with GLUT4 vesicle docking in adipocytes but 
not in vesicle fusion. Based on literature from other vesicle trafficking pathways 
where Rab3 isoforms play a key role in vesicle docking and fusion, I hypothesise 
that Rab3B may have a similar role in GLUT4 trafficking and possibly vesicle 
fusion. Work described in this thesis therefore aims to investigate the possible 
involvement of the exocytic Rab3B and its effectors in the final stages of GLUT4 
translocation.  
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2.1.1 Chemicals, reagents and instrumentation 
 
All laboratory chemicals were of analytical grade and purchased from Sigma-
Aldrich Chemical Company (Sigma-Aldrich) or Fisher Scientific UK Ltd. (Fisher 
Scientific) unless otherwise stated. Double distilled H2O (ddH2O) was used in 




























Ambion Paisley, RFW, Scotland 
Amersham Biosciences Little Chalfont, BKM, UK 
Applied Biosystems Warrington, CHS, UK 
BD Biosciences Oxford, OXF, UK 
Beckman Coulter Wycombe, BKM, UK 
Bethyl Labs. Montgomery, TX, USA 
Bio-rad Hempstead, HRT, UK 
BMG Labtech. Aylesbury, BKM, UK 
Calbiochem Watford, HRT, UK 
Carl Zeiss, Ltd. Welwyn, HRT, UK 
CBS Scientific Systems Del Mar, CA, USA 
Clontech Labs. Inc. St-Germain-en-Laye, France 
Covance Res. Products Berkeley, CA, USA 
Enzo Life Sci. Exeter, DEV, UK 
Eppendorf Cambridge, CAM, UK 
Fisher Scientific UK Ltd. Loughborough, LEI, UK 
Fujifilm Sheffield, SYK, UK 
Greiner Stonehouse, GLS, UK 
Invitrogen Paisley, RFW, Scotland 































Table 2.1: List of suppliers. The table provides the names and addresses of all the 
suppliers from which laboratory reagents or equipment were purchased/used.
Millipore Watford, HRT, UK 
MJ Research Waltham, MA, USA 
Molecular Probes Paisley, RFW, Scotland 
MSE London, UK 
MWG Biotech. London, UK 
New England Biolabs Hitchin, HRT, UK 
Pall Life Sciences Port Washington, NY, USA 
Pierce Cramlington, NLD, UK 
Proteintech Group Inc. Manchester, GTM, UK 
Sarstedt Leicester, LEI, UK 
Sigma-Aldrich Chem. Co. Gillingham, DOR, UK 
Stratagene La Jolla, CA, USA 
Thomas Scientific Swedesboro, NJ, USA 
UVP Cambridge, CAM, UK 
Vector Labs. Peterborough, CAM, UK 
Worthington Biochem. Lakewood, NJ, USA 






























Goat anti-GST  
 








Mouse anti-HA  
 






















   






































GLUT4 C-terminus  
  
 

































Table 2.2: Sources of primary antibodies with dilutions for usage. The table provides a list of 
primary antibodies used together with their source and dilution for western blotting (WB), 
immunofluorescence (IF) and HA-translocation studies (HG). The antibodies for WB were diluted 
in TBS-T with BSA to a final concentration of 1% BSA and 0.02% NaN3 and stored at 4°C until use 
(as described in section 2.2.5.6). The antibodies for IF were prepared in permeabilisation buffer 
(as described in section 2.2.4.1). The anti-HA antibody for the HG assay was prepared in KRH 






Table 2.3: Sources of secondary antibodies with dilutions for usage. The table provides a list 
of secondary antibodies used together with their source and dilution for western blotting (WB) or 
immunofluorescence (IF). Secondary antibodies for WB were prepared in 5% milk in TBS-T (as 
described in section 2.2.5.6) and temporarily stored at 4°C until use. The antibodies for IF were 






The animals used in the following studies were male Wistar rats that weighed 
180-200 g and were 7-8 weeks old. The rats were sacrificed by cervical 
dislocation and immediately dissected to remove the necessary tissues. For 
mRNA extraction, tissues were stored in liquid nitrogen. For isolation of 
adipocytes, tissues were placed in Krebs-Ringer-HEPES-BSA (KRBH) buffer (131 
mM NaCl, 4.7 mM KCl, 1.25 mM MgSO4.7H2O, 2.5 mM CaCl2.2H2O, 2.5 mM 
NaH2PO4.2H2O, 10 mM HEPES pH 7.4 with 1% BSA (w/v)) and maintained at 































   
 
anti-mouse with HRP  
 
 








anti-rabbit with HRP  
 
 








anti-goat with HRP  
  
 












Serum affinity purified 
 








2.2.1 Preparation of constructs for cloning 
 
2.2.1.1 Primer generation  
 
Rattus norvegicus (TaxID: 10116) cDNA sequences for the gene of interest were 
obtained from NCBI's nucleotide repository. A restriction enzyme map of the 
gene’s coding sequence was generated with the New England Biolabs cutter 
(Vincze et al., 2003) to identify potential restriction sites present within a cDNA 
sequence. Primers (with non-naturally occurring restriction sites) were selected 
using the OligoCalc engine for determining primer-melting temperature (Tm) 
(Kibbe, 2007). Primers were selected based on their ability to avoid self-
complementarity and hairpins as determined by the OligoCalc engine. Primers 
were purchased from Invitrogen/MWG Biotech. Primers were reconstituted as 50 
µM stock solutions and stored at -20°C until use.  
 
 
2.2.1.2 General cloning methodology 
 
Total tissue cDNA was prepared as described in section 2.2.4.3. All the reaction 
components were made up on ice. The master mix for specific cDNA 
amplifications were prepared using the Phusion® (New England Biolabs) DNA 
polymerase and its respective buffer (see description in Table 2.4). PCR reactions 
were carried out using a PTC-150 MiniCycler PCR machine (MJ Research). The 
final volume of the reaction mixture was 50 µl and constituted as described in the 





Component Amount/reaction Concentration/reaction 
DNA template* 5 µl 0.05 or 50 ng 
10 µM 5’-3’ primer 2.5 µl 0.5 µM 
10 µM 3’-5’ primer 2.5 µl 0.5 µM 
10 mM dNTP 1 µl 200 µM 
5X buffer 10 µl 1X 
DNA polymerase 0.5 µl 1 U 
ddH2O  make upto 50 µl - 
  
B 
Stage Temp. Cycles Time 
Initial 
denaturation 
95°C 1 2 min 




Annealing  Tm minus 5°C 30 s 
Extension 72°C 1 min/kb 
Final extension 72°C 1 10 min 
Storage 4°C -  
  
C 
Stage Temp. Cycles Time 
Initial 
denaturation 
95°C 1 1 min 




Annealing  Tm minus 5°C 30 s 
Extension 68°C 2.5 min/kb 
Final extension 68°C 1 10 min 
Storage 4°C -  
 
Table 2.4: Cloning conditions for PCR. The table ‘A’ provides the components required for 
setting up a PCR to clone the Noc2 and Rab3 cDNA. The table ‘B’ lists the cycling conditions for 
cloning. The table ‘C’ lists the conditions for generating site-directed mutants for Rab3B and 
Noc2 constructs. 
* 0.05 ng was used when a plasmid was used as the DNA template and 50 ng was used when a 
cDNA library was the template DNA. 
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2.2.1.3 Preparation of XL-1-Blue competent cells 
 
On day 1, an inoculation loop was used to streak a glycerol stock of XL1-Blue 
cells (Stratagene) on a sterile lysogeny broth (LB; commonly referred to as Luria 
broth (Bertani, 2004)) agar plate (1% (w/v) BactoTM tryptone (BD Biosciences), 
0.5% (w/v) BactoTM yeast extract (BD Biosciences), 0.5% NaCl pH 7.5, 1.5% (w/v) 
agar, autoclaved). The plate was incubated at 37°C for 16 h. On day 2, a single 
colony was picked from the LB agar plate, inoculated into 2.5 ml of LB broth (1% 
(w/v) BactoTM tryptone, 0.5% (w/v) BactoTM yeast extract, 0.5% NaCl pH 7.5, 
autoclaved) and incubated overnight at 37°C at 250 x g on a shaking incubator. 
On day 3, the entire overnight culture was diluted 1:100 by inoculating the culture 
into 250 ml of LB broth containing 20 mM MgSO4 in a 1 l flask.  The 1 l flask 
containing this culture was incubated at 37°C on a shaking incubator at 250 x g. 
The density of the culture measured from absorption at 600 nm (A600 nm) was 
checked at regular 1 h intervals using a spectrophotometer. Once the A600 nm 
reached 0.6, the incubation was stopped and the cells were pelleted by 
centrifuging the culture at 4500 x g for 5 min at 4°C. The cell pellet was gently re-
suspended (using chilled pipettes and pipette tips) in ice-cold transformation 
buffer I (30 mM CH3COOK, 10 mM CaCl2, 50 mM MnCl2, 100 mM RbCl, 15% 
glycerol (v/v). The pH was adjusted to 5.8 with 1 M CH3COOH. The buffer was 
filter sterilised using a 0.2 µm filter (Millipore) and stored at room temperature). 
The cell suspension was incubated on ice for 5 min followed by centrifugation at 
4500 x g for 5 min at 4°C. The cell pellet was gently re-suspended in 10 ml of ice-
cold transformation buffer II (10 mM PIPES, 75 mM CaCl2, 10 mM RbCl2, 15% 
glycerol (v/v). pH was adjusted to 6.5 with 1 M KOH. The buffer was filter 
sterilised using a 0.2 µm filter and stored at room temperature). The cell 
suspension was incubated on ice for 60 min and then aliquots of 200 µl were 
transferred into 0.5 ml microfuge tubes (Eppendorf). Microfuge tubes were frozen 
in dry ice and isopropanol bath and stored at -70°C. 
 
 
2.2.2 Quantitative PCR (qPCR) 
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2.2.2.1 Primer generation for qPCR 
 
Primers to the concerned cDNA were generated using NCBI’s primer BLAST 
software (Ye et al., 2012) and the Primer3 software (Untergasser et al., 2007). 
The newly obtained primers were checked for self-complementarity using the 
OligoCalc software (Kibbe, 2007). Primers were also checked for 40-70% GC 
content, a Tm difference of 0.5°C between primers and no more than two G/C in 
the last 5 nucleotides at the 3’ end (if possible). A folding map of the cDNA of 
interest was generated to identify folding patterns in the DNA such as hairpins 
that could form at the primer annealing temperature of 60°C (Zuker, 2003). On 
analysis of the folding map, primers were selected that did not bind to the hairpin 
regions of the folded DNA template. Finally, another filter was used to select the 
optimal primers. Only those primers that spanned an intron were selected to avoid 
amplification of any contaminating genomic DNA that may have been retained in 
the final cDNA preparation by unavoidable experimental error. Exon-intron 
boundaries for the respective gene were identified using a BLAST-like alignment 
tool (BLAT) (Kent, 2002). Two sets of primers were selected for each cDNA and 
validated as per the procedure in section 2.2.2.5 to select the best primer based 
on the qPCR readout. 
 
 
2.2.2.2 RNA isolation 
 
Prior to isolating tissues, all the dissecting equipment was cleaned with 99.9% 
ethanol followed by RNase AWAY® (Sigma-Aldrich). Tissues were isolated from 
rats as described in 2.1.3, wrapped in clean aluminium foil squares and 
immediately frozen in liquid nitrogen. The tissue sample was weighed to contain 1 
g of tissue material and any additional tissue was cut off using a clean 
scalpel/blade. A mortar and pestle (precooled to -80°C) was used to grind the 
tissue to a fine powder. The mortar was kept in an ice bucket and liquid nitrogen 
was slowly added during the grinding process. The powdered tissue was 
transferred to a 55 ml Potter-Elvehjem glass pestle tissue grinder and mixed with 
10 ml of TRIzol® (Life Technologies) RNA isolation reagent. The mixture was 
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homogenised with 20 strokes at 1600 rpm using a Rexon DP-200 AS bench top 
drill. The homogenised mixture was clarified by centrifugation at 12,000 x g for 5 
min at 4°C. The supernatant was transferred to a fresh 30 ml aluminosilicate 
glass tube (Corex No. 8445) and allowed to stand at room temperature for 5 min. 
2 ml chloroform was added to the sample, the mouth of the glass tube was sealed 
in Parafilm® (Sigma-Aldrich) and the tube was vortexed for 15 s. The mixture was 
allowed to stand at room temperature for 10 min. The tubes were then centrifuged 
at 12,000 x g for 15 min to separate the contents into three phases. The upper 
colourless phase contained RNA, the interphase contained DNA and the bottom 
red organic phase contained protein. The upper colourless phase was transferred 
into a new 30 ml glass tube, mixed with 5 ml of isopropanol, sealed with Parafilm® 
and inverted several times to mix. The mixture was incubated for 10 min at room 
temperature to facilitate RNA precipitation. The mixture was then centrifuged at 
12,000 x g for 5 min at 4°C to pellet the RNA. The supernatant was discarded and 
RNA pellet was re-suspended in chilled 75% ethanol. The RNA was pelleted 
again by centrifugation at 7,500 x g for 5 min at 4°C. The ethanol supernatant was 
discarded and RNA was dissolved in 500 µl of diethylpyrocarbonate (DEPC)-
treated water (0.1% (v/v) DEPC in Milli-Q® H2O incubated at 37°C for 12 h and 
autoclaved). The dissolved RNA was transferred to 1.5 ml RNase free microfuge 
tubes (Eppendorf). The microfuge tubes containing RNA solution were incubated 
at 55°C for 15 min to completely dissolve the RNA. Freshly prepared RNA was 
quantified using a Bio Photometer UV spectrophotometer (Eppendorf) and stored 
at -80°C until cDNA preparation. 
 
 
2.2.2.3 cDNA preparation 
 
The following procedure was performed in a laminar airflow hood to avoid 
contamination. 5 µg of the RNA solution that was prepared as described in 
section 2.2.2.2 was pipetted into a 0.2 ml DNase/RNase free PCR tube and made 
up to 20 µl together with the addition of 1 µl of DNase I (Ambion) and 1 µl of 
DNase I buffer (Ambion). The DNA digestion reaction was carried out for 1 h at 
37°C in a PCR machine. DNase I was inactivated by heating the reaction at 75°C 
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for 15 min. RNA concentration was quantified using a spectrophotometer. 1 µg of 
RNA was used for generating the cDNA using the SuperScript® III First-Strand 
Synthesis SuperMix kit (Invitrogen). The following components were made up in 
an ice bucket. 10 µl RT reaction mix, 2 µl RT enzyme mix and 1 µg RNA were 
made up to 20 µl using DEPC-treated RNase free water. The contents were 
gently mixed and incubated at 25°C for 10 min followed by incubation at 50°C for 
30 min. Heating the tube at 85°C for 5 min terminated the reaction. The mixture 
was allowed to cool to room temperature. 1 µl (2 U) of RNase H was added to the 
mixture and it was incubated at 37°C for 20 min to dissolve any remaining RNA. 
The cDNA solution was diluted in a 1.5 ml DNase/RNase free microfuge tube 
(Eppendorf) with DEPC-treated RNase free water to get approximately 1 ng/µl 
and stored at -80°C until use. 
 
 
2.2.2.4 qPCR assay setup and data analysis 
 
All procedures for setting up the qPCR assay plate were done in a laminar airflow 
cabinet and made use of DNase/RNase free filter tips. A 96-well MicroAmp® 
(Applied Biosystems) plate was used to set up the qPCR reaction in a small ice 
bucket. Each well contained 5 ng of cDNA, 7.5 µl of iTaq SYBR Green Supermix 
with ROX (Biorad), 7.5 pmoles each of forward and reverse primers and DEPC-
treated RNase free water made up to a final volume of 15 µl. A control was used 
for each sample tested. This control contained only DEPC-treated RNase free 
water, primers, supermix and it was devoid of any cDNA sample. The qPCR plate 
was read on a qPCR machine (Applied Biosystems). The program that was set up 
included initial denaturation at 95°C for 2 min. Cycling was performed at 95°C for 
15 s followed by 60°C for 1 min. The cycling step was repeated 40 times. For the 
melt curve, the samples were heated up to 95°C for 15 s and then cooled down to 
60°C for 1 min. The temperature was then increased by 0.7°C increments until 
95°C following which the reaction was stopped. 
 
The qPCR data was analysed to check for optimal amplification efficiency (slope 
close to -3.3), optimal correlation coefficient (R2 value >0.99) and threshold cycle 
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(Ct) values. The Ct value is the number of cycles needed to surpass the 
background/threshold fluorescence signal. The lower the Ct value, the greater the 
amount of target in the sample. Hence, the Ct value is inversely proportional to 
the target oligo in the cDNA sample. The melt curve was also analysed for primer 
efficiency. The presence of one single peak on a melt-curve graph indicated 
primer specificity to the target oligo sequence and a good melt curve. If more than 
one peak was observed, the primer(s) were not used as it indicated primer self-
complementarity or more than one annealing site in the cDNA sample. Ct values 
were calculated as follows: 
 
Step1: 
Normalise sample to the housekeeping gene, 
ΔCt = Ct value of sample – 28S rRNA Ct value of sample 
 
Step2: 
ΔCt is normalised to a reference; in this case, 28S rRNA is set to 1, 
ΔΔCt = ΔCt - 1 
 
Step3: 
Increase in the amount of target cDNA in comparison to the reference, 
2 –ΔΔCt  
 
 
2.2.2.5 Primer validation in tissues 
 
The two sets of primers that were designed for each cDNA were tested in a range 
of tissues to obtain a primer that satisfied the criteria described in section 2.2.2.4. 
The two primers for each cDNA were also tested using serial dilutions of cDNA. A 
serial dilution of the total cDNA sample from a specific test tissue was prepared in 
the 96-well plate. Separate wells contained 5 ng, 2.5 ng, 1.25 ng or 0.625 ng of a 
tissue’s total cDNA together with the reaction mixture described in 2.2.2.4. 
Primers were tested in duplicates with each serial dilution. Since the dilutions 
were different by a factor of two, the amplification by a set of primers was 
expected to be one Ct value apart for each dilution. If the primers could not 
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correctly detect these changes in total cDNA concentration, they were discarded 
and replaced with newly designed primers.  
 
 
2.2.3 Preparation and use of primary rat adipocytes for in vitro studies 
 
2.2.3.1 Isolation and preparation of rat adipocytes 
 
6-8 rats were sacrificed by cervical dislocation and their epididymal fat pads were 
removed and placed in KRBH buffer (maintained at 37°C). 4 fat pads per 5 ml of 
sterile digestion buffer (131 mM NaCl, 4.7 mM KCl, 1.25 mM MgSO4.7H2O, 2.5 
mM CaCl2.2H2O, 2.5 mM NaH2PO4.2H2O, 10 mM HEPES pH 7.4, 1% BSA (w/v), 
0.05% collagenase (type I) (Worthington), 5 mM glucose) were transferred into a 
30 ml skirted conical bottom tube (Universal tube) and minced with scissors 
(approximately 120 chops). The skirted conical bottom tubes were transferred to a 
water bath at 37°C and shaken at 150 cycles/min for 30-35 min until no lumps 
were present. The cell suspension was filtered through 2 layers of nylon mesh 
that had a pore size of 250 µm and the mesh was washed with KRBH buffer into 
a new 30 ml skirted conical bottom tube. Cells were allowed to float to the top for 
1 min in a 37°C water bath. The infranatant was removed using a blunt ended 
needle; cells suspensions were adjusted to approximately 25 ml with additional 
KRBH buffer and gently inverted to mix. The KRBH buffer washing process was 
repeated 3 times and the cell suspension was adjusted to 50% cytocrit. To 
prepare the cytocrit, adipocyte suspension was roughly adjusted in KRBH buffer 
to contain 50% (v/v) KRBH buffer to adipocytes in the universal tube. The 
universal tube was gently inverted to evenly mix the adipocyte suspension and a 
capillary tube was inserted in this suspension to take a sample. The end of the 
capillary tube was sealed with plasticine before it was centrifuged at 1000 x g for 
1 min. The separated adipocyte and buffer volumes were calculated as a fraction 
of the adipocyte length in the capillary tube. The cytocrit was then adjusted to the 
required cytocrit with additional KRBH buffer. 
 
 
2.2.3.2 Electroporation  
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Dulbeco’s Modified Eagles Medium I (DMEM-I) (Dulbeco’s Modified Eagles 
Medium, 0.2 µM adenosine with 2 mM glutamine), DMEM-II (DMEM-I with 100 
µg/µl gentamycin) and DMEM-III (DMEM-II with 3.5% (w/v) BSA) were prepared 
1-2 h prior to electroporation and placed in an incubator with 5% CO2 at 37°C. An 
appropriate concentration of the mammalian expression vector(s) (described in 
the respective figure legend) was prepared in DMEM-I with 0.5 mg/ml final 
concentration of herring sperm DNA to yield the DNA mixture. The volume of 
DNA was diluted to provide sufficient material for 5 cuvettes per reaction condition 
or 1 ml of DNA mixture per reaction condition. Each electroporation cuvette 
accommodated 200 µl of the DNA mixture and 200 µl of cell suspension. 
 
Prior to electroporation, the cell suspension that was prepared in 2.2.3.1 was 
washed once in DMEM-I and allowed to float. The cell suspension was adjusted 
to 50% cytocrit as described in section 2.2.3.1. The cytocrit was adjusted to 50% 
with DMEM-I instead of KRBH buffer. The 50% adipocyte-DMEM-I suspension 
was placed in a water bath that was maintained at 37°C until electroporation.  
 
Cuvettes containing cell suspension and DNA mixture were electroporated using 
a Biorad Gene Pulser (Biorad) at 400 V and 500 µF. A time constant of 12-14 ms 
was achieved under these conditions. Cuvette contents from each condition were 
pooled into a 15 ml polypropylene centrifuge tube (Fisher Scientific). The 15 ml 
tube was adjusted to approximately 13 ml with DMEM-II and incubated at 37°C 
until the next set of cuvettes were electroporated. The infranatant from the 15 ml 
tube was removed using a sterile blunt ended needle and the remaining cells 
were re-suspended in 4 ml of DMEM-III. The newly re-suspended cells were 
transferred to a 5 ml cell culture petri dish and maintained overnight (16 h) in an 
incubator at 37°C with 5% CO2, unless otherwise mentioned in a figure legend. 
 
On the next day, adipocytes were transferred to 15 ml flat-bottomed 
polypropylene tubes (Sarstedt) and washed thrice with KRBH buffer. This was 
done to remove residual DMEM-III prior to treating the adipocytes with insulin. 
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2.2.3.3 Insulin stimulation 
 
The adipocyte suspension(s) prepared in section 2.2.3.1 (without electroporated 
plasmid) or 2.2.3.2 (with electroporated plasmid) were separated into 15 ml flat-
bottomed polypropylene tubes that were labelled as basal or insulin samples. The 
samples from section 2.2.3.1 that were prepared without any electroporation were 
stimulated with 20 nM insulin for 20 min at 37°C. The samples from section 
2.2.3.2 that were electroporated with plasmid(s) were first re-suspended in 10 ml 
KRBH buffer and allowed to stand at 37°C. The infranatant was then removed 
with blunt ended needles. This re-suspension step with KRBH buffer was 




2.2.3.4 HA-GLUT4 translocation studies 
 
Adipocytes prepared as described in section 2.2.3.2 and 2.2.3.3 were transferred 
to 4 ml polypropylene tubes prior to insulin stimulation. The polypropylene tubes 
were labelled as basal or insulin samples. The adipocyte samples were then 
stimulated with 60 nM insulin. The polypropylene tubes were gently inverted every 
5 min to ensure adequate mixing. After 20 min, intracellular GLUT4 trafficking  
was stopped by addition of KCN to a final concentration of 2 mM. The tubes were 
gently inverted to mix the KCN. The samples were moved from the 37°C water 
bath to room temperature. Each adipocyte cell suspension sample was washed 
twice using blunt ended needles to remove the infranatant after each wash. After 
each wash, the cells were allowed to float to the top of the tube. Washes were 
done with 2 ml Krebs-Ringer-HEPES (KRH) buffer (131 mM NaCl, 4.7 mM KCl, 
1.25 mM MgSO4.7H2O, 2.5 mM CaCl2.2H2O, 2.5 mM NaH2PO4.2H2O with 10 mM 
HEPES pH 7.4) containing a final concentration of 2 mM KCN. The sample was 
made up to 1 ml, inverted to mix and 100 µl of the cell suspension was 
transferred (using cut pipette tips) to a 1.5 ml microfuge tube containing 100 µl 
SDS sample buffer (2% (w/v) SDS, 62.5 mM Tris-HCl pH 6.8, 0.01% (w/v) 
bromophenol blue, 10% (w/v) glycerol and 100 mM dithiothreitol (DTT)). The 200 
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µl cell suspension sample mixed with SDS sample buffer was frozen at -20°C (it 
was used as a control with the SDS-PAGE gel and western blotted to check the 
electroporated plasmid expression levels). The remaining adipocyte suspension 
samples were washed once more with 2 ml KRBH buffer containing 2 mM KCN 
and incubated with the mouse anti-HA antibody (see Table 2.2) for 1 h at room 
temperature with mixing by inversion every 15 min. The cells were then washed 
twice with 2 ml KRBH buffer containing 2 mM KCN. The adipocyte suspension 
was adjusted to 1 ml and incubated with anti-mouse secondary antibody 
(conjugated with β-galactosidase) (Southern Biotech.) for 1 h at room temperature 
with mixing by inversion every 15 min. Each of the adipocyte suspensions 
(treated as basal or insulin) were washed once with 2 ml KRBH buffer containing 
2 mM KCN and then thrice with 2 ml KRH buffer only. The adipocyte suspensions 
were transferred to a Bijou tube and were adjusted to a final 3 ml volume with 
KRH buffer. A black microtitre plate (Greiner) was set up containing 50 µl of KRH 
buffer. Simultaneously, the stock fluorescein di-β-D-galactopyranoside (FDG) 
reagent (Molecular Probes) was prepared at a dilution of 1:200 in KRH buffer. 
The adipocyte suspension was inverted and mixed well before pipetting 50 µl 
from each sample as quintuplicates into each well of the microtitre plate that 
already contained 50 µl KRH buffer. 100 µl of the diluted FDG reagent was added 
to each well and fluorescence was measured using a PHERAstar FS microplate 
reader (BMG Labtech.). 50 µl of the adipocyte suspension from the Bijou tube 
was transferred to a microfuge tube containing 50 µl of 0.2 M NaOH and assayed 
for protein content using the BCA method (as described in section 2.2.5.7).  
 
 
2.2.3.5 Subcellular fractionation studies 
 
Adipocyte suspensions were electroporated with HA-Noc2 or HA-Noc2 AAA and 
maintained overnight (as described in section 2.2.3.2). Basal and insulin-treated 
adipocytes were washed in HEPES-EDTA-sucrose (HES) buffer (20 mM HEPES 
pH 7.2, 1 mM EDTA and 225 mM sucrose) containing SigmaFAST protease 
inhibitors (Sigma-Aldrich) and phosphatase inhibitors (10 mM NaF, 200 µM 
Na3VO4, 1 mM Na2MoO4, 0.1 µl NIPP1 stock). This washing step was performed 
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18°C and the adipocytes were allowed to float. The infranatant was removed and 
1 ml of HES buffer was added to the adipocytes. The adipocytes were 
homogenised with 10 strokes of a 55 ml Potter-Elvehjem homogeniser (Thomas 
Scientific) at a speed of 1600 rpm using a Rexon DP-200 AS bench top drill. The 
homogenised adipocyte preparation was transferred to 1.5 ml microfuge tubes 
(Eppendorf) and centrifuged at 1000 x g at 4°C for 1 min in a refrigerated 
centrifuge. 100 µl of this homogenate was saved to run on an SDS-PAGE gel and 
to analyse protein expression levels. The homogenate was then centrifuged at 
17,500 x g for 20 min at 5°C. The resulting pellet was used to isolate the plasma 
membrane and the infranatant was used to isolate the cytosol while the top layer 
of fat was discarded. The infranatant was removed using a needle (21 G x 1.5”) 
(BD Biosciences) attached to a 2 ml syringe (BD Biosciences) and transferred to 
a fresh ultra-clear centrifuge tube. All the following centrifugation runs were done 
in a Beckman TL-100 bench-top ultracentrifuge with a TLA-100.3 fixed angle rotor 
(Beckman Coulter) maintained at 4°C. The infranatant was centrifuged at 49,000 
x g for 9 min. The supernatant contained the cytosol and low-density microsomes 
(LDM) and the pellet contained the high-density microsomes (HDM). The 
supernatant was centrifuged at 541,000 x g for 17 min and the resulting 
supernatant was transferred to a new 1.5 ml microfuge tube (Eppendorf) and 
assayed for cytosolic protein content.  
 
To isolate the plasma membrane, the pellet (obtained after the 17,500 x g 
centrifugation for 20 min) was re-suspended in 1 ml of chilled HES buffer, 
homogenised in a small 5 ml glass homogeniser with 5 strokes and transferred to 
2 ml ultra-clear centrifuge tubes (Beckman Coulter). 1 ml of HES buffer was 
added to the homogeniser and it was homogenised with 2 strokes to mop up any 
remaining sample. This 1 ml was transferred to the same ultra-clear centrifuge 
tube containing the pellet homogenate. The pellet homogenate was centrifuged at 
17,500 x g for 20 min. The pellet was re-suspended in 300 µl of HES buffer and 
layered onto 600 µl of HES sucrose cushion (20 mM HEPES pH 7.2, 1 mM EDTA 
and 1.12 M sucrose) and centrifuged at 105,000 x g for 20 min in a TLS-55 swing 
out rotor. The resulting pellet contained mitochondria and nuclei. The interface 
was used to isolate the plasma membrane. To 700 µl of the plasma membrane, 2 
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ml of HES buffer was added and it was centrifuged at 74,000 x g for 9 min. The 
plasma membrane pellet was re-suspended in another 2 ml of HES buffer and 
centrifuged at 74,000 x g for 9 min. The plasma membrane was again re-
suspended in 100 µl HES buffer and assayed for protein content using the BCA 
protein assay protocol described in section 2.2.5.7. 
 
 
2.2.3.6 Lysis of rat adipocytes 
 
Adipocytes were treated as basal or insulin samples (as described in section 
2.2.3.3), washed once with 10 ml KRH buffer maintained at 37°C and allowed to 
float. The infranatant was removed and an equal amount of the lysis buffer 
containing Halt protease inhibitor cocktail (Fisher Scientific) was added to the 
adipocyte suspension. HEPES-NaCl lysis buffer (20 mM HEPES pH 7.5, 100 mM 
NaCl, 2% (v/v) Triton X-100) was used for the Rab3B pull-down studies and Tris-
NaCl lysis buffer (20 mM Tris-HCl pH 7.5, 200 mM NaCl, 10% glycerol, 2% (v/v) 
Triton X-100) was used for the Noc2 pull-down studies. The adipocytes were 
lysed by vortexing the sample for 15 s and incubating it at 18°C for 20 min. The 
lysate sample was vortexed once again for 15 s after 20 min and transferred to 
1.5 ml microfuge tubes followed by centrifugation at 17500 x g for 20 min. The 
microfuge tubes containing the sample were then kept on ice for 10 min to allow 
the fat to solidify. A 21 G x 2” needle (BD Biosciences) was used attached to a 2 
ml syringe (BD Biosciences) to remove the clear lysate from the solidified fat that 
formed a white layer at the top of the lysate. The clear lysate was assayed for 
protein content using the BCA protein assay protocol described in section 2.2.5.7.  
 
 
2.2.3.7 Rab3B pull-down studies 
 
Rab3B was loaded with GTPγS or GDP. A GST only protein was also subjected 
to the following protocol as a control but the buffers for the GST only protein were 
devoid of any guanine nucleotide. The method in this section is adopted from 
Christoforidis and Zerial (2000) and involves a number of steps to ensure a stable 
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Rab3B-(GTPγS/GDP) interaction. Mg2+ is required for facilitating the binding and 
stabilisation of GTP or GDP to the switch region of a Rab GTPase. When EDTA 
is present in excess, it chelates Mg2+ thereby releasing any bound guanine 
nucleotide from the switch region. The nucleotide loading (NL) buffers that contain 
excess EDTA in relation to MgCl2 facilitate unloading of any bound guanine 
nucleotide from the Rab protein and loading of the guanine nucleotide present in 
the respective buffer. The buffers that contain excess MgCl2 in relation to EDTA 
facilitate stabilisation of guanine nucleotide present in the respective buffer.  
 
The GST-only construct and GST-Rab3B was expressed as described in 2.2.5.1 
and dialysed in HEPES-NaCl buffer (20 mM HEPES pH 7.5, 100 mM NaCl). 
Glutathione agarose beads (Pierce) were washed once with PBS and twice with 
HEPES-NaCl buffer to precondition them for GST–Rab3B binding. 20 mg of GST 
or 40 mg of GST-Rab3B was incubated with 1 ml of glutathione beads in 2 ml 
Talon disposable gravity column (Clontech Labs Inc.). Incubation was carried out 
for 1 h at 4°C on a rotator. The following buffers were prepared and the procedure 
was followed as depicted in Fig. 2.1.  
 
• Nucleotide Loading buffer I (NL-I): 20 mM HEPES-HCl pH 7.5, 100 mM NaCl, 
10 mM EDTA, 5 mM MgCl2, 1 mM dithiothreitol (DTT), 10 µM GTPγS (or 10 µM 
GDP). 
• Nucleotide Loading buffer II (NL-II): 20 mM HEPES-HCl pH 7.5, 100 mM NaCl, 
10 mM EDTA, 5 mM MgCl2, 1 mM dithiothreitol (DTT), 1 mM GTPγS (or 1 mM 
GDP). 
• Nucleotide Stabilisation buffer I (NS-I): 20 mM HEPES-HCl pH 7.5, 100 mM 
NaCl, 5 mM MgCl2, 1 mM dithiothreitol (DTT), 10 µM GTPγS (or 10 µM GDP). 
• Nucleotide Stabilisation buffer II (NS-II): 20 mM HEPES-HCl pH 7.5, 100 mM 







Figure 2.1: Loading of GST-Rab3B with GTPγS or GDP. Nucleotide loading (NL) and 
nucleotide stabilisation (NS) buffers were prepared separately for Rab3B containing glutathione 
beads that needed to be loaded with GTPγS or GDP (Sigma-Aldrich). GST-only sample was 
treated with buffers that were prepared with no nucleotide. The steps in Fig. 2.1 were carried out 
at 22°C in Talon columns (Clontech Labs Inc.), which contained a preparation of GST-only or 
GST-Rab3B fusion protein bound to glutathione agarose beads (Pierce). Protocol for Rab3B pull-
down was adapted from Christoforidis and Zerial (2000). 
 
 
The glutathione beads containing Rab3B (loaded with either GTPγS or GDP) and 
the glutathione beads containing GST-only were washed once with HEPES-NaCl 
buffer before incubation with adipocyte lysates. The adipocytes were lysed in lysis 
buffer (as described in section 2.2.3.6) and quantified for protein content using the 
BCA method (as described in section 2.2.5.7). An equal concentration of 10 mg 
adipocyte lysate was added to columns containing GST, GST-Rab3B-GTPγS or 
GST-Rab3B-GDP immobilised on glutathione beads. The columns were sealed 
and the lysate and beads were incubated for 2 h at 4°C on a rotator. The lysate 
was then drained out of each column. The beads in each column were then 
washed with 10 ml of NS-I buffer followed by 10 ml of Nucleotide Stabilisation 
buffer III (NS-III) (20 mM HEPES-HCl pH 7.5, 250 mM NaCl, 5 mM MgCl2, 1 mM 
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dithiothreitol (DTT), 10 µM GTPγS (or 10 µM GDP) and 10 ml of NS-III buffer 
without any guanine nucleotide. The GST-only column was treated in the same 
way but the buffers contained no nucleotide. Endogenously bound proteins were 
eluted from the beads by exchanging the nucleotide on each column using the 
guanine elution buffer. Proteins from the Rab3B-GTPγS column were eluted with 
elution buffer containing GDP (20 mM HEPES pH 7.5, 1.5 M NaCl, 20 mM EDTA, 
1 mM dithiothreitol (DTT), 5 mM GDP (or GTPγS). Proteins from the Rab3B-GDP 
column were eluted with elution buffer containing GTPγS while proteins from the 
GST-only column were eluted with elution buffer containing no nucleotide (the use 
of GTPγS or GDP in the elution buffers ensured that only the GTPγS or GDP 
specific proteins that bound to the Rab3B beads were eluted). The beads were 
incubated with their respective elution buffers at room temperature for 20 min on 
a rotator. Eluted protein samples were concentrated on a 15 ml Amicon® Ultra 
spin column (Millipore) (as per manufacturer’s instructions) to 100 µl and mixed 
with SDS sample buffer before being separated on an SDS-PAGE gel. 
 
 
2.2.3.8 Noc2 pull-down studies 
 
Adipocytes were isolated and electroporated with FLAG-Rab3B and maintained 
overnight (as described in sections 2.2.3.1 and 2.2.3.2). On the next day, the 
electroporated adipocytes were maintained as basal or treated with insulin (as 
described in section 2.2.3.3) and lysed with Noc2 lysis buffer (as described in 
section 2.2.3.6). The lysates were quantified for protein content using the BCA 
method (as described in section 2.2.5.7) and placed in an ice bucket. The basal 
lysate volume was split equally into two samples. One sample was maintained as 
the basal condition and the other sample was segregated so that it could be 
loaded with GTPγS. GTPγS was added to the segregated basal lysate sample to 
give a final concentration of 1 mM GTPγS and this sample was incubated for 10 
min at 37°C. The basal-GTPγS sample was then transferred to an ice bucket. The 
GTPγS loading was stabilised by the addition of a final concentration of 10 mM 
MgCl2 to the basal-GTPγS lysate sample. To maintain consistency, a final 
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concentration of 10 mM MgCl2 was added to the basal and insulin lysate samples 
as well.  
 
25 µg of the GST protein or 50 µg of the GST-His-Noc2 fusion protein was added 
to 100 µl of glutathione agarose beads in a 1.5 ml microfuge tube and maintained 
for 2 h at 4°C on a rotator. When the MBP-tagged Noc2 construct was used 
(instead of the GST-His-tagged Noc2 construct), 30 µg of MBP-Noc2 was added 
to 100 µl of amylose beads and maintained for 2 h at 4°C on a rotator. After the 2 
h incubation of beads with GST-His or MBP-tagged Noc2, the beads were 
washed once with Noc2 lysis buffer. An equal concentration of the lysate from 
basal, insulin or GTPγS samples (described above) was added to the beads and 
the incubation was carried out for 1 h at 4°C on a rotator. The beads were 
washed with 1 ml wash buffer (20 mM Tris pH 7.5, 200 mM NaCl, 5 mM MgCl2, 
5% glycerol, 0.2% Triton X-100) five times.  
 
Proteins bound to the GST-tagged Noc2 were eluted with 80 µl SDS sample 
buffer. Proteins bound to the MBP-tagged Noc2 were eluted with maltose elution 
buffer (20 mM Tris pH 7.5, 200 mM NaCl, 5 mM MgCl2, 40 mM maltose). Eluted 
protein samples were separated on an SDS-PAGE gel and western blotted (as 
described in sections 2.2.5.3, 2.2.5.5 and 2.2.5.6). 
 
 




 Basal or insulin stimulated adipocytes were fixed by incubation with 4% (w/v) 
paraformaldehyde in KRH buffer for 20 min at room temperature, and washed 3 
times with PBS using a blunt ended needle and syringe. Cells were then 
incubated with permeabilisation buffer (1% (w/v) BSA, 3% (v/v) goat serum, 0.1% 
(w/v) saponin, PBS) for 45 min at 22°C. The permeabilisation buffer was removed 
and respective primary antibodies (see Table 2.2) diluted in permeabilisation 
buffer were added to the cell samples, which were incubated overnight at 22°C on 
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a rotary shaker. After 18 h, the cells were washed four times using wash buffer 
(1% (w/v) BSA, 0.1% (w/v) saponin, PBS). Following the washes, the cell 
samples were incubated with species-specific fluorophore conjugated secondary 
antibodies (see Table 2.5) for 2 h at 22°C on a rotator.  
 
After the 2 h incubation with the secondary antibody, the cell samples were 
washed similarly (as done after the primary antibody incubation) with wash buffer 
five times. The cell samples were roughly adjusted to 50% cells to the wash 
buffer. 10 µl of a 50% adipocyte cell suspension was added on a microscopy slide 
containing 10 µl of Vectashield mounting medium (Vector Labs.). Coverslips were 











Table 2.5: Secondary antibodies for immunofluorescence. The table provides a list of the 
Alexafluor® conjugated secondary antibodies that were directed to the target primary antibody 
(see Table 2.2). 
 
 
2.2.4.2 Confocal microscopy 
 
Confocal microscopy was performed using a Zeiss LSM 510 META microscope 
with 63 x 1.4 NA oil-immersion objective and with dual or triple laser excitation at 
458–488, 543 and 633 nm.  
 
 
2.2.5 Protein biochemistry techniques 
 





Alexafluor® conjugated  
secondary antibody 
GLUT4 or HA-GLUT4 Anti-rabbit 633 
Early Endosomal Antigen 1 (EEA1) Anti-mouse 568 
Transferrin receptor (TfR) Anti-mouse 546 
syntaxin-6 (Stx6) Anti-mouse 546 
Ubiquitin (Ub) Anti-mouse 568 
 63 
A glycerol stock of E.coli containing the protein expression construct (listed in 
Table 2.6) was gently streaked using sterile pipette tip and inoculated into a 50 ml 
conical flask containing 10 ml of LB broth and the concerned antibiotic (1 mg per 
10 ml of ampicillin for the AmpR constructs and 0.5 mg per 10 ml of kanamycin for 
the KanR constructs). The culture was grown overnight in a shaking incubator at 
37°C at 250 x g. This culture was inoculated into a larger 2 l conical flask 
containing 500 ml LB broth on the next day. The 500 ml culture was incubated on 
a shaking incubator at 37°C at 250 x g. The density of the culture measured from 
absorption at 600 nm (A600 nm) was checked regularly at 1 h intervals. Once the 
A600 nm reached 0.6-0.8, the culture was induced with isopropyl β-D-1 
thiogalactopyranoside (IPTG) as described in Table 2.6. The culture was then 
allowed to express the fusion protein for 3 h at room temperature. In some cases, 
the expression time and temperature were varied and this is indicated in the 
respective figure legends. Following expression, the 500 ml culture was 
centrifuged at 5000 x g for 10 min at 4°C. The supernatant was discarded and cell 
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E.coli Lemo21 (DE3) 
 
fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS/ 




Table 2.6: List of bacterial strains and respective genotypes. The bacterial strains were 
transformed with the desired bacterial expression vector (see Supplementary table S1 for list of 
expression vectors) and expression was induced with the IPTG concentration listed in this table 
(see section 2.2.5.1 for a more detailed explanation on protein expression). 
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2.2.5.2 Purification of tagged protein constructs 
 
The frozen pellet obtained from a 500 ml culture (as described in section 2.2.5.1) 
was defrosted on ice and re-suspended with 10 ml of ice cold phosphate buffered 
saline (PBS) (12.5 mM Na2HPO4, 154 mM NaCl pH 7.2) (unless otherwise 
specified) containing 100 µl Protein Phosphatase Inhibitor Set II (Calbiochem) in 
a 50 ml conical centrifuge tube (Fisher Scientific). The cell suspension was 
sonicated on ice using a bench top ultrasonic disintegrator (MSE). Sonication was 
done at 15 s bursts followed by 45 s of cooling period on ice. This process was 
repeated 10 times. The sonicated cell suspension was centrifuged at 20,000 x g 
for 45 min at 4°C to clarify the lysate. The clear ~10 ml supernatant was 
transferred to a new 15 ml conical centrifuge tube and incubated with 500 µl of 
glutathione agarose beads (Pierce) in the case of GST-tagged fusion proteins. 
MBP-tagged fusion proteins were purified using an amylose resin (New England 
Biolabs). Proteins were bound to the beads (or resin) for 1 h at 4°C on a rotator 
with even mixing. Post binding, the beads were washed 5 times with 10 ml 
HEPES-NaCl buffer for Rab3B fusion proteins or Tris-NaCl buffer (20 mM Tris-
HCl pH 7.4, 200 mM NaCl) for Noc2 fusion proteins. The fusion protein was either 
left on the beads or eluted using an elution buffer. To elute the fusion proteins, 
beads were incubated with 500 µl glutathione elution buffer (for GST-tagged 
fusion proteins) (20 mM HEPES pH 7.5, 100 mM NaCl, 20 mM reduced 
glutathione, 5 mM β-mercaptoethanol) or maltose elution buffer (for MBP-tagged 
fusion proteins) (20 mM Tris pH 7.5, 200 mM NaCl, 5 mM MgCl2, 40 mM maltose) 
and gently mixed for 5 min at room temperature. The 1.5 ml microfuge tube 
containing beads and eluate was centrifuged for 1 min at 1000 x g to sediment 
the beads. The eluate was transferred to a fresh microfuge tube. This elution 
process was repeated 5 times and all elutions were pooled together. The pooled 
eluate was concentrated on a spin column to 0.5-1 ml and dialysed with 5 litres of 
the respective HEPES-NaCl or Tris-NaCl buffer. The dialysed fusion protein 




His-tagged fusion proteins were purified on a 1 ml HisTrap FF (GE Healthcare) 
column using an AKTA FPLC machine (Amersham Biosciences) (Bornhorst and 
Falke, 2000). The HisTrap FF column was washed with five column volumes of 
20% ethanol followed by five column volumes of wash solution (20 mM Tris-HCl 
pH 7.5, 200 mM NaCl, 20 mM Imidazole). The His-tagged fusion protein sample 
was injected into the HisTrap FF column. The column was washed with wash 
solution until the A280 nm on the FPLC machine dropped to 0, indicating that any 
unbound proteins had been washed out from the column. The His-tagged fusion 
protein bound to the column was eluted at a gradient using an elution buffer (20 
mM Tris-HCl pH 7.5, 200 mM NaCl, 400 mM imidazole). The eluted fractions 
were collected, pooled, concentrated on a 15 ml Amicon® Ultra spin column 






SDS-PAGE electrophoresis was performed using the Laemmli discontinuous 
buffer system (Laemmli, 1970). Generally, gel slabs were used that had a 
thickness of 1.5 mm. For samples that had a small volume, the mini-Protean II gel 
system (Biorad) was used while for samples of bigger volumes or to achieve 
better resolution of proteins, the CBS gel system (CBS Scientific) was used. Gels 
were prepared using ProtoGel (Fisher Scientific) acrylamide/bis-acrylamide (30% 
w/v acrylamide) in stacking (0.5 M Tris-HCl pH 6.8, 0.4 % (w/v) SDS) or resolving 
buffers (1.5 M Tris-HCl pH 8.8, 0.4 % (w/v) SDS). The amount of ProtoGel 
solution used for making the different percentage gels was determined using the 
following formula: VP = (X) (VT) / 30. Where, VP is Volume of 30% ProtoGel, X is 
% of the monomer desired in gel and VT is the total volume of gel casting solution. 
The polymerisation of acrylamide and bis-acrylamide was initiated using 10% 
(w/v) ammonium persulfate (APS) and undiluted N,N,N,N’-tetramethylenediamine 
(TEMED) as a catalyst. The final concentration of APS was 0.05% in stacking 
gels and resolving gels while the final concentration of TEMED was 0.1% in the 
stacking gels and 0.05% in the resolving gels. Protein samples for SDS-PAGE 
were solubilised by addition of SDS sample buffer and 25 mM DTT followed by 
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boiling for 5 min on a heat block. Samples were loaded into the wells alongside a 
Novex® Sharp pre-stained protein maker (Invitrogen). The gels were run using 
electrophoresis buffer (25 mM Tris-HCl pH 6.3, 0.1% (w/v) SDS, 0.2 M glycine) at 
a constant voltage of 200 V for 1 h until the dye front had run out of the gel.  
 
 
2.2.5.4 Coomassie staining 
 
For visualisation of proteins directly on the gel, coomassie staining was carried 
out. The SDS-PAGE gel was rinsed once in water to get rid of any electrophoresis 
buffer. The gel was then incubated for 2 h with Fermentas PageBlueTM Staining 
Solution (Thermo Scientific) and was de-stained overnight in ddH2O. Images of 
the gel were taken using a Hamamatsu camera attached to the EPI Chem II 
darkroom (Ultra-Violet Products). 
 
 
2.2.5.5 Electrophoretic transfer of proteins for western blotting 
 
Nitrocellulose membrane (Pall Life Sciences) and two pieces of extra thick blot 
paper (Biorad) were cut to an appropriate size for the gel and soaked in transfer 
buffer (39 mM glycine, 48 mM Tris pH 8.8, 0.0375% SDS (w/v), 20% methanol 
(w/v)). For electrophoretic transfer, the TransBlot SD Semi-Dry Transfer Cell 
apparatus (Biorad) was used. A piece of wet blotting paper was first placed on the 
anode. The nitrocellulose membrane and then the resolving gel piece were 
placed on the wet blotting paper. Any air bubbles were gently removed using a 
handheld roller. Another piece of wet blotting paper was placed over the gel. A 
roller was rolled across the top of this set-up to remove any air bubbles. The 
apparatus was sealed with the cathode lid. Electrophoretic transfer was carried 
out at constant current for 1 h 50 min. The current used was calculated at 0.8 mA 
per cm2 of gel area. 
 
 
2.2.5.6 Western blotting 
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The nitrocellulose membrane was washed with ddH2O and stained with Ponceau 
S solution (0.1% (w/v) Ponceau S, 3% (w/v) trichloroacetic acid). The markers 
were labelled with a pencil. 5% dried skimmed milk from Marvel was prepared in 
Tris-buffered saline containing Tween-20 (TBS-T) (10 mM Tris-HCl pH 7.4, 154 
mM NaCl, 0.1% (v/v) Tween) to make the 5% blocking solution. The membrane 
was blocked with 5% blocking solution on a shaker for 1 h. The membrane was 
washed five times with 5 min each time in TBS-T followed by incubation with the 
primary antibody on a shaker overnight at 4°C or for 2 h at room temperature. The 
primary antibody was washed off the membrane five times with 5 min each time in 
TBS-T followed by incubation with secondary antibody. The secondary antibody 
was diluted (1:5000 unless otherwise specified) in 5% blocking solution and 
incubated with the membrane on a shaker at room temperature for 45 min. The 
secondary antibody was washed off six times with 5 min each time using TBS-T. 
The membrane was dried on the bench for 1 min and incubated for 3 min with 1:1 
ratio of ECL (A and B) or for 5 min with Dura (Thermo Scientific) or ECL advance 
(Amersham Biosciences). The fluorescent bands were detected on the membrane 
using a Hamamatsu camera attached to the EPI Chem II darkroom  
(Ultra-Violet Products). 
 
To re-probe the same blots with another antibody, the nitrocellulose membranes 
were stripped of the bound antibodies by incubating the membranes with stripping 
buffer (62.5 mM Tris-HCl pH 6.7, 100 mM β-mercaptoethanol, 2% SDS) for 30 
min at 50°C with gentle shaking. The membranes were then washed twice with 10 
min each time using TBS-T, blocked with 5% blocking solution and re-probed by 
following the western blot procedure again. 
 
 
2.2.5.7 Protein quantification assays 
 
Protein assays were carried out using bicinchoninic acid (BCA) (Pierce) or the 
ready to use 660 nm Protein Assay reagent (Pierce). The protein standards were 
prepared from a stock of 1 mg/ml BSA protein solution and diluted to yield 0.2, 
0.4, 0.6, 0.8 and 1.0 µg per 10 µl sample. The 10 µl sample was added to each 
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well of a 96-well microtitre plate (Greiner). Samples were assayed in duplicates. 
10 µl of the test protein sample was loaded in duplicates alongside the above 
standards for quantification. In case of the BCA protocol, Reagent A (Pierce) and 
Reagent B (4% (w/v) CuSO4.5H2O) were prepared in a 50:1 dilution. 200 µl of the 
BCA preparation or 200 µl of the 660 nm Protein Assay reagent was added to 
each well containing the standards or sample. The 96-well plate was incubated at 
37°C for 30 min and then kept at room temperature for 2 min before it was read 
on a PHERAstar FS microplate reader (BMG Labtech.). Plates prepared with 
BCA reagent were read at 565 nm while those prepared with the 660 nm Protein 
Assay reagent were read at 660 nm. 
 
 
2.2.5.8 Extraction of proteins from SDS-PAGE gels for mass 
                   spectrometry 
 
After analysis of the SDS-PAGE coomassie gel, the bands that needed to be 
excised for analysis were identified. The gel was placed on a clean surface and 
the bands were cut using a scalpel. The protocol for in-gel trypsin digestion and 
protein extraction was followed as described by Kinter and Sherman (2000). The 
gel pieces were transferred into a 1.5 ml microfuge tube containing 200 µl of 
wash solution (50 % methanol, 5% acetic acid in Milli-Q® H2O) and put on a 
rotator overnight. On the second day, the wash solution was removed and the gel 
sample was washed again with 200 µl of wash solution for 2 h on a rotator. The 
sample was centrifuged at 1000 x g for 1 min and wash solution was discarded. 
To dehydrate the sample, 200 µl of 50 mM acetonitrile was added and the sample 
as incubated for 5 min at room temperature. The acetonitrile was removed and 
the dehydration step was repeated once more. Protein samples were subjected to 
a reduction step, which was carried out by the addition of 30 µl of 10 mM DTT to 
the sample and incubating it for 30 min at room temperature. DTT was removed 
and 30 µl of 50 mM iodoacetamide buffer was added to alkylate the sample. 
Alkylation was carried out for 30 min at room temperature. Iodoacetamide was 
removed and 200 µl of 50 mM acetonitrile was added for 5 min at room 
temperature to dehydrate the sample. Acetonitrile was removed and 30 µl of ice-
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cold trypsin solution was added to the sample, which was then placed on ice for 
10 min. The sample was centrifuged at 1000 x g for 1 min and the excess trypsin 
solution was removed. 5 µl of ammonium bicarbonate was added to the sample 
and the protein sample was allowed to trypsin digest overnight at 37°C. On the 
third day, 50 µl of ammonium bicarbonate was added to the sample and it was 
incubated for 10 min with gentle vortexing. The supernatant was collected in a 
new 1.5 ml microfuge tube termed the collection tube. 50 µl of extraction buffer I 
(50 % acetonitrile, 5 % formic acid in Milli-Q® H2O) was added to each of the gel 
pieces. The gel pieces were then incubated for 10 min with occasional and gentle 
vortexing. The supernatant was transferred to the collection tube prepared in the 
previous step. 75 µl of extraction buffer II (85 % acetonitrile, 5 % formic acid in 
Milli-Q® H2O) was added to the tube containing the gel pieces and this sample 
was again incubated for 10 min with occasional and gentle vortexing. The 
supernatant was transferred to the same collection tube. The sample in the 
collection tube was then dried down in a speed-vac and re-suspended in a re-
suspension buffer (98% Milli-Q® H2O, 2% acetonitrile, 0.1% formic acid). This 
sample was sent to the liquid chromatography-mass spectrometry facility and 
analysed on an Agilent Q-TOF instrument in the University of Bath Chemical 
Characterisation and Analysis facility. 
 
 
2.2.5.9 Analysis of data 
 
Images (1024 x 942) of individual cells acquired using the confocal microscope 
were saved as TIFF files that were generated using the Zeiss LSM Image 
analysis software. The intensity of each wavelength channel was adjusted to a 
comparable dynamic range using Adobe Photoshop. Each individual channel is 
then represented in images as black and white signals. The channel intensities 
were merged into a final image. The merged channels represent the following. 
Overlap of green and red gives yellow, overlap of blue and red gives magenta, 




Images from the western blots and coomassie gels were analysed using 
LabWorks (v4) (Ultra-Violet Products).  
 
Statistical analyses (paired two-tailed t-tests) were performed using Microsoft® 
Excel and graphs were prepared using GraphPad Prism® (v6). 
 
qPCR data were processed using the StepOneTM (v2.3) software (Applied 
Biosystems) and exported to Microsoft® Excel. 
 
Peptides identified by mass spectrometry were subjected to NCBI’s BLAST 
search to identify the desired protein. 
 
! 71!
3 GLUT4 traffic through an ESCRT-III-dependent 





Membrane proteins and lipids are kept tightly regulated to homeostatic levels by 
efficient endosomal (or degradative) pathways (Maxfield and McGraw, 2004). 
Recognisable features of endosomes are the endosomal markers present on the 
cargo/vesicle membrane. These markers are often proteins, which help 
endosome protein sorting into the correct compartment and recruitment of the 
appropriate cellular machinery. GLUT4 undergoes increased endocytosis and is 
either degraded, stored or recycled back to the plasma membrane, normally in 
the presence of insulin (Huang et al., 2001; Sargeant and Pâquet, 1993). This 
chapter delves deeper into the properties of well-established machinery involved 
in endosomal maturation called Endosomal Sorting Complex Required for 
Transport (ESCRT) and examines its possible involvement in the GLUT4 





The discovery of class E vacuolar protein sorting (Vps) genes in yeast paved the 
way for identification of ESCRTs in mammals (Table 3.1) (Raymond et al., 1992; 
Robinson et al., 1988). Fig. 3.1 is representative of the sequential formation of the 
ESCRT complex. This complex involves recruitment of four ESCRT complexes 
(ESCRT-0, ESCRT-I, ESCRT-II and ESCRT-III) onto an endosomal membrane 
(Babst et al., 2002a; Babst et al., 2002b; Bilodeau et al., 2002; Katzmann et al., 
2001). The ESCRT-0 protein HRS (hepatocyte growth factor-regulated tyrosine 
kinase substrate) initiates recruitment of the ESCRT proteins by recruiting clathrin 
to the endosomal membrane (Raiborg, 2001). Clathrin self-polymerises to form a 
scaffold and this leads to formation of a clathrin coated vesicle (Edeling et al., 
2006). The clathrin coated vesicle also contains ubiquitin and PtdIns(3)P that 
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facilitate cargo sorting into endosomal compartments. HRS binds to ubiquitin via a 
UIM (ubiquitin interacting motif) (Raiborg et al., 2002) and a FYVE (Fab1p, YOTB, 
Vac1p and EEA1) domain that interacts with PtdIns(3)P (Stahelin et al., 2002). A 
correlation can be drawn here between ESCRT formation and GLUT4 
endocytosis. It has been shown that clathrin and PtdIns(3)P is involved with 
insulin-stimulated GLUT4 trafficking (Huang et al., 2007; Kong et al., 2006). It has 
also been proposed that ubiquitination of GLUT4 is necessary for sorting GLUT4 
to insulin-responsive compartments (Lamb et al., 2010). As ESCRT proteins are 
implicated in sorting ubiquitinated proteins in the endocytic pathway, it may be 
hypothesised that ESCRTs may traffic ubiquitinated GLUT4. 
 
 
3.1.2 ESCRT-III and Vps4 
 
Each ESCRT complex consists of a number of components that converge to form 
a multi-subunit ESCRT complex (Williams and Urbé, 2007). The ESCRTs aid in 
compartmentalisation, maturation and subsequent sorting of an endosomal 
vesicle via formation of a multivesicular compartment (Hanson et al., 2009). The 
ESCRT-bound multivesicular compartment acts as a hub for intracellular cargo 
sorting. The ESCRT pathway enters its final stages via the recruitment of the 
ESCRT-III components following which the ESCRT complex is dissociated 
(Nickerson et al., 2006). The removal of ubiquitin from the multivesicular ESCRT 
bound compartment by deubiquitinases (DUBs) (Agromayor and Martin-Serrano, 
2006) leads to the delivery of the endosomal cargo to another intracellular storage 
compartments or to the lysosomes for degradation (Luzio et al., 2009).  
 
ESCRT-III is a hetero-oligomeric protein complex cumulatively 450 kDa in size 
(Teis et al., 2008). ESCRT-III is anchored to the endosomal membrane via a 
myristoyl group at the N-terminus of charged multivesicular body protein (CHMP) 
6 (Babst et al., 2002a; Yorikawa et al., 2005) and a PtdIns(3,5)P2 interacting 
protein CHMP3 (Whitley et al., 2003). CHMP6 and another ESCRT-III member 
CHMP4 also link ESCRT-III with the ESCRT-II component EAP20 (ELL 
associated protein of 20 kDa) (Yorikawa et al., 2005). The N-terminal region of 
CHMP3 interacts with CHMP4 forming a coiled-coil complex. CHMP3 further 
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associates with CHMP2 and recruits CHMP1. CHMP1 uses its C-terminal MIM 
(MIT interacting motif) to coordinate binding to the N-terminal MIT (microtubule 
interacting and trafficking) domain of Vps4 (Nickerson et al., 2006). Perturbation 
of CHMP3 (Muzioł et al., 2006), CHMP1 (Howard et al., 2001) or the ESCRT-III 
associating protein Vps4 (Dukes et al., 2008; Fujita et al., 2003) causes 
accumulation and mis-sorting of cargo. In dendritic cells, ESCRT-III dysfunction 
causes autophagosome accumulation and leading to age dependent 
neurodegenerative disorders (Lee et al., 2007).  
 
 
Table 3.1: Nomenclature of proteins involved with the ESCRT complex. The table represents 
the yeast and mammalian homologues for the ESCRT machinery. All ESCRT proteins in this 
thesis have been referred to with the mammalian ESCRT terminology for consistency. 
Complex S. cerevisiae protein Mammalian protein/isoform 
ESCRT-0 Vps27 HRS, Hgs 
 Hse1 STAM (1,2) 
ESCRT-I Vps23 Tsg101 
 Vps28 Vps28 
 Vps37 Vps37 (A,B,C,D) 
 Mvb12 Mvb12 (A,B), 
UBAP1, LOC290595 
ESCRT-II Vps22 EAP30 
 Vps25 EAP20 
 Vps36 EAP45 
ESCRT-III Vps2 CHMP2 (A,B) 
 Vps20 CHMP6 
 Vps24 CHMP3 
 Snf7 CHMP4 (A,B,C) 
 Vps60 CHMP5 
 Did2 CHMP1 (A,B) 
 Ist1 - 
Vps4 Vps4 Vps4A and Vps4B (SKD1) 
 Vta1 LIP5 
Accessory Bro1 AIP1 
Deubiquitinase  Doa4 
 
UBPY 




Figure 3.1: Mechanism of ESCRT recruitment to endocytosed cargo. ESCRTs are recruited to the vesicle membrane sequentially. ESCRT 
recruitment is facilitated by recognition of clathrin and ubiquitin bound cargo by HRS and STAM (signal-transducing adaptor molecule) 
components of ESCRT-0. HRS also contains a FYVE (Fab1p, YOTB, Vac1p and EEA1) domain that interacts with PtdIns(3)P on the 
endosomal membrane. Vps37 aids progression in assembly of ESCRT-I. Vps37 is bound to Tsg101 (Tumour susceptibility gene 101). Tsg101 
contains an UEV (ubiquitin E2 variant) domain that anchors the other ESCRT-I components to the membrane. ESCRT-I and ESCRT-II are 
bridged together by the C-terminal of Vps28 and EAP45 (ELL associated protein of 45 kDa). EAP45 is important in ESCRT-II assembly as it is 
responsible for anchoring the ESCRT-II complex to ubiquitin and PtdIns(3)P via a GLUE (GRAM-like ubiquitin-binding in Eap45) domain. 
ESCRT-II helps bring together CHMP2, CHMP6, CHMP3, which form the components of the ESCRT-III complex. Additional recruitment of 
deubiquitinases (DUBs) such as AMSH (associated molecule with the SH3 domain of STAM) and UBPY (ubiquitin-specific protease Y) 
followed by Vps4 -mediated ATP hydrolysis causes ESCRT-III disassembly leading to formation of an intralumenal vesicle (ILV). The ILV then 
follows the ESCRT-MVB (multi-vesicular body) pathway described in Fig. 3.2. Figure adapted from Williams and Urbé, 2007, Lobert and 
Stenmark, 2011. 
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Vps4 is a 48 kDa protein containing an AAA+ ATPase domain (Babst et al., 
1997). This domain folds into two hexameric rings and binds ATP (Iyer et al., 
2004); ATP hydrolysis provides the driving force for remodelling and disassembly 
via unfolding of the ESCRT-III subunit complexes (Snider et al., 2008). The 
dissociation of ESCRT-III is also accompanied by deubiquiltylation of the 
endosomal vesicles by DUBs such as AMSH (Hurley, 2011). The dissociation of 
ESCRT-III via Vps4 is required for the formation of an intralumenal vesicle (ILV) 
and a multi-vesicular body (MVB). MVBs follow a lysosomal degradative pathway 





Figure 3.2: ESCRT-MVB pathway. Endocytosed vesicular cargo contains clathrin and 
ubiquitin. This vesicular cargo is sorted into early endosomes that associate with the 
ESCRT machinery. ESCRT bound endosomes may be recycled to the plasma membrane 
or form intralumenal vesicles (ILVs). ILV formation is triggered by ESCRT-III dissociation 
and removal of ubiquitin by DUBs. ILVs mature into late endosomes and form multi-
vesicular bodies (MVBs). MVBs fuse with lysosomes leading to cargo degradation. Figure 
adapted from Haglund and Dikic, 2012. 
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3.1.3 Aims and rationale for the study 
 
Phosphoinositides are insulin-regulated secondary messengers that facilitate 
GLUT4 trafficking (Berwick et al., 2004; Maffucci et al., 2003). Disruption of 
phosphoinositides may lead to defective GLUT4 trafficking and a reduced insulin 
signalling response in adipocytes (Ikonomov et al., 2007; Shisheva, 2008). 
Studies have shown that inhibiting PtdIns(3,5)P2 production by blocking its 
synthesising kinase PIKfyve, leads to reduced insulin stimulated GLUT4 
translocation and reduced glucose uptake (Ikonomov et al., 2007). PIKfyve is 
phosphorylated by Akt in response to insulin further implicating it in the insulin 
signalling pathway (Berwick et al., 2004). PtdIns(3)P was also shown to facilitate 
GLUT4 fusion with the PM in another study done in mice that contained a 
knockout for GLUT4 vesicle docking/fusion protein Munc18c (Kanda et al., 2005). 
 
ESCRT proteins are PtdIns(3)P and PtdIns(3,5)P2 binding proteins. HRS contains 
a FYVE domain that binds to PtdIns(3)P (Stahelin et al., 2002) while CHMP3 
binds to PtdIns(3,5)P2 (Whitley et al., 2003) via basic residue motifs (Muzioł et al., 
2006). Phosphoinositides PtdIns(3)P (Gillooly et al., 2000) and PtdIns(3,5)P2 
(Whitley et al., 2003) are involved in ESCRT biogenesis and are important lipid 
signalling messengers in GLUT4 trafficking (Shisheva, 2008). Ubiquitin is also 
involved in ESCRT biogenesis (Shields and Piper, 2011) and has been recently 
linked to GLUT4 endocytosis (Lamb et al., 2010).  
 
Phosphoinositides PtdIns(3)P and PtdIns(3,5)P2 and ubiquitin involvement in 
ESCRT assembly and GLUT4 trafficking provide an interesting link to the 
possibility of ESCRT involvement in GLUT4 trafficking. The described recent 
understanding of the role of ubiquitin and phosphoinositides in endocytosis and 
sorting of cargo has directed the aims of this chapter. It is unknown if GLUT4 
traffics though an ESCRT-dependent compartment. I hence aim to investigate if 




3.2.1 ESCRT-III and Vps4 mutants lead to enlarged GLUT4 vesicles 
 
In order to investigate whether GLUT4 traffics thorough an ESCRT-dependent 
compartment, the localisation of HA-GLUT4 when the ESCRT machinery function 
is perturbed was studied. The results indicate that HA-GLUT4 was present is 
enlarged compartments in comparison to the control. There was some overlap in 




        
Figure 3.3: Dominant negative CHMP3 and Vps4 constructs lead to formation of 
enlarged vesicles. Rat adipocytes were co-transfected with HA-GLUT4 (red) and EGFP-
tagged Vps4 WT, Vps4 E235Q or CHMP 31–179 (green) and incubated for 5 h at 37°C. After 5 
h, cells were stimulated with 60 nM insulin for 20 min. Cells were fixed with 4% 
paraformaldehyde, permeabilised in 0.1% saponin and immunostained with anti- HA 
primary antibody and anti-mouse IgG-Alexa 633 secondary antibody. Images represent 
single adipose cells and were acquired using an LSM510 Meta confocal laser scanning 
microscope. Results are representative of 3 independent experiments. Bars 20 µm. 
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Primary rat adipocytes were isolated and transfected with the following pEGFP 
tagged constructs: Vps4 WT or N-terminus of CHMP3 1-179 or Vps4 E235Q and HA-
tagged GLUT4 using the transfection method described previously (Al-Hasani et 
al., 1998). The truncated dominant negative mutant CHMP3 1-179 was previously 
characterised as binding to membranes leading to enlarged endosomal 
compartments (Dukes et al., 2008) but its wild type equivalent could not be used 
as a control as it was previously shown to mimic this enlarged phenotype 
(Zamborlini et al., 2006). Vps4 E235Q is a dominant negative mutant of the AAA 
ATPase Vps4 (Dukes et al., 2008; Whitley et al., 2003) which is unable to 
hydrolyse ATP, thereby keeping Vps4 tightly bound to the ESCRT-III complex and 
preventing its disassembly (Fujita et al., 2003).   
 
Fig. 3.3 shows Vps4 WT having a dispersed cytosolic appearance, not resulting in 
any anomaly in these adipocytes. HA-GLUT4 was evenly distributed as spots, 
which is a common phenomenon (Malide et al., 2000). The EGFP-tagged 
dominant negative mutants (CHMP3 1-179 and Vps4 E235Q) were detected as 
forming enlarged and swollen vesicles. These GFP positive ESCRT vesicles 
showed some colocalisation with HA-GLUT4. The extent of colocalisation 
between HA-GLUT4 and the dominant negative ESCRT-III constructs however 




3.2.2 ESCRT-III disruption leads to an enlarged hybrid compartment 
 
To better characterise the composition of the enlarged compartments, rat 
adipocytes were stained with endosomal markers. In basal control cells, GLUT4 
was cytosolic and sequestered in compartments positive for syntaxin-6 (Stx6) and 
ubiquitin (Ub); this is consistent with the presence of a TGN-like compartment. 
GLUT4 did not colocalise with the early endosome antigen 1 (EEA1). GLUT4 
however colocalised with the transferrin receptor (TfR) and was observed in 
compartments distinct from those that stained with Ub and Stx6 (Fig. 3.4A).  
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Figure 3.4: Vps4 E235Q overexpression leads to formation of a hybrid compartment. 
Endogenous GLUT4 was studied in isolated rat adipocytes together with endosomal markers of 
GLUT4 traffic that included EEA1, ubiquitin (Ub), syntaxin-6 (Stx6) and transferrin receptor 
(TfR). Localisation of GLUT4 (red in merged images) was compared with EEA1, Ub, Stx6 and 
TfR (blue in merged images) using the antibodies and dilutions described in Materials and 
Methods 2.1.2. The figures show the subcellular endosomal marker distributions in the 
presence of non-perturbing pEGFP-Vps4 WT in the basal state (A) and the insulin-stimulated 
state (B). The overexpressed pEGFP-Vps4 WT is highly dispersed and is cytosolic under these 
conditions (not shown for clarity). Overexpression of the mutant pEGFP-Vps4 E235Q (green in 
merged images) leads to enlarged tubulo-vesicular GLUT4 compartments. The endosomal 
markers EEA1, TfR, Stx6 and Ub colocalise with both endogenous GLUT4 and with EGFP-
Vps4 E235Q both in the basal state (C) and the insulin-stimulated state (D). Arrows point at 
enlarged, hybrid compartments. Bars 20 µm.  
 
Stimulating control cells with insulin led to GLUT4 being localised to a larger 
extent at the adipocyte plasma membrane which can be compared with previous 
studies (Fig. 3.4B) (Malide et al., 2000; Suzuki and Kono, 1980). 
 
Transfection of adipocytes with the dominant negative construct Vps4 E235Q, led to 
GLUT4 localising to the enlarged ESCRT-III compartment in an extensive manner 
(Fig. 3.4, C and D). The markers EEA1, TfR, Stx6 and Ub all associated with the 
enlarged compartment and GLUT4, making it a hybrid compartment (Fig. 3.4, C 
and D). The colocalisation of these markers with GLUT4 on the hybrid 
compartment was not significantly different between basal and insulin-treated 
adipocytes.  
 
Compared to the basal control cells (without Vps4 E235Q) where the EEA1 signal 
was low, EEA1 could be detected associating more visibly with GLUT4 and Vps4 
E235Q in cells transfected with Vps4 E235Q (Fig. 3.4, C and D). Ub, which also acts 
as a marker of the ESCRT pathway, associated with GLUT4 in the control cells 
(without Vps4 E235Q). However, the colocalisation was prominent 
in the hybrid compartment of the Vps4 E235Q transfected cells. The hybrid 
compartments were larger in size in comparison to the compartments observed in 
the control cells transfected with the non-perturbing Vps4 WT (see Table 3.2). 
 
Attempts were made to quantitate the degree of colocalisation between GLUT4, 
Vps4 E235Q and endosomal markers using JACoP and Pearson’s Scatterplot 
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Table 3.2: Quantification of hybrid compartment sizes in Vps4 E235Q-transfected cells. The 
cells transfected with pEGTP-Vps4 WT (control) or pEGFP-Vps4 E235Q and positive for EGFP, 
GLUT4, ubiquitin and endosomal markers were analysed using ImageJ. The area (in pixels) of 
the visible lumens was determined in µm2.  Results are mean and SEM from 10-14 individual 
cells. ***p<0.001 (enlarged vs control vesicles). Only large pixels from the hybrid compartments 
were accurately converted to µm2. 
 
 
3.2.3 The PIKfyve inhibitor YM201636 does not mimic a Vps4 E235Q - 
                  induced enlarged compartment 
 
The kinase PIKfyve generates PtdIns(3,5)P2 from PtdIns(3). PtdIns(3,5)P2 acts as 
a lipid anchor for ESCRT-III membrane binding via CHMP3 (Whitley et al., 2003). 
Since PIKfyve is currently the only known kinase generating PtdIns(3,5)P2, it was 
considered useful to study the effects of inhibiting PIKfyve using 800 nM of its 
inhibitor YM201636 (Jefferies et al., 2008). The adipocytes were stained for 
endogenous GLUT4 and Ub after treatment with YM201636 for 30 min, 2 h and 5 
h. The results of the YM201636 study showed that GLUT4 associated with Ub 
(Fig. 3.5) which has been reported before (Lamb et al., 2010). However, no 
enlarged compartments were observed when compared to the untreated controls 
(Fig. 3.5). 
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Figure 3.5: The PIKfyve inhibitor YM201636 does not mimic a Vps4 E235Q-induced 
swollen compartment. Primary adipocytes were isolated as described previously and either 
left untreated or treated with 800 nM of the PIKfyve inhibitor YM201636. Cells were then 
maintained in culture at 37°C for 30 min (A) 2 h (B) and 5 h (C). Confocal microscopy of GLUT4 
localisation (red in merged images) was compared with ubiquitin (blue in merged images) using 
the antibodies described in the Materials and Methods 2.1.2. The swollen endosomal phenotype 
observed with Vps4 E235Q was not seen in these adipocytes. Images were acquired using the 
LSM510 Meta confocal laser scanning microscope and represent a population of at least 3 
cells. Bars represent 20 µm. 
 
 
3.2.4 ESCRT-III disruption causes a long-term block of GLUT4 exit from 
                 the hybrid compartment 
 
An experiment was performed to determine if the block caused by ESCRT-III on 
GLUT4 traffic would reduce over time and entrapped GLUT4 would be released. 
Two time points were compared at 5 h and 24 h. After transfection with GFP-Vps4 
WT and Vps4 E235Q, it was observed that both the Vps4 (WT and E235Q) 
constructs increased in expression at 24 h (Fig. 3.6, A and B). Colocalisation of 
Ub and GLUT4 with Vps4 E235Q was consistent (Fig. 3.6B) with the other 
experiments with short-term treatments (Fig. 3.4 C and D). The colocalisation 
pattern was similar at 5 h and 24 h indicating that GLUT4 is completely trapped in 
this hybrid compartment (Fig. 3.6B). An incubation beyond 24 h leads to 













Figure 3.6: 24-hour expression of Vps4 E235Q increases accumulation of GLUT4 in a 
enlarged compartments positive for ubiquitin. Western blot analysis of the levels of 
expression of pEGFP-Vps4 and pEGFP-Vps4 E235Q in rat adipocytes observed at 5 h or 24 h 
(A). Examination of primary rat adipocytes transfected with pEGFP-tagged Vps4 E235Q and 
maintained in culture for 24 h (B). Ubiquitin (Ub) colocalised with endogenous GLUT4 and 
pEGFP-Vps4 E235Q after 24 h expression in both basal and insulin-stimulated cells. Images 
are from single adipose cells and represent the cell populations from tubulo-vesicular cells 
from at least two separate experiments. Arrows point at enlarged, hybrid compartments. 















Insulin stimulation results in a kinetically rapid re-distribution of the GLUT4 
transporter causing GLUT4 to be recycled from intracellular compartments to the 
plasma membrane. Whether GLUT4 is recycled or degraded, endocytosis is an 
indispensable step in both processes. The study described in this chapter 
implicates the involvement of the endocytic ESCRT machinery for the first time in 
GLUT4 traffic. The findings in this chapter and its associated publication 
(Koumanov et al., 2012), show that GLUT4 upon endocytosis accumulates in 
perturbed ESCRT-III positive compartments. Locations of various endocytic 
markers serve as additional evidence to indicate that these compartments are 
targeted towards the endosomal pathway. Colocalisation of the GLUT4-Vps4 
E235Q compartment with Stx6, EEA1, Ub and TfR all indicate that this compartment 
is present in fairly late stages of the endosomal pathway. This compartment has 
been designated as a hybrid compartment due to the presence of EEA1, Stx6, 
TfR and Ub markers. The results described in this chapter depict a multivesicular 
compartment. The findings observed suggest that GLUT4 is entrapped in a hybrid 
multivesicular compartment.  
 
An HA-GLUT4 translocation assay was performed that measured the amount of 
HA-GLUT4 that translocated to the plasma membrane in rat adipocytes that 
overexpressed Vps4 E235Q or CHMP3 1-179 (Koumanov et al., 2012). Trapping 
GLUT4 at an ESCRT or PtdIns(3,5)P2 dependent trafficking step possibly results 
in an inability of GLUT4 to traffic to an insulin sensitive compartment. Hence, 
GLUT4 contained in the hybrid compartment described (in the study in this 
chapter) cannot recycle or traffic to the plasma membrane in insulin-stimulated 
adipocytes, thereby causing a drop in plasma membrane GLUT4. 
 
Defects in GLUT4 traffic upon impairment of exocytic (Kanda et al., 2005; Zhao et 
al., 2009) and endocytic (Al-Hasani et al., 1998) machinery have been shown in 
adipocytes to affect the levels of GLUT4 translocated to the plasma membrane. 
Post endocytosis, an efficient sorting system (Maxfield and McGraw, 2004) was 
proposed as the key in maintaining surface GLUT4, thereby sustaining glucose 
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uptake during insulin stimulation. Sorting pathways are mainly thought to route 
insulin-stimulated GLUT4 via recycling endosomes (fast recycling) or via GSVs 
(slow recycling) to the cell surface or to other intracellular pools (Habtemichael et 
al., 2011; Leto and Saltiel, 2012). The compartment detected in this study was 
positive for a number of proteins, one of which was TfR. TfR has a really short 
half-life which is <2 min. TfR is also present on early endosomes and greater than 
95% of TfR recycles back to the plasma membrane (Koval and Pagano, 1989; 
Mayor et al., 1993; van Dam and Stoorvogel, 2002). Another marker that was 
detected on the hybrid compartment was EEA1, which is also present on recently 
endocytosed vesicles (Mu et al., 1995). As recently endocytosed vesicles mature, 
they are targets of other subcellular markers like those from the TGN. The hybrid 
compartment showed the presence of Stx6 (in Fig. 3.4, C and D) which is a 
predominantly TGN marker. Stx6 is also known to associate with early 
endosomes via EEA1 (Simonsen et al., 1999) and SHIP164 (Otto et al., 2010). 
Hence, the presence of the recently described endosomal markers and 
observation of a tubulo-vesicular phenotype (as seen in Fig 3.4), suggests that 
the hybrid compartment may be at the ‘late’ stages of endosomal traffic. 
 
Endocytosis of cargo is thought to occur via clathrin-coated pits. This form of 
endocytosis is usually accomplished by recruitment of the Clathrin Heavy Chain 
CHC17 to endocytosing vesicles (Antonescu et al., 2008). However, recent 
studies by Brodsky’s group suggest that GLUT4 traffics via a distinct retrograde 
endosome-TGN trafficking route (Esk et al., 2010; Vassilopoulos et al., 2009). 
Retrograde-TGN GLUT4 trafficking utilises the Clathrin Heavy Chain CHC22 
protein instead of CHC17. Knockdown of CHC22 produced tubular structures 
similar to the coalesced and extended structures seen in the results described in 
this chapter (Vassilopoulos et al., 2009). CHC22 is thought to sort GLUT4 into 
insulin-responsive compartments or GSVs via the TGN (Esk et al., 2010). The 
described endosomal markers (EEA1, Stx6 and TfR) used in this study (Figs. 3.4 
and 3.6) are indicative of early and TGN-derived compartments leading to the 
suggestion that the hybrid compartment observed in this study may traffic via 
recruitment of CHC22. The hybrid compartment may hence be a hub for GLUT4-
TGN retrograde trafficking.  
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Colocalisation of Ub with GLUT4 on the hybrid compartment (Fig. 3.4, C, D and 
Fig. 3.6B) provided new insights into the possible ubiquitination of the GLUT4 
transporter. This study confirmed that GLUT4 is present on the same 
compartment with ubiquitinated proteins and the ESCRT machinery. 
Ubiquitination may occur as mono/poly-ubiquitination at the lysine residue of 
proteins (Sadowski and Sarcevic, 2010), though what governs the production of 
either the mono/poly form of ubiquitin is still unclear. Ubiquitin-like proteins have 
previously been linked to GLUT4 vesicles. A ubiquitin-like domain containing 
protein called TUG (Tether containing an UBX domain, for GLUT4) was shown to 
tether to the intracellular loop of GLUT4 and sequester it in the basal state (Bogan 
et al., 2012a). The ubiquitin-like domain of TUG can be cleaved upon insulin 
stimulation permitting GLUT4 translocation and exocytosis (Bogan et al., 2012b). 
Also, another small ubiquitin-like modifier (SUMO) conjugating enzyme (Ubc9) 
and its SUMOlated partner Daxx (death-domain associated protein), both have 
been shown to bind either GLUT4 or the GLUT4 vesicle (Giorgino et al., 2000; 
Lalioti et al., 2002; Liu et al., 2007). Overexpression of Ubc9 results in reduced 
GLUT4 degradation and increased GLUT4 targeting to insulin-responsive storage 
compartments (Liu et al., 2007). Daxx facilitates GLUT4 vesicle movement along 
the microtubule by interacting with GLUT4 and the kinesin element KIF5B (Lalioti 
et al., 2009). In the ESCRT pathway, ubiquitin is eventually removed from the 
endosomal membrane upon ESCRT-III dissociation. Ubiquitin is removed by 
deubiquitinases (or DUBs) and can result in a reversal of the ubiquitination 
process. Deubiquitination may serve as a signal to rescue cargo by recycling it 
back to the plasma membrane, to intracellular sites, to the TGN or to the 
lysosome for degradation (Woodman and Futter, 2008). AMSH (associated 
molecule with SH3 domain of STAM) is a DUB that can be recruited to ESCRT-III 
and facilitate cargo recycling (Agromayor and Martin-Serrano, 2006; Clague and 
Urbé, 2006). The precise mechanisms governing where, and to what extent a 
maturing endosomal compartment is sorted or recycled by DUBs or an alternative 
process to intracellular sites is still unknown and can be a focus of further 
investigation.  
 
The term ‘hybrid compartment’ in this study is used in a fairly broad sense and it 
may include docked GLUT4 vesicles that may or may not be degraded (Futter et 
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al., 1996; Pavelka et al., 2008). As the hybrid compartment matures, it forms 
tubulo-vesicular structures with outward budding vesicles on the limiting 
membrane and it is these vesicle that may be recycled while those that bud 
inwards (called intralumenal vesicles) are those destined for degradation via the 
lysosome (Hanson and Cashikar, 2012; Piper and Katzmann, 2007). The 
described hybrid compartment (Fig. 3.4) does not distinguish between GLUT4 
vesicles and may also include newly formed GLUT4 vesicles that bud off from the 
cisternae of the TGN.  
 
It was described earlier that phosphoinositides are involved during ESCRT 
maturation. To summarise, PtdIns(3)P helps anchor ESCRT-0 and ESCRT-II 
while PtdIns(3,5)P2 assists in anchoring ESCRT-III via CHMP3 to the endosomal 
membrane (Williams and Urbé, 2007). Studies that used an inhibitor called 
YM201636 that blocked PIKfyve activity led to reduced cellular PtdIns(3,5)P2 
levels (Jefferies et al., 2008) and also reduced surface GLUT4 (Ikonomov et al., 
2009). The study described in this chapter aimed to test whether blocking PIKfyve 
using YM201636 caused similar hybrid compartments observed following 
overexpression of the dominant negative Vps4 E235Q construct in rat adipocytes. 
Though reduced surface GLUT4 was reported upon treatment with YM201636 
(Koumanov et al., 2012), the 800 nM concentration of the YM201636 inhibitor 
failed to show the degree of enlarged compartments (Fig. 3.5) as seen in Fig. 3.4, 
C and D. The reduced surface GLUT4 that that is observed following use of 
YM201636 (Koumanov et al., 2012) could be due to the fact that YM201636 is not 
a selective PIKfyve inhibitor as it also prevents >50% of Akt-Ser473 from being 
phosphorylated (Ikonomov et al., 2009) leading to an inhibition of Akt-mediated 
GLUT4 translocation. Secondly, an inability to observe enlarged GLUT4 
compartments with YM201636 (Fig. 3.5) could be interpreted as an inability of 
reduction in PtdIns(3,5)P2 levels to be the sole cause of GLUT4 perturbation in an 
endosomal trafficking step. Reduced PtdIns(3,5)P2 could mean that a GLUT4 
endosome may not progress to an ESCRT-III- PtdIns(3,5)P2 dependent stage but 
may instead be recycled from the ESCRT-I or ESCRT-II stage to another 





Figure 3.7: Model depicting ESCRT perturbation in rat adipocytes. The findings in 
this chapter show that perturbation of the ESCRT machinery leads to formation of a 
hybrid compartment that may contain tubulo-vesicular structures. The hybrid 
compartment contained early endosomal proteins (EEA1 and TfR) and TGN proteins 
(Stx6). The compartment may hence act as a sorting station for recently endocytosed 
GLUT4 vesicles or vesicles undergoing retrograde transport from the TGN. 
Colocalisation of GLUT4 with ubiquitin was also observed within this compartment. 
Ubiquitinated GLUT4 may undergo degradation or recycling. Deubiquitination by 
deubiquitinases (DUBs) may result in GLUT4 vesicles with outward membrane 
topology being either recycled to the PM or being sorted to GSV pools. Vesicles with 
inward facing topology of membrane domains in this compartment are likely to form 
ILVs following ESCRT-III dissociation and deubiquitination. Vesicles forming ILVs 





The data indicating GLUT4 traffic through the ESCRT pathway is novel. The Vps4 
E235Q mutant generates a ‘hybrid’ compartment. GLUT4 is sequestered in this 
hybrid compartment and there is consequently a reduction in GLUT4 recruitment 
to the cell surface upon insulin stimulation (Koumanov et al., 2012).  
 
There are still some questions that should be addressed in the future. The issue 
of identification of ubiquitin binding proteins that associate with GLUT4 vesicles 
need to be addressed together with resolution of the identity of DUBs that are 
involved in GLUT4-ESCRT traffic. A candidate ubiquitin like protein is TUG, which 
is known to associate with GLUT4 in the basal state and is cleaved upon insulin 
stimulation. Could TUG be involved in ESCRT disassembly and in the 
deubiquitination of GLUT4 prior to recycling? Also, the recent identification of 
Rab14 (Reed et al., 2013) on endosomal compartments raises the possibility of 
its involvement in the vesicle processing activity within an ESCRT-related 
compartment. Since AS160 is a downstream target of Akt and is also a Rab14 
GAP, a confirmation of the presence of Rab14 on an ESCRT-related GLUT4 









In the previous chapter, I discussed how phosphoinositides and ubiquitin played 
a role in recognition and recruitment of the ESCRT machinery. In this chapter, 
the focus is on another important class of proteins that give membranes an 
identity. These proteins are Rab GTPases commonly referred to as Rabs. Rabs 
were discovered in the yeast secretory pathway and initially classified as ‘ras-
like’ GTPases (Salminen and Novick, 1987). This discovery sparked a special 
interest in characterising Rabs in mammalian cells, which led to the identification 
of approximately 60 Rab family members (Bock et al., 2001). This makes Rabs 
the largest class of proteins in the small GTPase family.  
 
Rabs are small (20-30 kDa) monomeric GTPases and coordinate distinct stages 
of regulated inter-organellar membrane traffic such as vesicle budding, motility 
and fusion (Zerial and McBride, 2001). This brings about a need to classify the 
location and function of Rabs. Rabs work by a simple on/off switch mechanism 
(Lee et al., 2009). The guanine nucleotide is involved in this switch. For a Rab to 
be activated, it must be GTP-bound and this leads to the recruitment of other 
proteins called ‘effectors’ to the Rab and its associating vesicle (or cargo) 
(Kawasaki et al., 2005). Rabs are inactivated by the hydrolysis of GTP to GDP. 
A number of different regulators maintain a Rab in the GTP or GDP-bound state.  
 
Deconstructing Rab-mediated signalling will give us a better idea of how Rabs 
function. This literature review attempts to provide a structural and functional 
understanding of Rabs and the domains involved in the recognition of interacting 
proteins. This outline will aid us in understanding the molecular interactions 
between Rabs and GLUT4 vesicles or vesicle associating proteins. 
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Figure 4.1:  Rab activation and regulation. (1) Nascent cytosolic Rabs are maintained in 
a stable state by a multifunctional REP (Rab escort protein). A catalytic core region within 
the Rab acts as the recognition site for a Rab specific GGT (geranylgeranyl transferase). 
GGTs are activated during a stimulus (Goalstone et al., 1999). A trimeric complex is formed 
comprising Rab, REP and GGT. GGT prenylates the Rab on its C-terminal cysteine 
residue(s) and then dissociates. The REP escorts the Rab to an organelle following which 
REP dissociates. The Rab uses its prenylated moiety to anchor onto the organelle 
membrane’s phospholipid layer. (2) Once a Rab is anchored to a membrane, GEF 
(GDP/GTP exchange factor) facilitates exchange of the Rab’s GDP for GTP*, making a Rab 
‘active’. (3) An active Rab is recognised by specific effector proteins that are responsible for 
correctly targeting the organelle. (4) The Rab is inactivated when a GAP (GTPase activating 
protein) catalyses the hydrolysis of GTP to GDP. Rabs are extracted from membranes by a 
GDI (GDP dissociation inhibitor). GDI sequesters the isoprenyl group making the Rab 
unavailable for membrane interaction. The Rab is now soluble and cytosolic until the next 
stimulus. (5) GDF (GDI dissociation factor) frees the sequestered isoprenyl group thereby 
allowing a Rab to be presented to membranes and continue another round of cycling. Figure 
adapted from Hutagalung and Novick, 2011. 
*Recent studies in Cos-7 cells show that GEFs may also be involved in correctly directing a 
Rab to the target membrane (Blümer et al., 2013). 
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4.1.1 Rabs: From structure to function 
 
A key feature of Rabs is their ability to exchange GDP for GTP. The regulation 
of GTP-binding is accomplished by the recruitment of GEFs to Rabs. Rab GEFs 
are thought to cause a structural change in a Rab’s nucleotide binding site, 
thereby facilitating GTP-binding (Delprato and Lambright, 2007). DENN/MADD 
(differentially expressed in neoplastic versus normal cells domain/MAP-kinase 
activating death domain) proteins were recently identified as GEFs for a number 
of Rabs (Yoshimura et al., 2010). Upon binding to GTP, a Rab needs to be 
stabilised. Rabs contain two conserved switch motifs (switch 1 and switch 2), a 
P-loop motif and an associated Mg2+ ion that all play an important role in GTP-
binding and stabilisation. Ser/Thr in the P-loop motif and Thr in the switch 1 
motif interact with the γ phosphate of GTP. Mg2+ coordinates interactions 
between the GTP’s γ phosphate and Ser/Thr in these two motifs. Mg2+ is in turn 
stabilised by an Asp residue in the switch 2 motif. Structural studies have shown 
that for Rabs to be in a stable and ordered conformation, they need to be in a 
GTP-bound state (Dumas et al., 1999; Wittinghofer and Vetter, 2011). Mutation 
of key residues in the above motifs can mimic a stable Rab-GTP conformation. 
Mutation of the Ser/Thr in the P-loop motif (GxxxxGK(S/T)) to asparagine 
(creating an SN or TN mutant) abolishes the ability of such a mutant to interact 
with Mg2+, thereby interfering with GTP-binding while not affecting GDP-binding 
(Farnsworth and Feig, 1991; Nuoffer et al., 1994; Wittinghofer and Vetter, 2011). 
SN/TN mutants are hence dominant negative mutants. They mimic the GDP-
bound state and are called ‘GDP-locked’ mutants. Mutation of the DxxGQ 
region to DxxGL in the switch 2 motif mimics the GTP conformation (creating a 
constitutively active QL mutant). In addition to mimicking the GTP-bound state, 
QL mutants show reduced GAP (GTPase activating protein) catalytic activity i.e. 
reduced ability to be hydrolysed by a GAP from a GTP to GDP-bound state 
(Stenmark et al., 1994). Proteins containing the TBC (Tre-2/Bub2/Cdc16) 
domain form the majority of Rab GAPs known to date (Barr and Lambright, 
2010). The only other known Rab GAPs are the Rab3 GAPs (Fukui et al., 1997; 
Nagano et al., 1998). 
 
! 97!
A GTP bound Rab is recognised by Rab associating proteins called ‘effectors’. 
Effectors link Rabs to cytosolic motors, tethers or fusion proteins. Rabs hence 
serve as a link between a vesicle membrane and cellular scaffolding proteins via 
effectors (Hammer and Wu, 2002). Rabs are also linked (or attached) to vesicles 
via their hyper variable carboxy (C) terminal region (Ali et al., 2004). The Rab C-
terminus is modified by attachment of a prenyl group to terminal cysteine 
residue(s) by GGTs (geranylgeranyl transferases) (Joberty et al., 1993; Peter et 
al., 1992). This prenyl group assists in Rabs’ insertion into membrane 
phospholipids of vesicles or organelles (Alexandrov et al., 1994). Switch motifs 
and hyper-variable C-termini among with other domains (interswitch motifs, 
α3/β5 loop and complementary determining regions (CDRs)) mutually or 
exclusively also contribute in distinguishing which effector binds to a Rab 
(Dumas et al., 1999; Ostermeier and Brunger, 1999). Effector specificity and 
function will be covered in more detail in Chapter 5. 
 
 
4.1.2 Rabs and the cellular endomembrane system 
 
Cargo is transported in a cell via vesicles that contain a cytosolic protein coat 
complex. Rabs can be regarded as either interacting with or forming part of this 
cytosolic coat complex on a vesicle. As of now, most of the evidence shows that 
Rabs interact with vesicle/cargo associating proteins, rather than directly with 
the cargo itself (Fukuda, 2006; Jin et al., 2011; Jordens et al., 2005). In the early 
stages of vesicle biogenesis, vesicles bud from donor membranes that include 
the endoplasmic reticulum (ER) or the curved Golgi cisternae or both (Hong, 
1998). Rab1b along with other GTPases are responsible for recruiting the 
COPI/COPII complexes onto newly forming vesicles in the trans-Golgi network 
(TGN) (García et al., 2011). Rab8 and Rab12 facilitates the delivery of the Golgi 
derived vesicles to the plasma membrane (Huber et al., 1993; Iida et al., 1996). 
Rab5 and Rab6 facilitates vesicle movement along microtubules towards the cell 
periphery (Chavrier et al., 1990; Hill et al., 2000). The recruitment of vesicles to 
microtubules however, may not occur until Rab3 (Schlüter et al., 2002)/Rab10 
(Sano et al., 2007)/Rab11 (Takahashi et al., 2012) are activated. These Rabs 
are important to vesicles as they help in the late stages of vesicle translocation 
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to the plasma membrane. The late stages of vesicle translocation involve 
processes that include actin reorganisation and assembly. Rab35 is one of the 
Rabs thought to facilitate actin assembly (Chua et al., 2010). At the cell 
periphery, a vesicle is tethered to the PM. Studies in yeast show that Rabs may 
play a key role in associating with SNARE machinery thereby facilitating 
tethering and fusion of the vesicle-SNARE complex with the plasma membrane 
(Cai et al., 2007; Novick et al., 2006). Mis-localisation or mutations in Rabs have 
been linked to aberrant cellular dynamics (Pal et al., 2006), immune dysfunction 
(Krzewski and Cullinane, 2013) and neurodegeneration (Baskys et al., 2007). !!!
4.1.3 The exocytic Rab3 GTPase 
 
Preliminary data: In order to obtain more information on Rab proteins activated 
by insulin and involved in GLUT4 trafficking; a new Bio-ATB-GTP photolabel 
was employed (see Supplementary figure S7). This GTP analogue contained a 
biotin tag and a diazirine UV activated group (ATB), which allowed covalent 
crosslinking of the photolabel to GTP-bound small GTPases (Holman, 2010). A 
similar photolabelling approach has been described previously (Schwenk and 
Eckel, 2007; Sun et al., 2010). This Bio-ATB-GTP photolabel bound to GTP-
binding proteins from total membrane preparations from rat adipocytes that were 
left either untreated or insulin-stimulated. The photolabel-bound proteins were 
isolated, analysed on a 2D gel and identified by mass spectrometry. Along with 
other known GLUT4 trafficking associated Rabs, Rab3B was identified as an 
insulin-responsive Rab from two individual experiments using the photolabelling 
technique. Further studies showed that Rab3B was activated upon insulin 
stimulation and its GTP loading increased with insulin in a time dependent 
manner. (Koumanov et al., manuscript in preparation)  
 
Since Rab3 has been primarily implicated as an exocytic Rab in a number of 
studies (Lledo et al., 1993; Ohnishi et al., 1996; van IJzendoorn et al., 2002; 
Weber et al., 1996), it necessitates the need to better characterise Rab3B’s 
presence in adipocytes and a possible role in GLUT4 trafficking. 
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Rab3 has four isoforms, which are paralogous to each other. Rab3A, Rab3B, 
Rab3C and Rab3D all share >75% amino acid identity (Baldini et al., 1992). 
Rab3A was one of the first in the Rab3 family to be identified and its role in 
calcium-mediated neurotransmitter exocytosis led to many Rab3 functional 
studies (Doussau et al., 1998; Geppert and Südhof, 1998; Mahoney et al., 2006; 
Takai et al., 1996; Tanaka et al., 2001). Rab3A and Rab3D were the identifiable 
Rab3 isoforms in mouse and rat adipocytes that associated with different 
intracellular compartments (Baldini et al., 1995; Guerre-Millo et al., 1997).  
 
Rab3 was identified in a number of tissues where it stimulated exocytosis (or 
secretion). In pancreatic acinar cells, Rab3D overexpression enhanced amylase 
secretion (Ohnishi et al., 1997). Pancreatic islets were shown to contain Rab3A 
as the predominant Rab3 isoform that facilitated insulin granule secretion 
(Regazzi et al., 1996). Rab3A-/- mice showed reduced insulin granule secretion 
and glucose intolerance in pancreatic beta cells (Yaekura et al., 2003). A study 
in human pancreatic islets identified Rab3B as the predominant Rab3 isoform 
that colocalised with insulin granules (Piper et al., 2010). These studies suggest 
the occurrence of an inter-species difference in localisation of Rab3 isoforms 
(Piper et al., 2010).  
 
Though most studies have shown Rab3 involvement in vesicle trafficking to 
increase exocytosis to the plasma membrane, there have been studies that 
show that Rab3 may not have a positive effect on exocytosis. Overexpression of 
one or more Rab3 isoforms led to a negative regulation of catecholamine 
exocytosis (Holz et al., 1994; Johannes et al., 1994; Weber et al., 1996). Rab3A 
negatively affected exocytosis of dopamine beta hydroxylase in PC12 cells in a 
calcium-dependent manner (Johannes et al., 1994). In rat adipocytes, 
overexpression of Rab3D had no discernible effect on GLUT4 subcellular 
localisation or exocytosis (Cormont et al., 1996).  
 
A Rab3 knockout (KO) study was carried out in mice by Schluter (2004) to 
identify which of the Rab3 isoforms could be the limiting one in exocytosis. The 
study employed a single, double, triple and quadruple KO of all the four Rab3 
isoforms in mice to identify the limiting Rab3 isoform (Schluter, 2004). The 
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studies on the KO mice showed that single/double Rab3 isoform knockout mice 
survived while the triple/quadruple Rab3 isoform knockout mice perished shortly 
after birth (Schluter, 2004). A tissue-wide analysis of the Rab3 isoforms showed 
variations in the number and amounts of each isoform across different tissues 
(Schlüter et al., 2002). These two studies supported the notion that all the four 
isoforms were likely to act in a functionally redundant manner. Exocytosis via 
Rab3 may occur in conjunction with other Rabs or in conjunction with effectors. 
Identifying Rab3 effectors is essential to understanding Rab3’s functional role in 
signalling. It may help us understand why Rab3 shows differences in regulation 
of exocytosis across tissues/cell types. 
 
 
4.1.4 Aims and rationale for the study 
 
Rab3 has been characterised as an exocytic Rab in a number of tissues, which 
include insulin granule exocytosis in the pancreas while preliminary data from 
the Holman laboratory has suggested that a role in insulin-regulated GLUT4 
exocytosis could be explored. The aim of the study described here is to 
elucidate the role of Rab3 in insulin-regulated GLUT4 traffic in adipocytes. 
Based on the evidence that Rab3 works with effectors, this study will also aim to 





4.2.1 Analysis of Rab3 expression in insulin-responsive tissues 
 
To evaluate the level of expression of different Rab3 isoforms in different insulin-
sensitive tissues, a real time PCR study was carried out.   
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Figure 4.2: Analysis of Rab3 expression in insulin-responsive tissues. Rattus norvegicus 
tissues were isolated and mRNA was extracted using the TRIzol®-chloroform method. cDNA 
was generated by reverse transcription. The cDNA was used to study level of Rab3 isoforms in 
various rat tissues using a qPCR approach. Primers used are listed in Supplementary table S2. 
Rab10 was used as a control in the qPCR setup. Data in the bar graph represents an n of 3 from 
three independent sets of tissues/rats. The raw Ct values were normalised to the 28S rRNA 
housekeeping gene to yield ∆∆Ct values. Error bars represent SEM from 3 sets of rats/tissues. 
 
 
A qPCR profile of the insulin-responsive tissues revealed that Rab3 isoforms 
differ in their mRNA expression levels across the different tissues tested (Fig. 
4.2). Rab10 was shown to play a critical role in GLUT4 translocation to the 
plasma membrane in adipocytes (Chen and Lippincott-Schwartz, 2013; Chen et 
al., 2012; Sadacca et al., 2013; Sano et al., 2007; Sano et al., 2008). Rab10 
expression was hence measured as a control to compare it with Rab3 
expression in these tissues. In rat adipocytes, Rab3B and Rab10 show similar 
expression patterns. Rab3B however is the predominantly expressed Rab3 
isoform in rat adipocytes followed by Rab3D and Rab3A (Fig. 4.2A). The levels 
of Rab3D in rat adipocytes and heart correspond to a northern blot analysis of 
Rab3D in 3T3L1 adipocytes (Baldini et al., 1992). In Fig.4.2A, Rab3B is the 
major isoform observed in rat heart followed by Rab3A and Rab3D. Rab3B 
expression is higher than Rab10 in rat heart. In skeletal muscles, Rab10 shows 
highest expression while Rab3 isoforms show lower expression levels (Fig. 
4.2B). In rat flexor digitorum brevis (FDB) Rab3A and Rab3B show similar 
expression while in tibialis anterior (TA) and soleus, Rab3A is predominantly 
expressed. Of all the Rab3 isoforms, Rab3C shows marginal or no expression in 
the insulin-responsive tissues tested. These studies hence confirm the 
expression of Rab3 in insulin-responsive tissues. Questions hence arise as to 
Rab3’s role in these insulin-responsive tissues and its role in GLUT4 trafficking. 
 
 
4.2.2 Generation of Rab3B constructs and site-directed mutants 
 
Rab3 mRNA expression studies provided some good evidence that Rab3B is 
the predominant Rab3 isoform in adipocytes (Fig. 4.2). This section describes 
attempts to subclone the Rab3B gene to characterise its role in adipocytes. 
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Figure 4.3: Subcloning of the Rab3B cDNA and generation of Rab3B Q81L. Rab3B was 
successfully amplified at the correct size (672 bp) from the pET28 vector using primers in 
Supplementary table S1 and analysed on a 1% w/v agarose gel (A). This 672 bp amplicon 
was inserted into the pcDNA3.1 and a digest using Rab3B flanking restriction enzymes 
(BamHI and XhoI) showed a correctly inserted sequence (B).  Site-directed mutagenesis 
was performed and an internal restriction enzyme (EcoRV) site flanking the Rab3B Q81L 
mutation was used to test correct mutagenesis (C). The grey shaded region in D 
represents the primer that was designed with the Q81L mutagenesis codon (red) and two 
silent mutations (blue) such that this site (gat_^atc) could be ‘test-digested’ by EcoRV. 
Sequencing results confirmed a correctly inserted Q81L mutation but absence of the silent 
mutations and hence no EcoRV cleavage site (D). 
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Dr J. D. Richardson (from the Holman lab) had cloned the Rab3B cDNA from an 
adipocyte library belonging to Rattus norvegicus into a pET28 vector. This 
pET28-Rab3B was used as a template from which Rab3B was amplified (Fig. 
4.3A) and subcloned into a mammalian expression vector pcDNA3.1 (Fig. 4.3B) 
such that functional studies could be carried out in rat adipocytes. A 
constitutively active Rab3B Q81L construct was generated by site-directed 
mutagenesis (SDM) using the full-length pcDNA3.1-Rab3B as a template. The 
Rab3B Q81L construct is useful in understanding how an ‘active’ GTP-loaded 
Rab3B would affect the fate of GLUT4 trafficking in rat adipocytes upon its 
overexpression. 
 
During the site-directed mutagenesis (SDM) primer design, two silent mutations 
(shown in blue in Fig. 4.3D) were inserted within the framework of the Q81L 
primer (shaded grey in Fig. 4.3D). These silent mutations generated a site for 
EcoRV cleavage (gat_^atc, in Fig. 4.3D). A test restriction digest of the SDM 
samples with EcoRV could thus be used to confirm successful amplification from 
template DNA. This test restriction digest could be done in the laboratory before 
commercially sequencing the SDM samples. A test restriction digestion using 
EcoRV was attempted on 5 samples generated after the SDM procedure. 
Digestion with EcoRV was expected to yield a single linear 6041 bp fragment. 
However, upon digesting with EcoRV no linear (cleaved) 6041 bp fragment was 
obtained (Fig. 4.3C). The 5 samples were however still sequenced. The 
sequencing results unexpectedly showed that the Q81L mutation was indeed 
inserted confirming correct mutagenesis (shown in red in Fig. 4.3D). The 
sequenced constructs however lacked any of the silent mutations that were 
generated in the primer (shown in blue in Fig. 4.3D) to create a restriction site 
for EcoRV (gat_^atc, in Fig. 4.3D). This could be an error with the commercially 
synthesised primer. Since the silent mutations for EcoRV were only inserted as 
a preliminary measure to check for mutagenesis in the laboratory, the construct 
was still suitable to use as a constitutively active mutant as sequencing results 
confirmed the necessary Q81L mutation. 
 
The Rab3B T36N dominant negative construct was prepared in the same way as 
the Rab3B Q81L construct, except no silent mutations could be inserted. 
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However, creating the T36N mutation led to an automatically generated 
restriction site gaann_^nnttc for which a restriction enzyme (XmnI) was 
available. A restriction map with XmnI following the T36N mutation was 
expected to yield three (3378, 1367 and 1293 bp) DNA products instead of two 
large (3378 and 2260 bp) DNA products (Fig. 4.4A). Test digestion of the SDM 
samples with XmnI was performed. The clones 4 and 10 yielded one large 
fragment  (3378 bp) and two smaller fragments (~1300 bp each) (Fig. 4.4B), 
which indicated successful site-directed mutagenesis. These samples were sent 









Figure 4.4: Site-directed mutagenesis for generating Rab3B T36N. (pcDNA3.1) Rab3B 
was used as a template and site-directed mutagenesis was performed as described in 
Methods 2.2.1.2. An internal restriction site for the restriction enzyme XmnI was generated 
when creating the T36N mutation (A).  10 colonies from the Rab3B T36N SDM experiment 
were isolated and grown overnight. Plasmids from these colonies (clones) were test 
digested with XmnI. Clones 4 and 10 showed one ~3 kb and two ~1.3 kb cleaved products 
(B). Clones 4 and 10 were sequenced and confirmed correct insertion of the T36N 
mutation.  
! 106!
4.2.3 Effect of Rab3B on GLUT4 translocation 
 
The following study was undertaken to study the effect of Rab3B on GLUT4 
translocation to the plasma membrane in rat adipocytes treated with or without 
insulin. The constitutively active Q81L and dominant negative T36N Rab3B 
constructs were used to understand the effect of GTP-active and GTP-inactive 
Rab3B on GLUT4 translocation to the plasma membrane. Rab3B constructs 
were transfected into primary rat adipocytes together with HA-tagged GLUT4, 
the latter of which was used as a reporter. An empty pcDNA3.1 vector was used 
as a control. Following insulin stimulation, HA-GLUT4 at the adipocyte cell 
surface was detected with a mouse anti-HA antibody. The anti-mouse 
secondary antibody was conjugated to β-galactosidase. A fluorescein di-β-D-
galactopyranoside substrate was used in the assay that is hydrolysed by the β-
galactosidase conjugated secondary antibody to yield a highly fluorescent 
fluorescein compound. Fluorescein was released in proportion to the amount of 





Figure 4.5: Rab3B increases GLUT4 translocation in basal rat adipocytes. Primary rat 
adipocytes were transfected by electroporation with (pCis) HA-GLUT4 and pcDNA3.1 alone 
(empty vector), (pcDNA3.1) Rab3B WT, (pcDNA3.1) Rab3B Q81L or (pcDNA3.1) Rab3B T36N and 
maintained in culture overnight (for 16 h). HA-GLUT4 at the cell surface was detected with an 
anti-HA primary antibody and b-galactosidase conjugated secondary antibody. The signal from 
the bound secondary antibody was measured with a fluorescent b-galactosidase substrate. 
Results are mean and SEM from 3 independent experiments. **** p=<0.0001, **p<0.01 (paired 
two tailed t-test comparisons vs Rab3B WT). 
Note: I conducted the preliminary experiments for this assay and Dr D.J.Fazakerley repeated the 
work to obtain an n of 3, which is graphically represented in this figure. 
 
 
On analysis of the results (Fig. 4.5), the wild type Rab3B-transfected rat 
adipocytes showed no difference to the empty vector (pcDNA3.1 only) control 
across basal and insulin-treated samples. The constitutively active Rab3B Q81L-
transfected adipocytes showed a significant 2-fold increase in HA-GLUT4 at the 
cell surface in basal adipocytes compared to the empty vector control and wild 
type Rab3B-transfected adipocytes. 
 
The dominant negative Rab3B T36N construct showed reduced cell surface levels 
of HA-GLUT4. In Rab3B T36N-transfected basal cells, surface HA-GLUT4 was 
significantly reduced by 2.47-fold compared to the basal Rab3B WT sample. 
Insulin-treated cells containing Rab3B T36N showed levels of HA-GLUT4 that 
were reduced by 2.94-fold compared to the insulin-treated Rab3B WT sample. 
 
The findings of this HA-GLUT4 translocation assay suggest that the 
constitutively active form of Rab3B may not be acting alone in GLUT4 
exocytosis. Rabs work in concert with effectors and these findings necessitate 
the need to identify Rab3B effectors in adipocytes. 
 
 
4.2.4 Rab3B pull-down of effectors from rat adipocytes 
 
Effectors govern the regulatory function of Rabs. Effectors may assist a Rab in 
vesicle formation, movement, tethering or fusion. With the identification of 
Rab3B as a regulator of GLUT4 translocation (Fig. 4.5), the identification of a 
Rab3 effector is likely to yield more information on the interacting partners, 
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functional characteristics, and the stage of GLUT4 trafficking that Rab3B may be 
involved with. Different trafficking proteins are recruited at different stages of 
GLUT4 vesicle movement. Since there has been no study yet, positively linking 
Rab3B or it’s effectors to GLUT4 trafficking in adipocytes, a protein-protein 
interaction study was employed to uncover novel Rab3B interacting proteins 
(effectors) from rat adipocytes. GST-Rab3B was bound to either GTPγS or GDP 
to identify Rab3B-GTPγS specific effectors. 
 
GST-Rab3B was successfully expressed using a 2 l culture and purified via 
conjugation to glutathione beads (Fig. 4.6) to yield approximately 82.17 mg of 
GST-Rab3B in a 2 ml protein sample. The GST-Rab3B was bound to either 
GTPγS or GDP to yield active or inactive forms of the Rab3B protein. A GST-
only control was also employed in this pull-down study. The GST tagged 
proteins were incubated with glutathione agarose beads. The fusion protein 
conjugated beads were added to columns (as described in Materials and 
Methods 2.2.3.7). The columns containing GST-only or GST-Rab3B 
(GTPγS/GDP) conjugated to glutathione beads were incubated with adipocyte 
lysates. 
 
The pull-down using Rab3B loaded with GTPγS yielded two distinct bands from 
two individual experiments. Mass spectrometry analysis revealed the two distinct 
bands (1 and 2 in Fig. 4.7) as members of the heat shock protein 70 (Hsp70) 
family. Band 1 (71 kDa) was identified as Hsp70-8 and band 2 (74 kDa) was 
identified as glucose-regulated protein 75/78 (GRP75/GRP78). GRP is also a 
member of the Hsp70 family. These proteins were not observed in the control 
GST-only glutathione beads, further confirming Hsp70 specificity to the 











Figure 4.6: Expression of the GST-Rab3B fusion protein. (pGEX4T) GST-Rab3B and 
(pGEX4T) GST were expressed in BL21 DE3 cells with 0.3 mM IPTG induction at 25°C for 
3 h and purified on glutathione beads. The expression and purification profile was 
analysed on a 12% SDS-PAGE gel followed by western blotting for GST-Rab3B with a 
goat anti-GST antibody (A). GST-Rab3B was detected at 51 kDa and GST-only at 25 kDa. 
Coomassie brilliant blue staining was used for quantification (B). The purification yielded 
82.17 mg (805.6 µM) GST-Rab3B conjugated to 2 ml of beads and 43.5 mg (1740 µM) 
GST conjugated to 1 ml of beads from a 2 l culture. 






                          
 
 
Figure 4.7: Pull-down of Rab3B effectors following GTPγS loading yields an 
interacting protein. 40 mg (400 µM) of GST-Rab3B or GST alone was conjugated to 
glutathione beads. GST-Rab3B beads were loaded with nucleotide GTPγS or GDP. The 
beads were incubated with adipose cell lysates. Bound proteins were eluted with a 
nucleotide exchange buffer and run on a 10% SDS-PAGE gel. The gel was stained with 
colloidal coomassie. Numbers 1 (71 kDa) and 2 (74 kDa) on the gel represent the distinct 
bands that were bound to the Rab3B-GTPγS column. These were extracted and analysed 
via mass spectrometry. This experiment was repeated again and the same distinct bands 
were identified between 60-80 kDa. Please refer to 2.2.3.7 in the Materials and Methods 




This chapter attempts to implicate novel Rabs as regulators in the GLUT4 
trafficking pathway. Rab3B was identified using qPCR studies as a Rab3 family 
member highly expressed in rat adipocyte and heart tissues (Fig. 4.2). This 
finding adds to a previous study performed in the Holman lab that identified 
Rab3B as a membrane associated and insulin-responsive Rab, in rat adipocytes 
(Koumanov et al., manuscript in preparation). 
 
Rabs are involved in a variety of vesicle trafficking steps, one of which is vesicle 
fusion (Cai et al., 2007). The recent studies identifying Rabs in the GLUT4 
exocytic pathway paves the way to make an assumption that a Rab could likely 
be involved in the final stages of GLUT4 coupling to the plasma membrane. The 
possibility that this could be the exocytic Rab3B was demonstrated by studying 
its effect on GLUT4 translocation (Fig. 4.5). The overexpression of the 
constitutively active Rab3B Q81L mutant resulted in a significant 2-fold increase in 
the levels of HA-GLUT4 at the plasma membrane in basal rat adipocytes 
mimicking an insulin response. The overexpression of a dominant negative 
Rab3B T36N mutant resulted in a decrease in the HA-GLUT4 insulin response to 
basal levels. These results provide new evidence for involvement of Rab3B in 
GLUT4 trafficking in rat adipocytes. The constitutively active Rab3B acted as a 
positive regulator of GLUT4 exocytosis. These results however, vary from an 
earlier study, which demonstrated that blocking Rab3 by microinjection of a 
Rab3 antibody in 3T3L1 adipocytes had no effect on basal/insulin GLUT4 
translocation (Vollenweider et al., 1997). The variation in results can possibly be 
explained by the fact that an antibody microinjection technique was used by 
Vollenweider et al. (1997) vs. an overexpression of Rab3B in the study in this 
chapter. Also, an inter-species variation in Rab3 isoform expression/function 
could exist between 3T3L1 adipocytes and rat adipocytes. The work described 
in this chapter revealed the potential importance of Rab3B in GLUT4 
translocation to the plasma membrane. The effect of Rab3B in this study mirrors 
other studies where knockdown of Rab3 isoforms reduced exocytosis in 
neuronal cells (Schluter, 2004). The association between Rab3B and GLUT4 
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vesicles has been demonstrated to increase in the insulin state with 
overexpression of Rab3B WT or Rab3B Q81L constructs in adipocytes (Koumanov 
et al., manuscript in preparation). However, earlier studies in rat adipocytes 
demonstrate that Rab3B is predominantly cytosolic and insulin stimulation did 
not bring about any change in the localisation of Rab3B (Cormont et al., 1993). 
The studies by Cormont et al. (1993) did not utilise overexpression of Rab3B or 
its mutant construct and differences in carrying out experimental procedures 
could also have contributed to the varied observations (Cormont et al., 1993). 
Overexpression of Rab3D WT was carried out but this construct had no effect on 
GLUT4 translocation in rat adipocytes (Cormont et al., 1996); this observation 
was similar to overexpression of Rab3B WT in the studies described in this 
chapter (Fig. 4.5). Hence, this suggests that an effect on trafficking is likely to be 
observed preferably with the constitutively active (Q81L) form of Rab3. The 
studies in this chapter provide the necessary data to investigate Rab3B and its 
potential effectors in GLUT4 trafficking. 
  
Recruitment of the correct effectors is crucial for Rab function (Grosshans et al., 
2006; Stein et al., 2012). An attempt was made using GST-Rab3B to pull-down 
and uncover potential Rab3B effectors that could assist in GLUT4 trafficking 
(Fig. 4.7). This effort led to the identification of two proteins from the Hsp70 
family, Hsp70-8 (HspA8/Hsc70) and GRP75/GRP78. This is the first finding 
linking Rab3B to heat shock proteins. Hsp70 is primarily involved in chaperone 
protein folding (Mayer and Bukau, 2005). Hsp70-chaperone complex may play a 
role in trafficking Rab3B from the plasma membrane to the cytosol in a similar 
way that Hsp90 retrieves Rab3A from presynaptic membranes to the cytosol 
(Sakisaka et al., 2002). Studies in mouse colon also showed that Hsp70 
colocalises with Rab4 and Rab5a (Stangl et al., 2011) further implicating Hsp70 
in the endocytosis, recycling and the retrieval pathway. The Hsp70-8 protein 
facilitates recycling by catalysing disassembly of recently endocytosed clathrin 
coated vesicles (Rothnie et al., 2011). Hsp70 has been detected in adipocytes 
before (Jiang et al., 2007) and Hsp70-8 was found to be a likely substrate of O-
linked N-acetylglucosamine (O-GlcNAc) in skeletal muscle L6 myotubes 
(Walgren et al., 2003). Increased modification of proteins by O-GlcNAc has been 
shown to cause insulin resistance and impaired Akt activation in 3T3L1 
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adipocytes (Vosseller et al., 2002). The association of Rab3B with Hsp70 will be 
of special interest when studying retrieval of GLUT4 vesicles from the plasma 
membrane and a further possible link, if any, to insulin resistance. However, 
there is not enough evidence to implicate Hsp70 as a direct regulator of GLUT4 




This chapter provides results on some novel findings. Firstly, profiling the Rab3 
isoforms in insulin-responsive tissues shows that Rab3B is highly expressed in 
adipocyte and heart tissues. Secondly, the constitutively active form of Rab3B 
was implicated as a positive regulator of GLUT4 translocation. However, a 
Rab3B effector that could be involved in GLUT4 translocation could not be 
positively identified using this pull-down approach. Hsp70 was positively 
identified as a Rab3B-GTPγS interacting protein which is interesting, but its role 
and function has been characterised as being primarily involved in chaperone 
targeting and protein folding (Mayer and Bukau, 2005; Morgan et al., 2013). The 
search for an effector involved with Rab3B and GLUT4 coupling to the plasma 
membrane would need another experimental approach. 
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The necessary trafficking proteins must be recruited to vesicles for successful 
regulated exocytosis. Rabs and their effectors help correctly target a vesicle to 
its cellular destination by associating with additional intracellular trafficking or 
cytoskeletal scaffolding proteins (Seabra and Coudrier, 2004). Effectors are also 
able to tether a vesicle to membrane phospholipids and interact with the PM and 
vesicle fusion machinery (Tsuboi and Fukuda, 2006). Some effectors multitask 
the different steps in vesicle exocytosis while others are restricted in the extent 
of their function. Effectors hence convey specificity and directionality to 
membrane traffic and are required in concert with Rabs to facilitate proper 
vesicle targeting.  
 
 
5.1.1 Rab effectors: Structural aspects and recognition 
 
Effectors usually recognise ‘active’ or GTP-bound Rabs. Ostermeier and 
Brunger (1999) provided the first insights into the interaction between a Rab3 
effector called Rabphilin-3A and Rab3A (Ostermeier and Brunger, 1999). The 
switch region and a specific CDR (complementarity-determining region) of 
Rab3A conferred specificity to Rabplilin-3A binding (Ostermeier and Brunger, 
1999). Structural studies on a Rab5 effector called Rabenosyn-5 led to the 
identification of small subsets of amino acid residues in the switch and 
interswitch regions of Rab5 that conferred specificity to Rabenosyn-5 (Eathiraj et 
al., 2005). An effector called Rabaptin-5 could recognise two Rabs (Rab5 and 
Rab4), using different sets of amino acid residues located in and around the 
switch region of Rabs (Eathiraj et al., 2005; Vitale et al., 1998). Like Rabaptin-5, 
another Rab effector, inositol polyphosphate 5-phosphatase (OCRL-1) also 
interacts with multiple Rabs (such as Rab1, Rab5, Rab6, Rab8 and Rab14) 
(Fukuda et al., 2008a). Though Rabs are fairly conserved, minor variations in 
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amino acids across the switch/interswitch/CDR region(s) lead to structural 
variations in the Rab protein and consequently functional differences (see Fig. 
5.1). Small structural variations can lead to the formation of distinct 
‘microdomains’ which allow further effector specificity to a particular Rab 
GTPase (Stenmark, 2009).  
 
Effectors are fairly divergent and vary in the composition of their motifs.  
Effectors also rely on motif diversity and structural folding patterns in order to 
recognise a cognate Rab (or its microdomain). Hairpins and helical coiled-coil 
structures formed by distinct amino acid regions on effectors are some of the 
structural components involved in stabilisation of effector and Rab interactions 
(Eathiraj et al., 2005). Rab-interacting lysosomal protein (a Rab7 effector) has 
two coiled-coil domains that self-interact and form a homodimer with two 
separate Rab7 molecules at a time (Wu et al., 2005). OCRL and Rab8 
interaction is facilitated by the ASH domain and C-terminal α-helix region of 
OCRL (Hagemann et al., 2012; Hou et al., 2011). Rabphilin-3A possesses an N-
terminal Rab-binding domain (RBD) and an SGAWFF motif that it uses to stably 
bind the Rab3 group of GTPases (Ostermeier and Brunger, 1999). To 
summarise, the affinity between effectors and Rabs is governed by a cumulative 
effect of interactions between the Rab, its microdomains and unique motifs 









Figure 5.1: Rab domains. Rabs contain two switch domains separted by an interswitch 
region, These domains are made up of six beta sheets flanked by five alpha helices. 
Single or groups of amino acids across the domains form the complementarity determining 
region (CDR). Differences across Rab domains and the CDR contribute to achieving 
specificity in effector recognition. 
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Effectors are involved with Rabs in various stages of endocytosis and 
exocytosis. Effector-mediated processes include vesicle recognition, formation, 
translocation, tethering, docking and fusion. In the early stages of vesicle 
formation, tail-interacting protein of 47 kDa (TIP47), a Rab9 effector interacts 
with the mannose 6-phosphate receptor (M6PR) and mediates vesicle trafficking 
through the TGN (Díaz and Pfeffer, 1998). Trafficking of vesicles in a cell can 
occur via microtubules and the motor protein kinesin (Goldstein, 1993; Vale et 
al., 1985). Rab6 is one of the well characterised Rabs that is involved with the 
microtubule-binding element Rabkinesin-6 (Echard et al., 1998; Hill et al., 2000). 
Some Rabs associate with microtubules via differentially expressed in normal 
and neoplastic cells (DENN) domain proteins (Niwa et al., 2008), while others do 
so via linker proteins, some of which may include receptors (Arimura et al., 
2009). DENN domain proteins were incidentally also characterised as Rab 
GEFs (Yoshimura et al., 2010). The finding that DENN domains have GEF 
activity leads us to the understanding that once activated, Rabs via GEFs (or 
DENN domains), chaperone vesicles along a microtubule to its designated 
organelle. Upon approaching an organelle, the vesicle gets tethered to it and 
additional Rab effectors are recruited. Tethering proteins (some of which may 
also act as effectors) then form a link between the organelle’s target membrane 
and the trafficking vesicle. Tethering of endoplasmic reticulum derived vesicles 
to the Golgi occurs with the Rab1 effectors p115 (Allan et al., 2000) and Golgi 
reassembly stacking protein of 65 kDa (Moyer et al., 2001). Tethering of an 
exocytic vesicle to the plasma membrane is thought to be brought about by 
Rabs and their effectors in a concerted manner with Rho and Ral GTPases 
(Novick and Guo, 2002). Rho GTPases are involved in actin remodelling at the 
plasma membrane (Kanzaki and Pessin, 2001) while Ral GTPases facilitate an 
interaction between the exocytic vesicle and the plasma membrane (Chen et al., 
2007). In GLUT4 trafficking, a vesicle associates with an exocyst complex, 
which is a multimeric complex that interacts with different small GTPases (that 
include Ral and Rho) and their effectors together with SNARE proteins. 
Sec1/Munc18 (SM) proteins are part of SNARE-mediated vesicle fusion and are 
believed to recognise certain Rab effectors. The SM protein, Munc18-1 has 
been shown to interact with Rab27 effectors during plasma membrane 
tethering/docking of neuroendocrine vesicles (Tsuboi and Fukuda, 2006).  
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5.1.3 Rab3 effectors 
 
The Rab3 group of GTPases are primarily involved in exocytosis of secretory 
vesicles to the cell periphery. A number of Rab3 effectors have concomitantly 
been shown to interact with another exocytic Rab called Rab27. This group of 
secretory GTPases (that include Rab3 and Rab27) may have a role in the 
GLUT4 trafficking pathway as Rab3, Rab27 and their effectors have been 
implicated in the late stages of vesicle exocytosis in other cell types (Schlüter et 
al., 2002). Neuronal cells constantly use vesicle exocytosis in signal 
transmission and hence are some of the best-studied examples of Rab3-
mediated exocytosis (Schluter, 2004). Neuronal studies revealed that Rab3 
effectors comprise two plasma membrane-interacting C2 domains (Wang et al., 
1997). These C2 domains were first identified in protein kinase C as Ca2+ and 
phospholipid-binding domains (Nalefski and Falke, 1996). Incidentally, recent 
studies have shown the requirement of a Ca2+-dependent mechanism as well as 
the involvement of plasma membrane-interacting C2 domains in GLUT4 
exocytosis (Xie et al., 2011; Yu et al., 2013).  
 
The first Rab3 effector to be identified was the C2 domain containing effector, 
Rabphilin3A. It was identified in brain tissue (Shirataki et al., 1993) and was 
shown to interact with Rab3A via an N-terminal zinc finger motif (Ostermeier and 
Brunger, 1999). Rab3A recruits Rabphilin3A that facilitates vesicle movement 
along the actin cytoskeleton by binding to the actin component α-actinin (Kato et 
al., 1996). Upon reaching the cell periphery, Rabphilin-3A is thought to bind 
soluble NSF attachment protein of 25 kDa (SNAP-25) of the SNARE machinery 
and prime vesicles for fusion (Deák et al., 2006). Rab3 Interacting Molecule 
(RIM) is another C2 domain containing effector localised to the plasma 
membrane and it associates with a number of proteins in the exocytic pathway, 
such as synaptic Munc13-1 (Dulubova et al., 2005), 14-3-3 (Sun et al., 2003) 
and SNAP-25 (Coppola et al., 2001). RIM regulates vesicle fusion in a Rab3 
dependent manner (Wang et al., 1997) and has also been implicated in insulin 
exocytosis in the pancreas (Iezzi et al., 2000). Another Rab3 effector called 
granuphilin (Slp4a) has also been linked to insulin granule exocytosis and fusion 
in pancreatic cells (Gomi et al., 2005). Like RIM, granuphilin was shown to 
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interact with Rab3A, Munc-18 and syntaxin-1a of the SNARE fusion machinery 
(Coppola et al., 2002; Torii et al., 2002).  
 
 
5.1.4 Noc2: A potential Rab3 effector in adipocytes 
 
A recent study that broadened the understanding of the GLUT4 trafficking 
pathway was the discovery that double C2-like domain-containing protein 
(Doc2b) is involved with the SNARE dependent fusion of GLUT4 vesicles to the 
plasma membrane (Fukuda et al., 2008b). Ca2+ was shown to be necessary in 
this Doc2b dependent fusion process (Yu et al., 2013). Doc2b contains two 
Ca2+-binding C2 domains and it interacts with the SNARE complex via the 
Munc18c-syntaxin-4 complex in insulin-responsive tissues (Fukuda et al., 
2008b; Ramalingam et al., 2012). These findings suggest the involvement of 
Ca2+-dependent sensors (that could include Rab3 effectors) in GLUT4 vesicle 
fusion to the plasma membrane. A Rab3 effector that could be related to Doc2b 
is Noc2. Noc2 is located next to Doc2b on chromosome 17 in Homo sapiens 
(and chromosome 10 in Rattus norvegicus). There could have been an 
evolutionary gene fission event of a Rab3 effector that resulted in Noc2 and 
Doc2b evolving as separate genes. The relationship between Noc2 and Doc2b 
is described in further detail in Figure 5.2. 
 
Noc2 (or No C2) is a Rab3 effector that lacks the C2 domains and was identified 
to be homologous to another Rab3 effector, Rabphilin3A (Kotake et al., 1997). 
Noc2 like other effectors binds to the ‘active’ form of Rab3 (Shibasaki and Seino, 
2005). In neuroendocrine cells, Noc2 was also linked to Ca2+-dependent 
exocytosis where it was shown to be a negative regulator of exocytosis (Haynes, 
2000). In pancreatic acinar cells, it was proposed that Noc2 might be 
responsible for activating a Ca2+-dependent pathway for exocytosis (Ogata et 
al., 2012). The role of Noc2 as a positive or negative regulator may indeed vary 
across cell types. The distinguishing feature of Noc2 is that it lacks the C2 
domains that are extensively characterised in exocytic Rab3 effectors. The 
missing C2 domains, however do not affect Noc2’s Rab binding ability. The N-
terminal region of Noc2 contains the RBD that is conserved across Rab3 
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effectors and an SGAWFY motif that assists Noc2 in Rab3 recognition and 
binding (Fukuda et al., 2004). The interaction between Noc2 and Rab3 has been 





5.1.5 Aims and rationale for the study 
 
The identification of Rab3 as a candidate Rab in the GLUT4 trafficking pathway 
also opens the possibility to involvement of Rab3 effectors as regulators of 
GLUT4 trafficking. Noc2 is a Rab3 effector that shows close chromosomal 
proximity to a well-characterised GLUT4 vesicle regulating C2 domain protein, 
Doc2b. Noc2 has been shown to act in concert with Rab3 in regulating vesicle 
and granule exocytosis in neuronal tissues and pancreas. This makes Noc2 an 
interesting Rab3 effector to study in relation to GLUT4 exocytosis. 
 
The aim of this chapter would be to investigate if Noc2 is present in adipocytes 
at the cellular level. The role of Noc2 in GLUT4 trafficking and a relationship with 
Rab3B will also be explored.  
 
 
Figure 5.2: Relationship between Doc2b and Noc2. The locus for Doc2b in Homo sapiens 
is 17p13.3. At this very same locus, next to the Doc2b gene, the Rab3 effector Noc2 (Rph3al) 
is located. Noc2 contains the Rab binding domain (RBD) but it lacks the C2A and C2B 
domains that is present in most Rab3 effectors (reviewed in Cheviet et al., 2004). Doc2b lacks 
a RBD but contains the C2A and C2B domains and is well-characterised in GLUT4 traffic. 
There could have been an evolutionary gene fission event of a Rab3 effector resulting in two 
seprate genes, Noc2 and Doc2b. Doc2b has been well characterised in SNARE-mediated 
GLUT4 exocytosis and fusion. The link between Noc2 and Doc2b has not been explored 





5.2.1 Analysis of Noc2 expression in insulin-responsive tissues 
 
A quantitative PCR (qPCR) study was designed to check if insulin-responsive 
tissues contained the putative Rab3 effector, Noc2. The results of the qPCR 





The qPCR results demonstrate the variation in the levels of Noc2 across insulin-
responsive tissues. Although the insulin-responsive tissues tested here show 
Noc2 expression, the levels were ~14 times lower in comparison to the cDNA 
tested for Noc2 expression in rat testes which can be considered as a control 
 
        
Figure 5.3: Analysis of Noc2 expression in insulin-responsive tissues. mRNA was extracted 
using the TRIzol®-chloroform method from insulin-responsive tissues belonging to Rattus 
norvegicus. cDNA was generated by reverse transcription. The primers used in this Noc2 
study were first validated in rat testes prior to being used (Supplementary figure S4B). The 
figure shows Noc2 gene expression normalised to the 28S rRNA housekeeping gene. 
Each bar represents an n of 3 or 5, from independent sets of tissues/rats. Error bars 
represent mean and SEM from 3 or 5 rats or independently isolated tissues. 
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(Supplementary figure S4). However, though the levels were low, it can be 
concluded that Noc2 is indeed expressed in insulin-responsive tissues and its 
role will need to be explored to characterise its effect on GLUT4 exocytosis. 
 
Other Rab3 effectors were also screened in insulin-responsive tissues using a 
qPCR approach, but their levels were found to be well below Noc2 2 -ΔΔCt values 
(Supplementary figures S5A and S5B). 
 
 
5.2.2 Generation of Noc2 constructs and a site-directed mutant 
 
Noc2 contains an SGAWFY motif (conserved across Rab3 effectors) that is 
proposed to stably bind Rab3/27. Mutations can be made to this conserved motif 
by substituting amino acids tryptophan (W), phenylalanine (F) and tyrosine (Y) 
with alanine (A) residues. This generates an SGAAAA mutant  (or Noc2 AAA). 
Noc2 AAA is incapable of binding to Rab3 or Rab27 (Handley and Burgoyne, 
2008; Haynes, 2000).  
 
Noc2 was amplified at 909 bp from adipocyte and heart cDNA (from the cDNA 
extracted in Materials and Methods 2.2.2.3 protocol). The 909 bp Noc2 amplicon 
was cloned into the pHM6 mammalian expression vector. The pHM6-Noc2 
plasmid was test digested to check for a correctly inserted Noc2 with HindIII and 
NotI restriction enzymes. These enzymes correctly recognised the respective 
restriction sites flanking the Noc2 cDNA (Fig. 5.4B). A Noc2 AAA mutant was 
generated from the Noc2 WT construct (Fig. 5.4C) using site-directed 
mutagenesis primers (Supplementary table S1). The Noc2 WT and Noc2 AAA 
genes were subcloned into vectors pGEX-4T (a bacterial expression vector that 
would yield a GST-Noc2 fusion protein) and p3X-FLAGCMV TM -10 (Sigma-






5.2.3 Expression and purification of the GST–Noc2 fusion protein 
 
Fusion proteins are efficient tools for studying protein-protein interactions in vitro. 
In order to perform a pull-down of Noc2 to study the interaction of Noc2 with 
Rab3B, GST-Noc2 and GST-His-Noc2 constructs were prepared. 
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Figure 5.4: Cloning of Noc2 cDNA and 
generation of the mutant Noc2 AAA 
construct. Noc2 was amplified with PCR 
primers described in Supplementary table S1. 
A 909 bp amplicon was analysed on a 1% w/v 
agarose gel (A). This 909 bp amplicon was 
inserted into the pHM6 mammalian expression 
vector. A test digest of pHM6-Noc2 constructs 
was performed (B). Sample 3 was used to 
generate the Noc2 AAA mutant by site-directed 
mutagenesis (C). Sequencing results of Noc2 
WT and Noc2 AAA is provided in Supplementary 













The (pGEX-4T) Noc2 construct was transformed into E.coli BL21 cells and 
expression followed by purification was carried out as described in Materials and 
Methods 2.2.5.1. Fig. 5.5A is representative of protein expression carried out at 
37°C for 5 h. This expression using E.coli BL21 cells yielded 48 µg/ml of GST-
Noc2 from 1.5 l of culture and mainly a GST degradation product (Fig. 5.5, A 
and B).  This yield of protein was insufficient for experimental use. To increase 
the yield, the (pGEX-4T) Noc2 construct’s expression in E.coli BL21 was 
induced with higher concentration of IPTG. 0.5 mM and 1 mM IPTG was used 
during expression of the GST-Noc2 protein, but the increase in IPTG 
concentration did not improve the yield of GST-Noc2. The (pGEX-4T) GST-Noc2 
construct was then transformed into E.coli (RosettaTM(DE3)pLysS, 
D 
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Figure 5.5: Noc2 protein expression. E.coli BL21 competent cells were transformed with the 
GST (or GST-His) tagged Noc2 vector. Induction was carried out with 0.5 mM IPTG and the 
culture was grown at 14°C overnight. Purification was carried out using glutathione beads. 
Expression and purification samples were run on a 12% SDS-PAGE gel.  
(A) Expression of the (pGEX-4T) GST-Noc2 WT fusion protein with IPTG stimulation for 5 h at 
37°C followed by purification on glutathione beads. Figure shows a western blot with anti-GST 
antibody. 
(B) SDS-PAGE coomassie gel quantification of the purified GST-Noc2 WT from A. 
(C) Expression of the (pAT109) GST-His-Noc2 WT fusion protein with IPTG stimulation for 16 h 
at 12°C followed by purification on glutathione beads. Figure shows a western blot with anti-
GST antibody. 
(D) Coomassie gel quantification of the GST-His-Noc2 WT protein (from C) following another 
round of purification on a HisTrap FF column. Figure shows elutions from His and glutathione 
purifications.  
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Lemo21(DE3) and ArcticExpress(DE3)) strains to obtain a better protein yield. 
Expression of (pGEX-4T) Noc2 in each strain was tested with different 
concentrations of IPTG (0.1, 0.3, 0.4 and 0.5 mM) and different expression times 
(3, 5 and 16 h). The E.coli ArcticExpress (DE3) cells gave a good yield of GST-
Noc2 though there was still GST degradation at ~25 kDa. To further reduce GST 
degradation products, Noc2 was subcloned into a pAT109 vector. The pAT109 
vector contained an N-terminal GST-tag and a C-terminal His-tag. This vector 
was used so that the Noc2 fusion protein could be purified using two different 
approaches. Fig. 5.5C shows the expression of the pAT109-Noc2 WT construct in 
the E.coli ArcticExpress(DE3) cells carried out at 14°C for 18 h. The E.coli 
ArcticExpress(DE3) cell pellet containing GST-His-Noc2 was split into two and 
each pellet was lysed separately with a different lysis buffer. One pellet was 
lysed with a lysis buffer containing 1% Triton X-100 while the other pellet was 
lysed without any Triton X-100. This was done to maximise chances of a pure 
protein and reduce degradation products. The two differently prepared bacterial 
lysates were purified using glutathione beads. The cell lysate that did not contain 
1% Triton X-100 showed a more pure protein than the cell lysate that contained 
1% Triton X-100 (Fig. 5.5C). The GST-His-Noc2 obtained from the lysis buffer 
containing no Triton X-100, was purified again on a HisTrap FF column (GE 
Healthcare). Fig. 5.5D shows a cleaner product with this new (GST-His) 
purification protocol yielding 530.4 µg/1.5 ml GST-His-Noc2 from 1.5 l of culture 




5.2.3.1 Purification of the GST-His-Noc2 using gel permeation 
                   chromatography (GPC) 
 
To remove any residual GST from the preparation, the protein was further 
purified using gel permeation chromatography (GPC). The GST-His-Noc2 
protein product was purified using a Superdex 200 10/300 GL column (GE 
Healthcare) to get a cleaner GST-His-Noc2 protein. The purified protein 
fractions were collected from the column (Fig. 5.6A) and run on a coomassie gel 
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(Fig. 5.6, B and C) to identify the positive GST-His-Noc2 product (or peak) from 













The (Pre-GPC) control loaded in these gels (Fig. 5.6) comprised a small amount 
of the GST-His-Noc2 prior to purifying it on the GPC column. Purified fractions 
were compared to this Pre-GPC control. Fractions in Peak 1 showed the correct 
GST-His-Noc2 product. Fractions from Peak 1 were hence pooled together and 
quantified on a coomassie gel. The GST-His-Noc2 product was quantified to be 
350 µg/ml of GST-His-Noc2 obtained from the 1.5 l culture (Fig. 5.6D). The yield 
obtained was of better concentration with less GST degradation products than 
previous purification attempts (Fig. 5.6B).  
 
The GST-His-Noc2 AAA construct was prepared in exactly the same way as the 
GST-His-Noc2 WT (Fig 5.5 and 5.6). The GST-His-Noc2 constructs were used in 
an antibody-competition study for validating the Noc2 antibody (see section 5.2.4) 
and studying the interaction between Noc2 and Rab3B (see section 5.2.7). 
 
 
5.2.4 Validation of the Noc2 antibody  
 
A commercial anti-Noc2 antibody was available to test rat adipocyte 
endogenous Noc2 at the protein level in rat adipocytes. The antibody was tested 
using western blots of rat adipocyte and heart lysates to check whether the 
Noc2 antibody could detect the endogenous Noc2 protein. Adipocyte and heart 
tissues are thought to contain Noc2 based on the qPCR data in Fig. 5.3. The 
results of the antibody test are shown in Fig. 5.7A. The commercial anti-Noc2 
antibody detected the presence of a possible Noc2 band at 34.5 kDa. The 34.5 
kDa band was 0.5 kDa more than the calculated size of the Noc2 protein, which 
is 34 kDa. The heart lysate showed 28.85-fold more Noc2 protein compared to 
the adipocyte lysate (Fig. 5.7A). To check if the band at 34.5 kDa was indeed 
Figure 5.6: Gel permeation purification of GST-His-Noc2. A Superdex 200 10/300 GL 
column was washed with 20% ethanol and calibrated in a Tris-NaCl buffer. 3 ml of the GST-
His-Noc2 protein was loaded onto the column and 1 ml fractions were collected (A). 20 µl of 
each of the fractions were run on a 12% SDS PAGE gel (B, C). The SDS-PAGE gel also 
contained the GST-His-Noc2 protein sample as a control (labelled as Pre-GPC in figure). 
Fractions were quantified on a 12% SDS-PAGE coomassie gel containing BSA standards (D). 
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the Noc2 protein, the anti-Noc2 antibody was validated as follows. The GST-His-
Noc2 protein was incubated with the Noc2 antibody overnight on a rotator at 
4°C. After incubation of the anti-Noc2 antibody with the His-GST-Noc2 fusion 
protein, western blotting was performed on adipocyte and heart lysates with this 
antibody (Fig. 5.7B). The 34.5 kDa Noc2 band in the adipocyte lysate was 
reduced by 92.39% and that in the heart lysate was reduced by 83.96% when 
compared to their respective controls at 34.5 kDa in Fig. 5.7A. 
 
This study demonstrates two crucial findings. First, the commercial anti-Noc2 
antibody is able to detect the Noc2 protein in the insulin-responsive tissues 
tested. Second, the antibody confirms that Noc2 is present at the protein level in 
adipocyte and heart lysates and we can detect it at an expected size of 34.5 kDa 




   A            B 
 
 
Figure 5.7: Competition assay for validating the Noc2 antibody. Adipose and heart 
tissues were lysed in lysis buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100 
and protease inhibitors). 25 µg of the adipose lysate and 5 µg of the heart lysate were run 
on a 12% SDS-PAGE gel in duplicates and transferred to a nitrocellulose membrane. One 
nitrocellulose membrane was western-blotted directly with 0.0048 pmoles of the Noc2 
antibody (A). The other membrane was western blotted with 0.0048 pmoles of the Noc2 
antibody (which was first preincubated, with 0.24 pmoles (50 times more) of the His-GST-
Noc2 fusion protein overnight at 4°C) (B). The potential Noc2 bands in the two western 
blots were quantified as a % decrease of the control Noc2 band in A. 
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5.2.5 Localisation of Noc2 in adipocytes 
 
Studying the cellular localisation of Noc2 may yield more information on its 
function. Preliminary studies were carried out by Dr F. Koumanov to identify the 
cellular location of endogenous Noc2 in adipocytes. Subcellular fractions of the 
plasma membrane and cytosol were western blotted with the Noc2 antibody. 
The findings (Fig. 5.8A) showed that Noc2 was present at the plasma 
membrane and to a lesser extent in the cytosol. In insulin-treated adipocytes, a 
significant 63% drop in Noc2 was observed at the plasma membrane when 
compared to the plasma membrane from basal adipocytes (Fig. 5.8B). These 
findings were further investigated by transfecting adipocytes with the HA-tagged 
Noc2 constructs to identify differences in subcellular localisation (if any) with the 
Noc2 AAA mutant construct. 
 
 
A               B 
 






Figure 5.8: Western blots showing Noc2 localisation in adipocytes. Primary rat 
adipocytes were isolated and treated with insulin. Adipocytes were subfractionated in HES 
buffer to isolate the plasma membrane and cytosol. The plasma membrane and cytosol 
were run on a 12% SDS-PAGE gel and blotted with for Noc2 (A). Amount of Noc2 at the 
plasma membrane was quantified as a percentage of the basal plasma membrane and 
represents mean and SEM from 5 independent experiments. *p=<0.001 (paired two tailed 
t-test vs basal PM)(B). Rat adipocytes with transfected HA-Noc2 WT or HA-Noc2 AAA and 
were maintained overnight at 37°C. On the next day, transfected adipocytes were insulin-
treated and subfractionated. Western blot was performed with an anti-HA antibody (C). 




HA-Noc2 WT or HA-Noc2 AAA was transfected into rat adipocytes by 
electroporation and adipocytes were maintained overnight at 37°C. The next 
day, adipocytes were left untreated or insulin-stimulated, homogenised and 
subfractionated. The homogenate, plasma membrane and cytosolic fractions 
were western blotted. The blots were probed with an anti-HA antibody (Fig. 
5.8C). Expression of the HA construct was low but fairly even across the Noc2 
WT and Noc2 AAA samples as seen in the homogenate (Fig. 5.8C).  
 
Quantification of Noc2 on western blots was performed using densitometry and 
LabWorks (UVP products). HA-Noc2 WT showed a 40.93% decrease at the 
plasma membrane in the insulin-treated adipocytes (Fig. 5.8C) corroborating the 
earlier study on endogenous Noc2 localisation (Fig 5.8, A and B). HA-Noc2 AAA 
showed no difference across basal and insulin plasma membrane samples and 
appeared to be at a baseline level (Fig. 5.8C). This may suggest that Noc2 WT 
could attach to the PM via a Rab, as the Noc2 AAA is deficient in Rab3/Rab27 
binding. The functional relevance of Noc2 WT and Noc2 AAA to the GLUT4 
trafficking process therefore seemed to warrant further investigation. Also, it was 
considered that interaction studies between Noc2 and Rab3B would shed more 
light on potential insulin dependence of the Noc2/Rab3 interaction in adipocytes.  
 
 
5.2.6 Effect of Noc2 on GLUT4 translocation in adipocytes 
 
Following the confirmation that Noc2 is present in adipocytes, an experimental 
approach was used to study Noc2’s effect on GLUT4 translocation. An HA-
GLUT4 translocation assay that was similar to that described in Chapter 4 
(section 4.2.3) and other literature (Al-Hasani et al., 1998; Koumanov et al., 
2012) was employed to study the effect of Noc2 in adipocytes. HA-GLUT4 alone 
or HA-GLUT4 and FLAG-Noc2 WT or FLAG-Noc2 AAA were electroporated into 
adipocytes and the adipocytes were maintained overnight under culture 
conditions. The next day, basal and insulin-stimulated adipocytes were assayed 
for surface HA-GLUT4. As seen in Fig. 5.9, there was an approximately 2.6-fold 
increase in the surface HA-GLUT4 in insulin-stimulated adipocytes containing 
only the HA-GLUT4 construct (which was the control). The level of increase in 
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Figure 5.9: Noc2 decreases GLUT4 translocation in insulin-treated adipocytes. 
Primary rat adipocytes were isolated, transfected by electroporation with HA-GLUT4 or 
HA-GLUT4 and Noc2 WT or Noc2 AAA. The transfected adipocytes were maintained in 
culture overnight (for 16 h). On day 2, adipocytes were treated as basal or insulin. HA-
GLUT4 at the cell surface was detected with an anti-HA antibody and β-galactosidase 
conjugated secondary antibody. The signal was measured with a fluorescent β-
galactosidase substrate. Results are expressed as a percent of HA-GLUT4-Basal and 
represent mean and SEM from 4 independent experiments. * p=<0.05 (paired two tailed t-
test vs HA-GLUT4-Insulin) (A). Western blots show expression of the transfected HA-




However, insulin-stimulated adipocytes containing FLAG-Noc2 WT showed a 
significant decrease in the levels of HA-GLUT4 on the cell surface. The 
translocation assay data suggests that Noc2 WT overexpression directly or 
indirectly affects the amount of HA-GLUT4 translocated to the cell surface. 
 
 
5.2.7 Noc2 pull-down of Rab3B from adipocytes 
 
The results seen in Fig. 5.8 suggest that Noc2 is PM bound in the basal state 
and cytosolic in the insulin-stimulated state. An inability of the Rab binding 
deficient mutant (Noc2 AAA) to be detected at the plasma membrane in either 
basal/insulin-stimulated states (Fig. 5.8C) suggests that a Rab3 isoform might 
facilitate the Noc2-PM interaction. To study a Noc2-Rab3B interaction, a study 
was designed to pull-down Rab3B from lysates using GST/MBP-tagged Noc2. 
 
In the study shown in Fig. 5.10A, His-GST-Noc2 WT immobilised on glutathione 
agarose beads, was used to pull-down FLAG-Rab3B from adipocyte lysates. 
The lysates were spiked with GTPγS to load Rab3B with guanine and convert it 
to its ‘active’ form. The GST-His-Noc2 AAA mutant, defective in its Rab3 binding 
ability, did not pull-down any FLAG-Rab3B, confirming the Noc2 AAA construct’s 
ineffectiveness in binding a Rab3, in this case Rab3B. The Noc2 WT protein was 
able to pull-down Rab3B (Fig. 5.10A). 
 
The experiment was repeated using insulin-stimulated adipocytes to understand 
the effect of insulin on Noc2-Rab3B binding. The GTPγS spiked lysate was used 
as a positive control for the pull-down. The results obtained from this setup (Fig 
5.10B) show a difference in amounts of FLAG-Rab3B detected in basal and 
insulin pull-downs on a western blot. The level of FLAG-Rab3B pulled-down by 
GST-His-Noc2 in the insulin samples was 65.10% lower than the basal samples 
(Fig. 5.10C). This indicated a lower affinity of Noc2 for Rab3B upon insulin 
stimulation. The results represent data from two individual experiments. Due to 
the limitations in expression of the His-GST-Noc2 construct and to obtain a 
statistically significant result (n=3), a new expression vector (pMAL-C2) was 
















Figure 5.10: Pull-down of Rab3B from adipocytes 
using GST-His-Noc2. Primary rat adipocytes were 
transfected with FLAG-Rab3B and maintained overnight 
at 37°C. On the next day, adipocytes were treated as 
basal or stimulated with insulin and then lysed. An aliquot 
of the basal lysate was treated with 1 mM GTPγS.  
Glutathione conjugated agarose beads were pre-loaded 
with 25 µg GST or 50 µg His-GST-Noc2 WT or His-GST-
Noc2 AAA. GST protein pre-loaded beads were incubated 
with the same concentrations of basal or insulin or 
GTPγS lysate at 4°C for 1 h. SDS sample buffer was 
added directly to the beads to elute the bound protein 
from the beads. Pull-down samples and pre pull-down 
lysate (controls) were run on a 12% SDS-PAGE gel and 
western blotted. The blot was probed for FLAG-Rab3B 
with an anti-FLAG antibody. 
(A) This figure shows Noc2 pull-down of FLAG-Rab3B 
from adipocyte lysates to which GTPγS had been added.  
(B) This figure shows Noc2 pull-down of FLAG-Rab3B 
from adipocyte lysates from basal or insulin-treated or 
with GTPγS added to the lysate from basal cells. 
(C) The graph demonstrates percentage values showing 
decrease in FLAG-Rab3B pull-down in insulin-treated 
sample (B) with respect to the basal. Error bar represents 





A new vector that incorporated an MBP-tagged Noc2 construct was expressed 
and purified to yield an MBP-Noc2 fusion protein (Supplementary figure S6). 
Pull-down of FLAG-Rab3B using the MBP-Noc2 construct (Fig. 5.11) showed 
similar results to the GST-Noc2 pull-down (Fig. 5.10). There was a basal-insulin 
difference in the amount of FLAG-Rab3B pulled-down (Fig. 5.11). The insulin 
samples showed a significant 59.39% decrease in FLAG-Rab3B pulled-down 
when compared to the basal samples (Fig 5.11B). 
 
These pull-downs employed whole cell lysates and did not distinguish between 
the plasma membrane and cytosol. However, the idea that a Noc2-Rab3B 
interaction is lost in the insulin-stimulated state may hold true. This is due to the 
significant decrease in amount of Rab3B pulled-down by Noc2 in the insulin-






Figure 5.11: Pull-down of Rab3B from adipocytes 
using MBP-Noc2. Primary adipocytes were 
transfected with FLAG-Rab3B and a pull-down was 
carried out similar to Fig. 5.10. Amylose beads were 
loaded with 10 µg MBP-Noc2 WT and incubated with 
equal concentrations of basal or insulin or GTPγS 
lysates. Bound proteins were eluted with maltose 
elution buffer. Eluted samples were run on a 12% SDS-
PAGE gel and western blotted. 
(A) This figure shows Noc2 pull-down of FLAG-Rab3B 
from adipocyte lysates from basal or insulin-treated or 
with GTPγS added to the lysate from basal cells.  
(B) The graph demonstrates percentage values 
showing decrease in FLAG-Rab3B pull-down in insulin-
treated samples with respect to the basal. Error bar 
represents SEM from 3 individual experiments with 
MBP-Noc2 (n=3). *p=<0.05 (paired two tailed t-test vs. 




The results in this chapter can be summarised with a few key findings. (1) Noc2 
is present in adipocytes and is localised mainly to the plasma membrane in the 
basal state (Figs. 5.3 and 5.8). (2) Upon insulin stimulation, Noc2 levels at the 
plasma membrane significantly drop (Fig., 5.8 A and B). (3) Overexpression of 
Noc2 leads to a significant decrease in the levels of GLUT4 translocated to the 
plasma membrane (Fig. 5.9). (4) Insulin stimulation of adipocytes leads to less 
Rab3B binding to exogenous Noc2 as detected using a protein pull-down 





Figure 5.12: Summary of key findings. The findings in Chapter 4 implicated Rab3B Q81L as a 
positive regulator of GLUT4 translocation. The findings in this chapter suggest that in the basal 
state Noc2 is localised to the PM. Noc2 also binds more Rab3B in the basal state. Little to no 
PM localised Noc2 could be detected in the basal state when the (Rab3/Rab27-binding 
deficient) Noc2 AAA construct was overexpressed in adipocytes. Upon insulin-stimulation, Noc2 
levels at the PM were reduced. Noc2-Rab3B interaction decreased when adipocytes were 
treated with insulin. Noc2 was also implicated as a negative regulator of GLUT4 translocation. 
These findings suggest that Noc2 may sequester Rab3B in the basal state and release it upon 
insulin-stimulation leading to GLUT4 translocation. It is unclear how Noc2 may be localised to 
the PM in the basal state and this is an area for further investigation. Additionally, it would be 
interesting to understand how the Noc2-PM interaction is lost upon insulin-stimulation. 
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Noc2 has been localised to membranes in pancreatic cells (Cheviet, 2003). 
Noc2 may also be located at the cell periphery to facilitate the final stages of 
membrane docking and fusion (Fukuda et al., 2004). However, the inability to 
detect Noc2 AAA at the PM (Fig. 5.8C) raises the possibility that Rab3 or Rab27 
might be involved via an additional interacting protein (that anchors to the PM) 
and facilitates the basal Noc2 WT or endogenous Noc2 PM localisation (Fig. 5.8, 
A and C). Such a tripartite interaction (comprising Noc2-Rab3/27-PM anchoring 
protein, if it exists) would be devoid of any bound GLUT4 vesicle(s). Firstly, this 
is because Rab3B for instance associates with GLUT4 vesicles more in the 
insulin-stimulated state (Koumanov et al., manuscript in preparation). Secondly, 
evidence that a Rab would likely need to be geranylgeranylated to anchor to a 
vesicle supports the idea that a ‘Rab-bound vesicle’ is unlikely to be present in a 
tripartite complex with Noc2 in the basal state at the PM. This could be the case, 
as geranylgeranylation of Rab3 at least, is thought to occur primarily upon 
insulin activation in studies using 3T3L1 adipocytes (Goalstone et al., 1999).  
 
The study described in this chapter implicates Noc2 as a negative regulator of 
GLUT4 translocation (Fig. 5.9). Overexpression of Noc2 in pancreatic β-cells 
(Cheviet, 2003), neuroendocrine cells (Haynes, 2000) and epithelial cells 
(Manabe et al., 2004) leads to an inhibition of regulated exocytosis of vesicles or 
secretory granules. Granuphilin is another Rab3 effector that negatively affects 
regulated exocytosis of secretory granules in pancreas and neuroendocrine cells. 
A study by Handley and Burgoyne (2008) reported that Noc2 closely associates 
with the C2 domain containing effector granuphilin and this association may affect 
vesicle tethering/docking at the plasma membrane (Handley and Burgoyne, 
2008). Granuphilin was hard to detect at the mRNA level in rat adipocytes using a 
qPCR approach (Supplementary figure S5B) and hence was not investigated at 
the protein level in the studies described in this thesis. A separate study in the 
Holman lab was able to detect granuphilin at the protein level in rat adipocyte 
lysates. Investigating granuphilin in rat adipocytes would hence be interesting as 
it may associate with Noc2 in regulating GLUT4 exocytosis via an exocytic Rab 
(such as Rab3). 
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Noc2 bound ~60% less Rab3B in a pull-down assay from insulin-stimulated 
adipocyte lysates than basal adipocyte lysates (Figs. 5.10 and 5.11). In ideal 
conditions, one would expect an insulin stimulus to cause Rab3B activation and 
lead to Rab3B being in the GTP-bound state, thereby binding more Noc2 
presented as an exogenous protein in the pull-down assay (Fig. 5.10 and 5.11). 
But the data observed in this chapter shows less Rab3B being pulled-down by 
Noc2 following insulin-stimulation. It must however be noted that the Rab3B that 
was pulled-down by Noc2 as observed in Figs 5.10 and 5.11, could have been 
either in the GTP or the GDP-bound state. Noc2 is able to pull-down some of the 
‘inactive’ GDP form of Rab3B in the presence of the ‘active’ GTP form of Rab3B 
from a lysate (Haynes, 2000; Matsumoto et al., 2004). Hence, in the observed 
results (Figs. 5.10 and 5.11) the Rab3B detected, as being bound to Noc2 could 
have been GDP-bound in basal conditions. In the insulin-stimulated state the 
decrease in Noc2-Rab3B binding can be attributed to the GTP-active Rab3B 






With only a limited number of published studies on Noc2, it is difficult to draw a 
conclusion on the functional aspects of this exocytic Rab effector. Based on the 
results described in this chapter, it is evident that Noc2 is insulin-responsive and 
does have an effect on GLUT4 translocation. Its interaction with Rab3B in 
adipocytes provides an insight into the involvement of exocytic Rabs and their 
effectors in regulating GLUT4 exocytosis to the plasma membrane.  
 
It was earlier hypothesised that Noc2 and Doc2b might share an evolutionary 
relationship (Fig. 5.2). However, Doc2b is primarily implicated in translocation to 
the plasma membrane upon insulin stimulation and facilitates GLUT4 
exocytosis, therefore Doc2b acts as a positive regulator (Fukuda et al., 2008b). 
Noc2 was shown to have the opposite effects to Doc2b in the study described in 
this chapter. If future studies show that Doc2b associates with Noc2 at the PM 
or at the subcellular level, it may open consideration of a more complex 
mechanism in regulation of GLUT4 traffic. 
 
Published data on Noc2 have included competition studies with its cognate 
Rabs (3, 8A and 27). Some of this published data reports that Noc2 is 
predominantly a Rab27 effector (Fukuda et al., 2004; Handley and Burgoyne, 
2008). Since Rab27 mRNA levels were found to be low (Supplementary figure 
S5B) and the protein was not detected on total membranes using the 
photolabelling approach (Chapter 4, 4.1.3), Rab27 did not form a part of this 
study. Probing for Rab27 by western blotting adipocyte protein lysates may yield 
more information on its presence at the protein level. Rab8A is another Rab 
involved in GLUT4 translocation and could be a potential Noc2 interacting 
protein. If Rab27 is not detectable, a competition study in adipocytes between 
Noc2, Rab8A and Rab3 (A, B, D) could yield some important findings on the 
preferred Rab for Noc2. Further binding assays between Noc2 and cytoskeletal 
motors will help map the binding partners for Noc2 in adipocytes. Investigation 
of Noc2 (and its interacting proteins) will shed more light on the involvement of 
exocytic Rabs and their effectors in regulating GLUT4 exocytosis to the PM. 
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6 Final discussion and conclusion 
 
6.1 Final discussion 
 
The overall purpose of the studies described in this thesis was to identify novel 
proteins that facilitated GLUT4 trafficking in adipocytes. The work in this thesis 
identifies Rab3B and its effector Noc2 as novel regulators of GLUT4 trafficking. 
The model in Figure 6.1 illustrates some of the key findings in this thesis and the 
proposed role of Rab3B and Noc2 in regulating GLUT4 traffic to the plasma 
membrane. GLUT4 trafficking via the ESCRT pathway was also identified as a 
new route of GLUT4 trafficking.  
 
A number of Rabs have been extensively characterised in neurotransmitter 
secreting cells as regulators of cellular development, neurite growth, cell 
polarisation and vesicle exocytosis (Ng and Tang, 2008). Rab3 has been 
particularly well characterised in the release of secretory vesicles in a Ca2+-
dependent manner and has also been implicated in synaptic vesicle fusion 
(Schluter, 2004). The involvement of a Rab3 family member in GLUT4 trafficking 
is suggested from consideration of the data described in this thesis. This 
involvement provides a mechanism for modulation of the GLUT4 transporter by a 
class of exocytic GTPases that are known to be involved primarily with secretory 
vesicles. Overexpression of the Rab3B Q81L constitutively active construct alone 
caused a significant increase in GLUT4 at the plasma membrane in basal 
conditions (Fig. 4.5). Overexpression of the dominant negative Rab3B T36N 
constructs showed a decreased basal-insulin response while Rab3B WT showed 
a normal basal-insulin response. Rab3 is hence active when it is bound to GTP 
(or mimicked by the Q81L mutation) (Brondyk et al., 1993). Rab3B’s activation to 
the GTP bound form is triggered in rat adipocytes upon insulin stimulation 
(Koumanov et al., manuscript in preparation). These results implicate activated 
Rab3B as a positive regulator of GLUT4 exocytosis. 
 
Insulin signalling is shown to activate a number of Rabs in GLUT4 traffic. Rab10 
has been particularly well studied as it is AS160-regulated and knockdown of 
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Rab10 attenuated GLUT4 translocation (Ng and Tang, 2008; Sano et al., 2007). 
However, the fact that the AS160-Rab10 system is only partly responsible for 
GLUT4 translocation (Park et al., 2012; Sadacca et al., 2013), allows 
consideration for other Rabs as likely candidates in this exocytic pathway. Rab3B 
is known to facilitate movement of fusion competent vesicles to the plasma 
membrane (Schonn et al., 2010; Vadlamudi et al., 2000). There is evidence that 
Rab3B colocalises with SNARE components, SNAP-25 and syntaxin in rat 
pituitary cells (Matsuno et al., 2003). Rab3 may also be recruited to recycling 
endosomes upon insulin-stimulation. Rab3B/Rab3C positive recycling 
compartments have been identified in dendritic cells (Zou et al., 2009). Hence, 
co-immunostaining of Rab3 with GLUT4 vesicle associating SNAREs, SNAP-23 
and/or syntaxin-4 will yield information on Rab3B localisation in rat adipocytes. 
 
The GSV localised Rab10, is regulated by an insulin sensitive GAP (AS160) and 
not its GEF (DENND4C) (Park et al., 2012; Sadacca et al., 2013; Sano et al., 
2011). This finding suggests a possible route for Rab regulation in GLUT4 traffic 
via Rab GAPs. It would hence be useful to investigate if Rab3B is also regulated 
by an insulin-dependent GAP. AS160 was identified as an insulin-regulatable 
GAP for a number of Rabs in GLUT4 traffic (Mîinea et al., 2005; Vadlamudi et al., 
2000). AS160 activated Rabs include Rab8A (Sano et al., 2007; Sun et al., 2010), 
Rab10 (Sadacca et al., 2013; Sano et al., 2007) and Rab14 (Ishikura et al., 2007; 
Schonn et al., 2010). Studies in muscle cells led to the conclusion that AS160 is 
not the only insulin-regulatable GAP in insulin-responsive tissues. TBC1D1 (a 
paralog of AS160) plays a similar role in muscle, in addition to AS160 (Sakamoto 
and Holman, 2008). Recently, TBC1D13 was identified as a Rab35 GAP in 3T3L1 
adipocytes (Davey et al., 2012). Could rat adipocytes harbour a specific GAP for 
Rab3? A GAP called Rab3-GAP is specific to the Rab3 family, which makes it an 
ideal study candidate (Fukui et al., 1997). Functional studies on Rab3-GAP 
suggest that it may be involved in the homeostatic control of Rab3-mediated 
vesicle release by competing with Rab3 effectors such as Rabphilin-3A or Noc2 
(Clabecq et al., 2000; Müller et al., 2011). Studies on synaptic transmission 
confirm that Rab3 is directly regulated by the Rab3-GAP in synaptic vesicle 
release (Müller et al., 2011; Sakane et al., 2006). The Rab3-GAP can be 
identified in rat adipocytes by using quantitative PCR and an antibody can be 
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used for studying it at the protein level using adipocyte lysates. Alternatively, a 
TBC domain library can also be screened for a Rab3 GAP using a yeast two-
hybrid (Y2H) system (Itoh et al., 2006). 
 
The data described in this thesis showed that Noc2 bound >50% more Rab3B in 
the basal state than in the insulin-stimulated state. Noc2 hence could be 
sequestering any free Rab3B until insulin stimulation, following which it releases 
Rab3B to facilitate GLUT4 translocation to the plasma membrane. It is plausible 
that Noc2 sequesters Rab3B-GDP in the basal state and this sequestration may 
encompass a close association with another Rab3 effector, granuphilin. 
Granuphilin in fact negatively regulates exocytosis (Coppola et al., 2002) and 
does so by interacting with the GDP-bound form of another exocytic Rab, Rab27 
(Fukuda, 2003). Though granuphilin levels were fairly low in the qPCR study 
(Supplementary figure S5B), it could be detected at the protein level in rat 
adipocytes (unpublished data). Functional studies on granuphilin could provide 
more information on its role if any in GLUT4 trafficking. 
 
The dissociation of Noc2 from the plasma membrane in insulin-stimulated rat 
adipocytes described in this thesis may be explained by an interaction between 
an SM (Sec1/Munc18-like) protein and Noc2. The SM protein in adipocytes is 
Munc18c (also known as Munc18-3). Munc18c could be responsible for 
sequestering Noc2 in the basal state at the plasma membrane and releasing it 
upon insulin stimulation, at which point Noc2 becomes cytosolic. The role of 
Munc18c in GLUT4 trafficking is to regulate the SNARE dependent fusion 
process. Munc18c is known to sequester the SNARE associating protein, 
syntaxin-4, in an insulin-dependent manner, preventing syntaxin-4 interacting 
with VAMP2 thereby decreasing GLUT4 vesicle docking/fusion (Thurmond et al., 
1998; Thurmond et al., 2000). Noc2 has not been shown to interact with 
Munc18c or any SM protein as such; an interaction with Munc18c in relation to 
GLUT4 trafficking will be novel. Interestingly, another SM protein, Munc18-1 has 
been shown to interact with the Rab3/Rab27 effector granuphilin and Rab27 to 
mediate exocytosis (Gomi et al., 2005; Tsuboi and Fukuda, 2006). The ability of 
SM proteins to interact with exocytic Rabs and their effectors make them strong 
candidates to further explore Rab3-mediated GLUT4 trafficking. 
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Rabs are known to facilitate vesicle movement via the cell cytoskeleton. Myosin-
5A was characterised as a Rab10 partner in GLUT4 vesicle delivery to the 
plasma membrane in 3T3-L1 adipocytes (Chen et al., 2012). Myosin-5A is a well-
known Rab27 associating protein that transports melanosomes along actin 
filaments (Hume et al., 2001). Movement of myosins along the actin cytoskeleton 
is facilitated by myosin ATPase activity, or by calcium influx in a calmodulin 
dependent fashion (Holman and Sakamoto, 2008). The trigger of ATPase activity 
and calcium influx could well be mediated by insulin (Leto and Saltiel, 2012; Yip et 
al., 2008). A recent study showed that Rab3 family members too can interact with 
Myosin-5A (Lindsay et al., 2013) and hence a Rab3-Myosin-5A interaction in 
GLUT4 traffic is plausible in rat adipocytes. 
 
Vesicle trafficking involves coordination with a number of signalling molecules.   
Insulin signalling in particular requires a constant supply of lipid secondary 
messengers called phosphoinositides. Hence, there is bound to be some overlap 
between Rabs and phosphoinositides along routinely trafficking vesicles. 
However, the overlap between the two does seem to be more than more than 
just a mere coexistence of these molecules on the same vesicles. It has been 
found that some Rabs and phosphoinositides share the same effector molecules 
as well. This crosstalk or coincidence detection between Rabs and 
phosphoinositides could be useful in uncovering potential Rab effectors (Jean 
and Kiger, 2012). A common example is that of Rab5 and PI 3K, which together 
regulate PtdIns(3)P levels (described in Introduction 1.5.7). Insulin activates 
Rab5 by recruiting a GEF and this leads to Rab5 being GTP-bound. It is this 
Rab5, activated in this manner by its GEF, that that was shown to regulate 
PtdIns(3)P production (Lodhi et al., 2008). PtdIns(3)P, together with Rab5, 
facilitates endosomal maturation (Lawe et al., 2002). Another Rab3 effector, 
Rabphilin-3A, binds to PtdIns(4,5)P2 via its C2 domains and this interaction could 
help accurate targeting of Rabphilin-3A to membranes/vesicles along the actin 
cytoskeleton (Montaville et al., 2008). Similarly, the Rab3 effector, granuphilin 
has C2 domains that show an affinity for PM lipids PtdIns(4,5)P2 and 
PtdIns(3,4,5)P3. These lipids are likely to assist in granuphilin insertion at the PM 
(Lyakhova and Knight, 2013). Rabs, effectors and phosphoinositides hence 
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coordinate in membrane recognition and studying them together may add to the 
larger picture of homeostatic regulation of trafficking at the subcellular level (Jean 
and Kiger, 2012).  
 
The study in this thesis also demonstrated GLUT4 trafficking through an ESCRT-
III-dependent sorting compartment. This finding leads to questions that concern 
the amount of GLUT4 that may be degraded via the ESCRT endocytic pathway in 
comparison to the amount that may actually be recycled back to the plasma 
membrane or to GLUT4 storage/reserve pools. Could ubiquitin-related, GLUT4 
associating proteins such as Ubc9 and TUG be recruited to an ESCRT-GLUT4 
compartment? Ubc9 is shown to be a regulator of turnover in GLUT4 storage 
pools (Liu et al., 2007). TUG is a tether that can be cleaved off from GLUT4, 
facilitating GLUT4 translocation to the plasma membrane (Bogan et al., 2012b). 
Ubc9/TUG may direct GLUT4 to reserve/storage pools such that the necessary 
Rabs and/or priming/fusion markers (like VAMP2) can be recruited to recycle 




Figure 6.1: Proposed mode of action of Noc2 in regulating GLUT4 trafficking in 
adipocytes. Noc2 contains a zinc finger FYVE-related domain and this domain is known 
to interact with PtdIns(3)P (reviewed in Stenmark and Aasland, 1999). In the basal state, 
Noc2 may be anchored to the PM by a phosphoinositide or another PM-interacting 
protein. Rab3B is possibly bound to Noc2 at the PM. Rab3-GAP could be a GAP that 
maintains Rab3B in the inactive GDP-bound state. A Noc2-Rab3B complex may 
contribute to Noc2 overexpression showing a decrease in GLUT4 translocation (Fig. 5.9). 
Insulin stimulation causes Noc2 removal from the PM (Fig. 5.8) and a cytosolic protein 
may sequester Noc2. Rab3B is GTP-loaded upon insulin stimulation and binds to GLUT4 
vesicles facilitating GLUT4 trafficking (manuscript in prep. and Fig. 4.5). Rabs work in 
concert with effectors to facilitate vesicle trafficking. A currently yet unidentified Rab3 
effector may be involved in GLUT4 vesicle exocytosis upon insulin stimulation.  
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6.2 Final conclusions 
 
GLUT4 trafficking is a dynamic process. Different interacting proteins are 
recruited at distinct stages of GLUT4 vesicle transport. The studies on Rabs have 
gained momentum in recent years. This interest in Rabs is due to their ability to 
mediate GLUT4 trafficking and ultimately affect the rate of glucose transport into 
insulin-responsive tissues. Chapters 4 and 5 in this thesis described the 
examination of the role of Rab3B and its effector Noc2 in regulating GLUT4 
exocytosis. To understand whether Rab3 or Noc2 participates in the final stages 
of GLUT4 translocation, we would need to understand whether vesicle fusion 
proteins interact with Rab3 or Noc2. This would entail protein-protein interaction 
studies (such as pull-down assays) between Rab3 or Noc2 and plasma 
membrane phospholipid-binding proteins (such as C2-domain containing 
proteins) that facilitate or constitute SNARE-mediated vesicle fusion. 
Alternatively, to mimic conditions in a cell in vitro, a coflotation assay can be used 
described previously by Yu et al. (2013) that showed an interaction between 
Doc2b and the SNARE complex. In this assay, SNARE components are 
reconstituted into liposomes and can be incubated with a Rab or its effector; the 
incubation is followed by density gradient centrifugation. The protein that 
interacts with the SNARE liposome, complexes with it and is detected at the top 
of the gradient (Yu et al., 2013).  
 
The data in Chapter 3 of this thesis showed that the ESCRT pathway is involved 
in regulating GLUT4 trafficking. A further examination of the fate of endocytosed 
GLUT4 will be required as an important part of the further understanding of the 
GLUT4 trafficking process. GLUT4 is known to sort to storage/reserve/recycling 
pools or undergo retrograde trafficking to the plasma membrane via the TGN. 
Consideration of how this retrograde trafficking system fits within the ESCRT 
pathway and which proteins ‘route’ GLUT4 away from a degradative fate will lead 
to a more detailed endocytic GLUT4 trafficking map. Deubiquitinases (or DUBs) 
are good candidate proteins that should be considered for further investigation. 
Studies could investigate how GLUT4 degradation can be prevented such that 
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more GLUT4 is available for recycling and for replenishing GLUT4 that has 
become depleted at the plasma membrane. 
 
Future work will hence focus on identifying novel proteins that are activated upon 
insulin stimulation. In order to identify interacting proteins in the ESCRT system 
or to identify Rab effectors, the yeast two-hybrid (Y2H) system is a good tool that 
could be employed. The Y2H system can be explored by utilising a rat adipocyte 
library to screen for effectors of currently identified Rabs (3B, 4, 5, 8A, 10, 11, 13, 
14, 31, 35) involved in GLUT4 traffic or to identify novel binding partners of 
GLUT4 in the ESCRT pathway. The known Rab or ESCRT component called the 
‘bait’ protein can be inserted in a yeast vector and screened against an adipocyte 
library of ‘prey’ proteins to identify which proteins interact with the bait. Clontech’s 
Matchmaker® Gold Y2H system is one of the commercially available tools that 
uses mating between a haploid yeast bait strain and a haploid yeast library strain 
to produce a diploid yeast cell yielding a bait-prey interaction. The Matchmaker® 
system can be used to identify as well as confirm novel protein-protein 
interactions by using different amino acid selection media. Proteins identified by 
the Y2H method, or an alternative approach, can be studied to see if they 
ultimately affect GLUT4 trafficking to the PM. Monitoring of GLUT4 trafficking to 
the PM can be accomplished using either the HA-GLUT4 translocation assay 
described in this thesis or alternatively an assay that utilises a fluorescent pH 
sensitive probe attached to GLUT4 vesicles. The probe called pHluorin 
(Miesenböck et al., 1998) is attached to IRAP on the GLUT4 vesicle and 
produces fluorescence when the acidic lumen of the vesicle fuses with the 
plasma membrane and is exposed to a neutral environment. Such a pH sensitive 
probe could be used to study GLUT4 vesicle fusion with the plasma membrane 
as well. Changes in fluorescence at the plasma membrane could be monitored 
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Gene/Target Vector Cloning primers 5’ – 3’ 
Rab3B pcDNA3.1 CAAGGATCCGAGATGGCCTCAGTAAC (sense); 
CAGCTCGAGCTAGCAAGAGCAGTT C (antisense) 
Rab3B Q8L pcDNA3.1 ACACGGCAGGGCTAGAGCGATATCG (sense); 
CGATATCGCTCTAGCCCTGCCGTGT (antisense) 
Rab3B T36N pcDNA3.1 GCAGCGTCGGGAAGAACTCCTTCCTTTTCCG (sense); 
CGGAAAAGGAAGGAGTTCTTCCCGACGCTGC 
(antisense) 
Noc2  pHM6 CGCACGAAGCTTTATGGCTGACACCATCT (sense); 
TGAATGCGGCCGCTCAGTAATGGGTAG (antisense) 




Noc2 pGEX4T-1 CGCATCGAATCCATGGCTGACACCATC (sense); 
GCAGCCCTCGAGTCAGTAATGGGTAG (antisense) 
Noc2 p3XFLAG GCCGCGAAGCTTATGGCTGACACCATCTT (sense); 
GTGCCGGATCCTCAGTAATGGGTAGTTGCC (antisense) 
Noc2 pAT109 CGGCGGGATCCATGGCTGACACCATCTT (sense); 
GCCGGGGTACCGTAATGGGTAGTTGCC (antisense) 
Noc2 pMAL-c2 CGGCGGGATCCATGGCTGACACCATCTT (sense); 
GCAGCCCTCGAGTCAGTAATGGGTAG (antisense) 
 
S1: Primers designed for cloning. The table shows the list of primers designed for cloning the Rab3B and 
Noc2 genes in the different vectors. Rattus norvegicus gene sequences were obtained from NCBI. Primers 
were designed using Northwestern University’s OigoCalc software to calculate the Tm and identify any 
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S2: Primers selected for qPCR study. The table shows the list of primers selected for quantitating 
the amount of cDNA of the desired genes. Primer gene IDs correspond to NCBI’s reference 
sequence ID or Genbank ID, both of which are searchable in NCBI. Two sets of primers were 
designed and validated in tissues that expressed the desired gene (Materials and Methods 2.2.2.5). 
The selected primers were checked for primer efficiency, self-complementarity and the ability to 









S3: Sequencing results of the Noc2AAA construct. Following site directed mutagenesis, the Noc2 
AAA construct was sequenced to confirm correct insertion of the triple alanine residues. The figure 
shows the (shaded) primer for generating the mutant using the wild type Noc2 sequence as a 











S4: Validation of Rab3 and Noc2 primers in rat tissues. mRNA from rat tissues was isolated 
using the TRIzol®-chloroform method. cDNA was generated by reverse transcription and 5 ng of 
cDNA was tested using a qPCR approach to quantify gene expression levels. cDNA was 
prepared as described in Materials and Methods 2.2.2.3. Primers for quantitating the cDNA levels 
of Rab3 were validated in rat brain (A) while for Noc2, primers were validated in rat testes and 








S5: Tissue qPCR profile of Rab3 effectors. mRNA from rat tissues was isolated using the 
TRIzol®-chloroform method. cDNA was generated by reverse transcription and 5 ng of cDNA was 
tested using a qPCR approach to quantify gene expression levels. cDNA was prepared as 
described in Materials and Methods 2.2.2.3. A qPCR profile was generated using a number of rat 
tissues. Potential Rab3 effectors were analysed with primers listed in Supplementary table S2. 
Rab27, which was previously been shown by others to co-exist with Rab3 in a number of tissues, 








S6:  Expression and purification of MBP-Noc2. MBP-Noc2 was cloned into the pMAL-c2 
bacterial gene expression system. The cloned construct was verified by sequencing. For 
expression of the MBP-Noc2, the construct was transformed into E.coli TB1 cells. Expression of 
the fusion protein was induced with 0.3 mM IPTG (final) and carried out at room temperature for 3 
h. Purification was done using an amylose resin (beads). The figure A shows a western blot with 
the different stages of expression and purification. The western blot was probed with an anti-MBP 
antibody which identified MBP-Noc2 at ~70 kDa (A). MBP-Noc2 was quantified on a 10% SDS-
PAGE coomassie gel using BSA standards (B) to yield 10 µg of MBP-Noc2 per 50 µl of resin 







S7: Structure of GTP photolabels. Bio-ATB-GTP is substituted on the ribose hydroxyls 
2/3-OH with both the photolabelling diazirine group and a biotin moiety (A). Azidoanilide-
GTP biotin-hydrozone is substituted in the terminal phosphate of oxidized GTP with a 
photolabelling azide group while the biotin moiety is substituted onto the ribose aldehydes 
from oxidation to form biotin hydrazones (B) (the structure is re-drawn from reference 
Schwenk et al 2007). 
GLUT4 Traffic through an ESCRT-III-Dependent Sorting
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Abstract
In insulin target tissues, GLUT4 is known to traffic through multiple compartments that may involve ubiquitin- and/or
SUMO-dependent targeting. During these trafficking steps, GLUT4 is sorted into a storage reservoir compartment that is
acutely released by insulin signalling processes that are downstream of PI 3-kinase associated changes in inositol
phospholipids. As ESCRT components have recently been found to influence cellular sorting processes that are related to
changes in both ubiquitination and inositol phospholipids, we have examined whether GLUT4 traffic is routed through
ESCRT dependent sorting steps. Introduction of the dominant negative inhibitory constructs of the ESCRT-III components
CHMP3 (CHMP3(1–179)) and Vps4 (GFP-Vps4E235Q) into rat adipocytes leads to the accumulation of GLUT4 in large,
coalesced and extended vesicles structures that co-localise with the inhibitory constructs over large parts of the extended
structure. A new swollen hybrid and extensively ubiquitinated compartment is produced in which GLUT4 co-localises more
extensively with the endosomal markers including EEA1 and transferrin receptors but also with the TGN marker syntaxin6.
These perturbations are associated with failure of insulin action on GLUT4 traffic to the cell surface and suggest impairment
in an ESCRT-dependent sorting step used for GLUT4 traffic to its specialised reservoir compartment.
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Introduction
The Endosomal Sorting Complex Required for Transport
(ESCRT) is essential for membrane compartment and membrane
protein organisation [1]. ESCRT proteins are conserved in
organisms ranging from archaea to eukaryotes where they fulfil
a range of diverse roles [1,2]. The ESCRT system has been
implicated in processes that include lysosome biogenesis via
multivesicular body (MVB) formation [3], cytokinesis [4,5],
enveloped virus budding [6] and autophagy [7]. A common
functional role for the protein components of the system is the
deformation of membrane lipids and the generation of invaginated
membrane structures including membrane tubes, buds and
multivesicular endosomes (MVE) [1]. The complexes are also
involved in membrane protein sorting and with selection of cargo
membrane proteins for degradation, recycling to the plasma
membrane or the trans-Golgi network (TGN).
The four ESCRT complexes include ESCRT-0, ESCRT-I,
ESCRT-II and ESCRT-III which are recruited sequentially to
membranes, particularly membranes of the endosome system
that are rich in phosphatidylinositol 3-phosphate (PI(3)P).
Components of ESCRT-0 have ubiquitin interacting motifs
(UIM) and ubiquitin binding domains (VHS) and these are
thought to facilitate the gathering of ubiquitinated cargo proteins
into membrane patches [8]. ESCRT-I and ESCRT-II continue
the process of concentrating membrane proteins while Charged
Multivesicular Body Protein (CHMP) components of ESCRT-III
allow membrane sorting and membrane deformation. The
CHMP proteins of ESCRT-III include CHMP4, CHMP3 and
CHMP2. These proteins can be autoinhibited through interac-
tions between their N- and C-terminal domains [9,10]. Removal
of this autoinhibition allows the separate roles of the N- and C-
termini to be manifest [11]. C-terminal regions of both CHMP3
and CHMP4 bind the ESCRT-III regulator Vps4 [12] and the
de-ubiquitinating hydrolases (DUBs) including AMSH [9,13].
The CHMP protein positively charged N-terminal regions
interact with negatively charged phosphoinositides including
phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) and this associ-
ation may allow a number of specific lipid targeting processes
[11,14].
ESCRT dependent selection of cargo appears to be associated
with ubiquitination cycles involving ubiquitin ligases and DUBs
[15,16] (including AMSH and USP8 in mammals [13]). Similar
considerations probably apply to the handling of SUMOylated
cargos, including Top1, by ESCRT proteins [17], but this has
not been widely studied. The sorting role for ubiquitin-like
domains in GLUT4 traffic is beginning to emerge from recent
studies [18–22] but the possibility of ESCRT-dependent sorting
of the tagged GLUT4 has not been previously addressed. Here
we provide evidence that GLUT4 is routed through an ESCRT
compartment in insulin-target cells and that perturbation of this
traffic leads to a failure of GLUT4 to reach its normal
intracellular storage vesicle compartment (GSVs) and by an
inability of GLUT4 to be recruited to the cell surface upon
insulin stimulation.
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Materials and Methods
DNA constructs
pCis2 HA-GLUT4 was a gift from Dr. Samuel Cushman and
has been described previously [23]. pEGFP-C1-VPS4, pEGFP-
C1-VPS4E235Q and pEGFP-N1-CHMP31–179 constructs have
been described previously [5,11].
Antibodies
Rabbit polyclonal GLUT4 antibody was raised against a
GLUT4 C-terminal peptide [24]. Mouse anti HA antibody (Clone
16B12) was purchased from Covance, mouse anti-EEA1 antibody
from BD Biosciences, mouse anti-Ubiquitin antibody (Clone FK2)
from BIOMOL, mouse anti-Syntaxin 6 antibody from BD
Biosciences and mouse anti-Transferrin receptor (TfR) antibody
from Zymed. AlexaFluor 546 conjugated goat anti-mouse IgG and
Alexa Fluor 633 conjugated goat anti-rabbit IgG were from
Molecular Probes. Mouse IgG secondary antibody b-galactosidase
conjugate was from SouthernBiotech.
Isolation of primary rat adipocytes
Adipose cells from epididymal fat pads of male Wistar rats,
weighing 180–200 g, were prepared by collagenase digestion as
described previously [25]. Cells were maintained at 37uC in
Krebs-Ringer-HEPES (KRH) buffer (140 mM NaCl, 4.7 mM
KCl, 2.5 mM CaCl2, 1.25 mM MgSO4, 2.5 mM NaH2PO4,
10 mM HEPES, (pH 7.4)) with 1% (w/v) bovine serum albumin
(BSA) and 200 nM adenosine. Before transfection the cells were
washed twice with DMEM supplemented with 200 nM adenosine
and brought to a 50% cytocrit.
Adipocyte transfection
Rat adipocytes were electroporated with pCis2 HA-GLUT4
alone or together with pEGFP-VPS4, pEGFP-VPS4E235Q or
pEGFP-CHMP31–179 according to the method described by Al-
Hasani et al. [23]. Briefly, 200 ml of 50 % cytocrit rat adipocytes
were added to 200 ml of DMEM containing 100 mg of carrier
DNA (hearing sperm DNA, Promega) and 0.1 mg of pCis2 HA-
GLUT4 alone or together with 0.8 mg of pEGFP-VPS4, pEGFP-
VPS4E235Q or pEGFP-CHMP31–179. The amounts of HA-
GLUT4 and inhibitory construct cDNA were optimised as
described [23]. Electroporation was carried out using the BioRad
Gene pulser with a capacitance extender attached in 0.4-cm gap-
width cuvettes (Bio-Rad). Each cuvette was electroporated once at
400 V, 500 mF. Cells from 4 to 5 cuvettes were pooled together,
washed once with DMEM supplemented with 200 nM adenosine
and then resuspended in DMEM supplemented with 3.5 % BSA
and 200 nM adenosine. The transfected adipocytes were incubat-
ed for 5 h at 37uC. After washing in KRH buffer supplemented
with 1% BSA and 200 nM adenosine cells were left un-stimulated
or stimulated with 60 nM insulin for 20 min at 37uC. Using the
above described electroporation conditions we obtained 20 to 25
% transfection efficiency as estimated by examining the cells by
fluorescent microscopy and recording GFP positive cells.
Determination of HA-GLUT4 antibody binding
Transfected rat adipocytes, left un-stimulated or stimulated with
60 nM insulin, were incubated in presence of 2 mM KCN for
3 min to stop GLUT4 recycling. Cells were then incubated with
1 mg/ml anti-HA antibody in Krebs-Ringer-HEPES buffer
supplemented with 5% BSA and 200 nM adenosine for 1 h at
room temperature with occasional mixing. After three washes in
Krebs-Ringer-HEPES buffer supplemented with 5% BSA and
200 nM adenosine, adipocytes were incubated with 1 mg/ml anti-
mouse IgG secondary antibody b-galactosidase conjugate. Cells
were then washed in Krebs-Ringer-HEPES buffer supplemented
with 200 nM adenosine 4 times and 10 ml of cell suspension were
added in quadruplicated in black 96 well plates (Fluotrac 200,
Greiner). Fluorescein digalactosidase (FDG) at a final concentra-
tion of 0.1 mM in Krebs-Ringer-HEPES buffer was added to each
well. The rates of fluorescence generated per mg protein were then
determined from measurements (for an hour at 15 sec intervals) in
a Pherastar (FS) fluorescent plate reader (BMG) at 520 nm. An
aliquot of cells from each condition was analyzed by immuno-
blotting to assess and normalize for the level of expression of HA-
GLUT4 cDNA.
Indirect immunofluorescence microscopy
Stimulated adipocytes were fixed by incubation with 4% (w/v)
paraformaldehyde in KRH buffer for 20 min at room tempera-
ture, and washed 3 times with PBS. Cells were then treated with
permeabilisation buffer (0.1% saponin, 1% (w/v) BSA, 3% (v/v)
goat serum in PBS) for 45 min. The co-localisation of the EGFP
tagged constructs with GLUT4 and cell organelle markers was
determined in adipocytes that were incubated with primary
antibodies diluted in permeabilisation buffer overnight at 22uC.
The primary antibodies were used at the following dilutions: rabbit
anti GLUT4 antibody (1:1000), mouse anti HA antibody (1:500),
mouse anti-EEA1 antibody (1:250), mouse anti-Ubiquitin anti-
body (1:400), mouse anti-Syntaxin 6 antibody (1:200) and mouse
anti-Transferrin receptor antibody (1:100). 18 hours later, the cells
were washed in permeabilisation buffer, incubated with species-
specific fluorophore conjugated secondary antibodies (1:300
dilution) for 2 h at room temperature with a final wash step in
permeabilisation buffer. Cells were mounted onto a glass coverslip
with Vectashield mounting medium (Vector Laboratories).
Confocal microscopy was performed on a Zeiss LSM 510
META microscope with 6361.4 NA oil-immersion objective and
with dual or triple laser excitation at 458–488, 543 and 633 nm.
Images (10246942) of individual cells were saved as TIFF files
using the Zeiss LSM Image analysis software and intensity levels of
the individual channels were adjusted to comparable dynamic
range [26] in Adobe Photoshop.
To measure the extent of enlargement of vesicles in which the
fluorescent signals from EGFP-VPS4E235Q, endogenous GLUT4
and endosomal markers co-localised, individual cells were
analysed with the Measure tool in the ImageJ National Institute
of Health software (http://imagej.nih.gov/ij/). Individual en-
larged vesicles with a visible lumen were selected using the circular
tool to define the regions of interest and the areas (in pixels) of
these structures were then determined. As a control, the areas of
vesicles positive for GLUT4 or for ubiquitin or for the endosomal
markers in cells transfected with pEGFP-Vps4 were measured. On
average 5 to 10 enlarged structures and 15 to 20 control structures
were measured per cell. Data were presented as average values
from 10 to 14 individual cells. Statistical significance was
calculated using two-tailed unpaired t-test. P values of less than
0.05 were considered significant.
Results
ESCRT-III constructs inhibit insulin-stimulated HA-GLUT4
translocation in rat adipocytes
We have used two ESCRT constructs to investigate the
dependence of GLUT4 translocation on movement through the
ESCRT pathway in insulin-stimulated adipocytes. The first
construct encodes the N-terminal portion of CHMP3, amino
acids 1 to 179. We have previously developed this N-terminal
ESCRT-Dependent GLUT4 Traffic
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construct as a dominant negative inhibitor of ESCRT-III function
[5]. The construct has an open conformation and is not
autoinhibited by the C-terminal domain. This construct has been
shown to bind to membranes and to induce an enlarged
endosomal compartment. The second construct, GFP-Vps4E235Q,
encodes the dominant-negative mutant of the AAA ATPase Vps4
which is deficient in ATPase activity, and consequently stops the
disassembly of the ESCRT-III components. The usual cellular
change induced by this construct includes the generation of
enlarged endosomal vesicles.
EGFP versions of these constructs were co-transfected into
primary rat adipocytes together with HA-tagged GLUT4 [23]
used as a reporter. The effects of GFP-Vps4E235Q and CHMP31–
179GFP on insulin-stimulated GLUT4 translocation were followed
by measuring the amount of HA-tag present at the surface of
intact cells. Both constructs decreased insulin-stimulated GLUT4
translocation by 70–80% without significantly affecting the basal
levels of GLUT4 present at the cell surface (Figure 1A). Expression
of the wild-type GFP-Vps4 construct had no effect on insulin-
stimulated HA-GLUT4 translocation to the cell surface. Wild-type
CHMP3-GFP could not be used as a control in this experiments as
over-expression of the wild-type protein has been reported to
induce an enlarged phenotype [27]. Immunoblotting analysis
indicated that the HA-GLUT4 was expressed to a similar level in
all conditions and that co-expression of the GFP-tagged ESCRT
constructs did not affect the level of expression of the HA tagged
GLUT4 (Figure 1B).
Localisation studies (Figure 2) revealed that the dominant
negative, but not the wild-type, GFP-Vps constructs generate a
distinct GFP-positive punctate staining of enlarged and swollen
structures throughout the cell. In the absence of the dominant
negative constructs GLUT4 is distributed widely and most of the
GLUT4 is present in small punctuate spots. This is typical of
mature rat fat cell GLUT4 [28], but typically GLUT4 distribution
in the adipose cell line 3T3-L1 is a mixture of dispersed vesicular
structures and a larger perinuclear compartment. Following the
perturbation of ESCRT-III, much of the HA-GLUT4 became
localised to enlarged coalesced-vesicular structures which partially
co-localised with the ESCRT proteins. The extent of co-
localisation of GLUT4 and the GFP-Vps4E235Q in the enlarged
vesicular structures was variable and in many cases these two
proteins appeared to be localised to the same swollen structures
but to non-overlapping and distinct sub-regions of these structures
(Figure 2).
As CHMP3 (and possibly other ESCRT components) interact
with PI(3,5)P2 [11] we have examined whether inhibition of
PI(3,5)P2 production with the PIKfyve inhibitor YM201636 also
reduces the insulin-stimulated translocation of HA-GLUT4 to the
cell surface of adipocytes. YM201636 at concentrations previously
reported to inhibit PIKyve [29] significantly inhibit translocation
of GLUT4 (Figure 1 C, D). However, we did not observe (data not
shown) the formation of an enlarged compartment comparable
with that observed following introduction of Vps4E235Q and
CHMP31–179.
ESCRT-III perturbation induces the formation of a hybrid
compartment
In the absence of ESCRT-III perturbation and in basal cells,
endosome marker experiments indicate that GLUT4 is seques-
tered in a cellular compartment in which there is extensive co-
localisation with Syntaxin6. Syntaxin6 localisation defines a TGN-
like compartment but is distinct from compartments in which TfR
and EEA1 are highly localised (Figure 3A). Following insulin
stimulation of these cells GLUT4 becomes more localised at the
cell surface and just below it (Figure 3B). These observations are
consistent with previous studies on rat fat cells [28,30–32].
Following the expression of the GFP-Vps4E235Q construct
GLUT4 becomes more extensively localised with the syntaxin6,
EEA1 and transferrin receptor in the swollen ESCRT-III
compartment (Figure 3 C,D). This suggests the formation of a
hybrid compartments in which there is merging, or lack of sorting,
of distinct endosome and TGN protein components. Under these
conditions, there are no significant differences between basal and
insulin-stimulated cells in the distributions of syntaxin6, EEA1 or
transferrin receptors.
In the absence of ESCRT-III perturbation the levels of co-
localisation of GLUT4 and ubiquitin are low (Figure 3 A,B). This
is partly a consequence of low and indistinct signal from the
cytosol and small membrane particles. The extent to which
ubiquitinated proteins cluster on enlarged membrane structures is
increased in the presence of the GFP-Vps4E235Q and there is also
increased co-localisation with GLUT4 and the co-associated
markers that reveal a hybrid endosome-TGN compartment
(Figure 3 C,D). Analysis of individual cells positive for the GFP-
Vps4E235Q signal revealed that on average 7.6960.60 enlarged
vesicles with a visible lumen and positive for GFP-Vps4E235Q,
GLUT4, ubiquitin or the endosomal/TGN markers were detected
in the perinuclear region of non-stimulated cells. Similarly, in
insulin-stimulated cells positive for GFP-VpsE235Q 7.3760.56
enlarged vesicles were observed per cell. The relative areas of
these enlarged structures were determined with the Measure tool
in the ImageJ software. This analysis revealed a 10-fold increase in
the pixel areas of the enlarged structures compared to the control
structures (Table 1). No differences were observed in the sizes of
the enlarged structures in comparing un-stimulated with insulin-
stimulated cells. Using the area measurement tool in the LSM
imaging software the areas of the enlarged compartments in basal
or insulin-stimulated cells were estimated to be 14.0061.74 mm2
and 18.0461.79 mm2 respectively (Table 1). The areas of control
vesicles could not be accurately calculated because of the limits of
light microscopy resolution. The average diameter of the hybrid
structures was 2.4060.14 mm for unstimulated and 2.7160.18 mm
for insulin-stimulated cells.
In order to determine if extended expression of the ESCRT-III
construct would further affect GLUT4 distribution we compared
rat adipocytes expressing GFP-Vps4 or GFP-Vps4E235Q for 5 h or
24 h. Immunoblot analysis revealed an increase expression of
GFP-Vps4 and GFP-Vps4E235Q after 24 h expression (Figure 4A).
Immunofluorescent analysis revealed that after 24 h expression,
GLUT4 and ubiquitin colocalise extensively with the increased
GFP-Vps4E235Q (Figure 4B). The distribution of GLUT4 is very
similar to that observed after 5 h expression. We conclude that
GLUT4 is completely trapped in the enlarged endosomal
compartment by the 5 h treatment. As the onset of the trapping
is relatively rapid we cannot make an inference as to whether
GLUT4 is first moved to the PM before transit to a sorting hub for
generation of GSV.
Discussion
GLUT4 proteins are sorted to insulin-responsive GLUT4
storage vesicles from which they are released to the cell surface
upon insulin stimulation. The signals involved in sorting GLUT4
to GSV’s are complex and various intracellular trafficking
itineraries have been proposed [33]. However, the involvement
of an ESCRT-dependent step in this traffic has not been
previously considered. We report here that perturbations of the
ESCRT machinery result in reduced levels of GLUT4 transloca-
ESCRT-Dependent GLUT4 Traffic
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tion to the plasma membrane in response to insulin. Furthermore,
we show that disrupting the function of the ESCRT machinery
leads to extensive accumulation of GLUT4 on intracellular
membranes containing endosomal markers and the TGN marker
syntaxin6 suggesting an accumulation in a hybrid enlarged tubulo-
and multivesicular compartment. This suggests that a large
proportion of GLUT4 is trapped by ESCRT perturbation and is
unable to gain access to an insulin-responsive compartment. In
comparison with unperturbed GLUT4 intracellular vesicle com-
partments, the enlarged GLUT4 compartment produced by
ESCRT perturbation is highly enriched in ubiquitinated proteins.
This suggests that, like other cargos that are routed through
multivesicular endosomes, GLUT4 may undergo changes in
tagging with ubiquitin-like domains or associate with chaperone
proteins that are ubiquitin tagged [8].
Insulin action in adipocytes is highly dependent on inositol lipid
signalling and perturbations in the levels of the phosphatidyl-
inositides, mainly phosphatidylinositol 3,4,5-trisphosphate (PIP3),
have been shown to be associated with formation of extended,
enlarged and vacuolated GLUT4 compartments [34]. Studies on
insulin-regulated GLUT4 traffic have led to the well-supported
proposal that signalling is mediated through activation of Class1A
PI 3-kinases and increases in PIP3. However, levels of PI(3,5)P2
are also increased by insulin signalling via activation of Class2 and
Class3 PI 3-kinases to produce PI(3)P and by activation of PIKfyve
[35–37]. It is therefore of note that ESCRT traffic is highly
Figure 1. ESCRT-III constructs lead to inhibition of GLUT4 translocation to the cell surface of rat adipose cells. (A) Primary rat
adipocytes were transfected by electroporation with pCis HA-GLUT4 and pEGFP VPS4, pEGFP VPS4E235Q or pEGFP CHMP31–179 and then maintained in
culture for 5 h. HA-GLUT4 at the cell surface was detected with anti-HA antibody and b-galactosidase conjugated secondary antibody. The signal was
measured with a fluorescent b-galactosidase substrate. Results are mean and SEM from 3 independent experiments. * p,0.05 (comparison of pCis
HA-GLUT4 only control vs. pCis HA-GLUT4 co-transfected with ESCRT-III pEGFP constructs). (B) Representative immunoblots for the levels of
expression of HA-GLUT4, EGFP-Vps4, EGFP-Vps4E235Q, CHMP31–179-EGFP and total GLUT4 in the transfected rat adipocytes. (C) The PIKfyve inhibitor
YM201636 decreases GLUT4 translocation to the cell surface in a dose dependent manner. Primary rat adipocytes were transfected by electroporation
with pCis HA-GLUT4 and then maintained in culture for 5 h. Cells were left untreated or incubated with 150 nM or 800 nM YM201636 for 30 min
prior to insulin stimulation. HA-GLUT4 at the cell surface was detected with anti-HA antibody and b-galactosidase conjugated secondary antibody.
The signal was measured with a fluorescent b-galactosidase substrate. Results are mean and SEM from 3 independent experiments. ** p,0.01
(comparison of Insulin stimulated control cells vs. YM201636 treated cells prior to insulin stimulation). (D) Representative immunoblots for the levels
of expression of HA-GLUT4 and total GLUT4 in the transfected rat adipocytes treated with YM201636.
doi:10.1371/journal.pone.0044141.g001
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dependent on CHMP3 which has been shown to bind inositol
lipids, particularly PI(3,5)P2. We observed inhibition of GLUT4
traffic following treatment with a PIKfyve inhibitor but we did not
observe a marked enlargement of endosomes. We cannot therefore
directly correlate the binding of CHMP3 to PI(3,5)P2 or to the
function of PIKfyve. An enlarged endosome phenotype does occur
in several other cell types following treatment with the PIKfyve
inhibitor [29,38]. By contrast, the morphological changes associ-
ated with inhibition of PIKfyve are generally not evident in
adipocytes [39]. Furthermore, the kinase dead PIKfyve mutant
does not induce an enlarged endosome phenotype in 3T3-L1
adipocytes [40]. This may mean that in adipocytes reduction in
PI(3,5)P2 alone is insufficient to fully perturb ESCRT function. It
will be of interest in future to determine the extent to which the
traffic of GLUT4 through the ESCRT compartment is dependent
on, or influenced by, insulin dependent changes in both PIP3 and
PI(3,5)P2. Similarly, silencing of CHMP3 with siRNA treatment
HeLa cells does not produce enlargement of endosomes and the
endosome enlargement effect is confined to the dominant negative
CHMP3 [41,42].
It has recently been reported that GLUT4 is ubiquitinated and
that this modification is necessary for its sorting into an insulin
responsive compartment [22]. However, only a very low
percentage (0.1%) of GLUT4 is reported to be ubiquitinated at
steady-state. In our studies, we were unable to detect this low level
of GLUT4 ubiquitination using immunoprecipitation of HA-
tagged GLUT4 followed by ubiquitin detection by western blot.
However, GLUT4 may associate with other proteins that may be
tagged with ubiquitin-like domains. The genesis of this compart-
ment is dependent on GGA adapters that bind to sortilin on the
GSVs. Additional proteins associated with this compartment
include TUG (Tether containing UBX domain for GLUT4). UBX
(ubiquitin associated) domains of TUG (which are similar in
structure to ubiquitin) are thought to retain the GSV and a
construct of the UBX domain can lead to release of the GSVs
from an intracellular storage location to the cell surface [43,44].
However, the mechanism by which insulin action leads to a
change in the GSV-TUG interaction is currently unknown. Direct
SUMOylation of GLUT4 has been reported to occur at quite high
levels [18,19,45]. In addition GLUT4 can associate with the Ubc9,
a SUMO conjugating enzyme [18] and with another SUMOy-
lated protein Daxx [19]. All these studies point towards a complex
array of processing of GLUT4 in conjunction with ubiquitin-
containing or ubiquitin-like protein domains and it will be of
interest in future to determine how much of this processing is
dependent on the ESCRT complexes.
Parallels have been drawn between the traffic of GLUT4 and
the yeast amino acid transporter Gap1p [22,46]. This protein
traffics between three main compartments, the TGN, the plasma
membrane and the vacuole. The Gap1p storage compartment is
associated with the TGN and residence in this compartment is
dependent on GGA and on ubiquitination. Under nitrogen
deficient conditions Gap1p is deubiquitinated and moves towards
the plasma membrane. Under nitrogen rich conditions the
ubiquitinated Gap1p is directed towards multivesicular endosomes
(MVEs) and to the vacuole for degradation as it is no longer
needed. In the case of GLUT4 it is proposed here that sequential
ubiquitination and deubiquitination of GLUT4 (or a GLUT4
vesicle associated protein) are required for directing GLUT4 to the
GSV compartment [22] rather than the plasma membrane (as in
the Gap1 case). This distinction probably occurs because insulin
action is required for movement from the GSV compartment to
the plasma membrane (Figure 5). The comparisons with the
Gap1p system [22,47,48] are relevant here as it has been
determined that amongst the yeast mutants that have defective
Gap1p traffic are ESCRT components including Vps24 (CHMP3)
and Vps4. In this case ESCRT mutants lead to reduced vacuole
targeting of Gap1p and increased traffic to the plasma membrane
[47,48]. Distinct roles of mono- and poly-ubiquitination have been
demonstrated in studies on ESCRT dependent traffic between
MVEs and the plasma membrane and between the TGN and the
MVEs, respectively [47].
GLUT4 that accumulates in the MVE upon ESCRT pertur-
bation may have previously entered from the plasma membrane or
trafficked to the MVE from the TGN. The latter route is more
consistent with the ubiquitin and GGA dependent sorting of
GLUT4 [22], but this route may require polyubiquitination [47].
GLUT4 is relatively stable protein with a half life of 48 hours in
3T3L1 adipocytes [49,50] and each GLUT4 molecule possibly
gains access to the plasma membrane and endosomes multiple
times before being eventually degraded, even in unstimulated cells
[51]. GLUT4 is now known to follow an unusual retrograde
trafficking route from endosomes to the TGN that involves the
Clathrin Heavy Chain CHC22 rather than CHC17 [26,52]. This
Figure 2. ESCRT-III constructs lead to swollen and extended GLUT4 compartments in rat adipose cells. Confocal microscopy
examination of primary rat adipocytes co-transfected with HA-GLUT4 (red) and EGFP-tagged Vps4 WT, Vps4E235Q or CHMP31–179 (green) and
stimulated with 60 nM insulin for 20 min. Cells were fixed with 4% paraformaldehyde, permeabilised in 0.1% saponin and immuno-stained with anti-
HA antibody and anti-mouse IgG-Alexa 633 secondary antibody. Images were acquired with LSM510 Meta confocal laser scanning microscope and
are from single adipose cells representative of the cell populations from at least three separate experiments. Bars 20 mm.
doi:10.1371/journal.pone.0044141.g002
ESCRT-Dependent GLUT4 Traffic
PLOS ONE | www.plosone.org 5 September 2012 | Volume 7 | Issue 9 | e44141
route is distinct from the early endosome to TGN pathway. The
CHC22 dependent step is downstream of the CHC17-dependent
early endosome sorting step suggesting that some cargos, such as
GLUT4, enter a ‘‘non-early’’ endosome compartment before
retrograde traffic to the TGN. CHC22 deletion interferes with this
step and causes GLUT4 loss, possibly due to GLUT4 degradation
[26]. Furthermore, knockdown of CHC22 causes some increased
tubulation of the GLUT4 [26] which is similar to the extended
and coalesced GLUT4 compartment reported here and illustrated
in a model form in Figure 5. GLUT4 may access this
Figure 3. ESCRT-III constructs lead to formation of a hybrid compartment in which endosomal markers co-localise with GLUT4. The
distribution of endogenous GLUT4 was detected with a rabbit polyclonal anti GLUT4 C-terminal peptide antibody. GLUT4 localization (red in merged
images) was compared with EEA1, ubiquitin, syntaxin6 and transferrin receptors (blue in merged images) using the antibodies described in the
Materials and Methods section. Endosomal marker distributions in the presence of non-perturbing wild-type GFP-Vps4 in the basal state (A) and the
insulin stimulated state (B). The EGFP-Vps4 is highly dispersed and is cytosolic under these conditions (not shown for clarity). Expression of the EGFP-
Vps4E235Q (green in merged images) leads GLUT4 vesicle coalescence to form swollen compartments. The endosomal markers EEA1, transferrin
receptors (TfR), syntaxin6 (Stx6) and ubiquitin (Ub) colocalise with both endogenous GLUT4 and with EGFP-Vps4E235Q both in the basal state (C) and
the insulin stimulated state (D). Images were acquired with LSM510 Meta confocal laser scanning microscope and are from single adipose cells
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compartment so that it can either be conserved by retrograde
traffic to the TGN-associated GSV compartment or alternatively
degraded by following an MVE to lysosome route. Consistent with
this possibility is the observation that residues close to the C-
terminal LL targeting signals on GLUT4 and Gap1p are similar,
but not identical, to those in the lysosome resident protein LIMPII
[53]. Mutation of GLUT4 in the vicinity of the LL motif can lead
to its traffic to the lysosome [53]. We envisage that the tubular-
vesicular MVE structures are an immature MVB (as described [3])
which acts as a hub or sorting station. This hub structure would
likely facilitate docking and fusion of incoming GLUT4 vesicles
with outward-facing topology and allow budding of vesicles with
cargos (such as GLUT4) not destined for degradation. Changes in
lipid domains within the same MVE could then be a platform for
ESCRT protein activity with production of an inward-facing
topology of membrane domains that leads to the degradation
route. Testing of the model described will require a dynamic and
kinetic analysis of movement between the proposed MVE
compartment and the GSV and plasma membrane compartments.
Membrane proteins such as EGFR and CXCR4 require
deubiquitination by DUBs prior to sorting into MVEs [54,55]
and the accumulation of ubiquitinated proteins suggests a failure
in the functional recruitment of DUBs to this compartment. Two
DUBs, AMSH and USP8 have both been shown to associate with
the ESCRT machinery via ESCRT-0 and ESCRT-III proteins
[56–59]. In the case of the interactions with ESCRT-III, both
DUBs contain MIT domains that interact with C-terminal MIT
interacting motifs (MIMs) of a number of ESCRT-III proteins
[60]. There is mounting evidence that spatial and temporal
Table 1. Enlargement of a coalesced tubulo-vesicular
structure in adipocytes treated with ESCRT-III constructs.
EGFP-Vps4 EGFP-Vps4E235Q
Basal Insulin Basal Insulin
Area
(pixels)
85.92624.11 131.5765.37 1411.616183.32*** 1448.526168.90***
Area
(mm2)
- - 14.0061.74 18.0461.80
Diameter
(mm)
- - 2.4060.14 2.7160.18
The areas of enlarged vesicular structures, with visible lumens and positive for
EGFP, GLUT4 and ubiquitin or the endosomal markers, were measured in pEGFP
VPS4E235Q and in wild-type pEGFP-Vps4 transfected adipocytes (as described in
the Materials and Methods section). Results are mean and SEM from 10 to 14
individual cells. *** p,0.001 (enlarged vs control vesicles). Only the large pixel
areas from the enlarged structures could be accurately converted to mm2.
doi:10.1371/journal.pone.0044141.t001
Figure 4. 24-hour expression of ESCRT-III constructs increases the intracellular accumulation of GLUT4 in a coalesced enlarged
compartment positive for ubiquitin. (A) Immunoblot analysis of the levels of expression of EGFP-Vps4 and EGFP-Vps4E235Q in rat adipocytes
transfected and maintained in culture for 5 h or 24 h. (B) Confocal microscopy examination of primary rat adipocytes transfected with EGFP-tagged
Vps4 WT or Vps4E235Q and maintained in culture for 24 h. Ubiquitin (Ub) colocalises with endogenous GLUT4 and with EGFP-Vps4E235Q after 24 h
expression in both basal and insulin-stimulated cells. Images were acquired with LSM510 Meta confocal laser scanning microscope and are from
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regulation of deubiquitination, rather than ubiquitination per se,
may be crucial in determining the fate of ubiquitinated proteins at
endosome, TGN and MVE sorting steps. For example AMSH and
USP8 can have very different effect on the sorting of ubiquitinated
membrane proteins. While AMSH is required for sorting of EGFR
into MVEs and degradation in lysosomes [61], deubiquitination of
EGFR by USP8 protects it from lysosomal degradation [54]. How
the ESCRT machinery is involved in regulating ESCRT related
DUB activity and alters the fate of cargo proteins needs to be
explored in further detail. We hypothesise that by functionally
disrupting the ESCRT machinery, and by interference with
deubiquitination of GLUT4 (or GLUT4 associated proteins), a
failure to sort GLUT4 to GSVs occurs (Figure 5 right panel). Both
of the dominant negative constructs used in this study could
interfere with the recruitment of MIT containing DUBs. The
truncated CHMP31–179GFP lacks its C-terminus which would
normally contain its MIT interacting motif (MIM) [61]. GFP-
Vps4E235Q contains an MIT domain that binds to MIMs on
ESCRT-III components [62]. This may prevent binding of MIT
containing DUBs as this mutated form of Vps4 cannot be released
from ESCRT-III due to defective ATPase activity. However, the
DUB family is very large and unidentified DUBs may influence
GLUT4 traffic during ESCRT-III sorting. It will be interesting to
determine whether knock down of levels of specific DUBs will
result in a failure of GLUT4 to sort to GSVs and thereby lead to
decreased levels of GLUT4 at the plasma membrane in response
to insulin. In addition, the possibility of ESCRT involvement in
the perturbation of GLUT4 traffic that occurs in insulin-resistant
cells remains to be explored.
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